<SEC-DOCUMENT>0001193125-21-145491.txt : 20210430
<SEC-HEADER>0001193125-21-145491.hdr.sgml : 20210430
<ACCEPTANCE-DATETIME>20210430170501
ACCESSION NUMBER:		0001193125-21-145491
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		7
CONFORMED PERIOD OF REPORT:	20210617
FILED AS OF DATE:		20210430
DATE AS OF CHANGE:		20210430

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BridgeBio Pharma, Inc.
		CENTRAL INDEX KEY:			0001743881
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38959
		FILM NUMBER:		21879429

	BUSINESS ADDRESS:	
		STREET 1:		421 KIPLING STREET
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94301
		BUSINESS PHONE:		(650) 391-9740

	MAIL ADDRESS:	
		STREET 1:		421 KIPLING STREET
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94301

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BridgeBio Pharma LLC
		DATE OF NAME CHANGE:	20180618
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>d131567ddef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<HTML><HEAD>
<TITLE>DEF 14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Proxy Statement Pursuant to Section 14(a) of the </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Securities Exchange Act of 1934 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by the
Registrant&nbsp;&nbsp;&#9746;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Filed by a Party other than the
Registrant&nbsp;&nbsp;&#9744;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="95%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Preliminary Proxy Statement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>Confidential, for Use of the Commission Only (as permitted by Rule <FONT STYLE="white-space:nowrap">14a-6(e)(2))</FONT></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Definitive Proxy Statement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Definitive Additional Materials</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Soliciting Material Under &#167;240.14a-12</TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:22pt; font-family:Times New Roman" ALIGN="center"><B>BridgeBio
Pharma, Inc. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Registrant as Specified In Its Charter) </B></P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
</B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment of Filing Fee (Check the appropriate box): </P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">No fee required.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title of each class of securities to which transaction applies:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Aggregate number of securities to which transaction applies:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule <FONT STYLE="white-space:nowrap">0-11</FONT>
(set forth the amount on which the filing fee is calculated and state how it was determined):</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Proposed maximum aggregate value of transaction:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(5)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Total fee paid:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Fee paid previously with preliminary materials.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Check box if any part of the fee is offset as provided by Exchange Act Rule <FONT STYLE="white-space:nowrap">0-11(a)(2)</FONT> and identify the filing for which the offsetting fee was paid previously. Identify the
previous filing by registration statement number, or the Form or Schedule and the date of its filing.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amount previously paid:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Form, Schedule or Registration Statement No.:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filing Party:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date Filed:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g131567g03d78.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>BridgeBio Pharma, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>421 Kipling Street </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Palo
Alto, CA </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>NOTICE OF ANNUAL MEETING OF STOCKHOLDERS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>To Be Held On June&nbsp;17, 2021 </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">Dear
Stockholder: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">You are cordially invited to attend the 2021 Annual Meeting of Stockholders (the &#147;Annual Meeting&#148;) of BridgeBio Pharma, Inc., a
Delaware corporation (the &#147;Company&#148;). The meeting will be held on Thursday, June&nbsp;17, 2021, at 9:00 a.m. local time. Our Board of Directors has determined, in the interests of public health and safety in light of the ongoing <FONT
STYLE="white-space:nowrap">COVID-19</FONT> pandemic, that this year&#146;s Annual Meeting will be held virtually via a live interactive audio webcast on the Internet. You will be able to vote and to ask questions of, and engage in dialogue with,
members of our Board of Directors and senior management at www.virtualshareholdermeeting.com/BBIO2021 during the meeting. Our Board of Directors intends to hold future stockholder meetings in person or using a &#147;hybrid&#148; <FONT
STYLE="white-space:nowrap">in-person</FONT> and virtual format as soon as practicable once it is safe to do so. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">The Annual Meeting will be held for the
following purposes: </P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">To elect three (3)&nbsp;directors, Eric Aguiar, M.D., Ali Satvat and Jennifer E. Cook, to serve as Class&nbsp;II
directors to hold office until the date of the annual meeting of stockholders following the year ending December&nbsp;31, 2023 and until their successors are duly elected and qualified, or until such director&#146;s earlier death, resignation or
removal. </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">To cast <FONT STYLE="white-space:nowrap">a&nbsp;non-binding,&nbsp;advisory</FONT> vote to approve the
compensation of our named executive officers. </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">To cast <FONT STYLE="white-space:nowrap">a&nbsp;non-binding,&nbsp;advisory</FONT> vote on the frequency of <FONT
STYLE="white-space:nowrap">future&nbsp;non-binding,&nbsp;advisory</FONT> votes to approve the compensation of our named executive officers. </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">To ratify the appointment of Deloitte&nbsp;&amp; Touche LLP as the independent registered public accounting firm
of the Company for its fiscal year ending December&nbsp;31, 2021. </P></TD></TR></TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">To transact such other business as may properly come before the meeting or any adjournment or postponement
thereof. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">These items of business are more fully described in the Proxy Statement accompanying this notice. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">Proposal 1 relates solely to the election of directors nominated by the Board of Directors and does not include any other matters relating to the election of
directors, including, without limitation, the election of directors nominated by any stockholder of the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">The Board of Directors has fixed the close
of business on Friday, May&nbsp;7, 2021, as the record date for the determination of stockholders entitled to notice of, and to vote at, the Annual Meeting, or at any adjournments of the Annual Meeting. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">In order to ensure your representation at the Annual Meeting, you are requested to submit your proxy over the Internet, by telephone or by signing and dating
the enclosed proxy as promptly as possible and returning it in the enclosed envelope (to which no postage need be affixed if mailed in the United States). If you virtually attend the Annual Meeting and electronically submit to the Secretary of the
Company an instrument revoking your proxy or a duly executed proxy bearing a later date, your proxy will not be used. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom">By Order of the Board of Directors</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="9"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom"><B>BridgeBio Pharma, Inc.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="9"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:9pt; font-family:Times New Roman">/s/ Neil Kumar</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom">Neil Kumar</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom"><I>Chief Executive Officer</I></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">Palo Alto, California </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">April
30, 2021 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><B>Your vote is important, whether or not you expect to attend the Annual Meeting. You are urged to vote either via the Internet or telephone, or
vote by mail by returning a signed and dated copy of the enclosed proxy card using the enclosed envelope. Voting promptly will help avoid the additional expense of further solicitation to assure a quorum at the meeting. </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc131567_1">PROXY STATEMENT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc131567_2">PROPOSAL <FONT STYLE="white-space:nowrap">1-ELECTION</FONT> OF
DIRECTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc131567_6">EXECUTIVE OFFICERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc131567_7">EXECUTIVE COMPENSATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc131567_8">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc131567_9">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED
 STOCKHOLDER MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc131567_10">DELINQUENT SECTION 16(A) REPORTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc131567_3">PROPOSAL <FONT STYLE="white-space:nowrap">2-NON-BINDING</FONT> ADVISORY VOTE
 TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc131567_4">PROPOSAL <FONT STYLE="white-space:nowrap">3-NON-BINDING,</FONT> ADVISORY VOTE
ON THE FREQUENCY OF FUTURE <FONT STYLE="white-space:nowrap">NON-BINDING,</FONT> ADVISORY VOTES TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc131567_5">PROPOSAL <FONT STYLE="white-space:nowrap">4-RATIFICATION</FONT> OF INDEPENDENT
 REGISTERED PUBLIC ACCOUNTING FIRM</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc131567_11">AUDIT COMMITTEE REPORT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc131567_12">HOUSEHOLDING OF PROXY MATERIALS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc131567_13">OTHER MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc131567_1"></A>BRIDGEBIO PHARMA, INC. PROXY STATEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOR THE 2021 ANNUAL MEETING OF STOCKHOLDERS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>June&nbsp;17, 2021 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INFORMATION CONCERNING SOLICITATION AND VOTING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This proxy statement (&#147;Proxy
Statement&#148;) is furnished in connection with the solicitation of proxies for use prior to or at the 2021 Annual Meeting of Stockholders (the &#147;Annual Meeting&#148;) of BridgeBio Pharma, Inc. (the &#147;Company&#148;), a Delaware corporation,
to be held virtually at 9:00 a.m., local time, on Thursday, June&nbsp;17, 2021, and at any adjournments or postponements thereof for the following purposes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">To elect three (3)&nbsp;directors, Eric Aguiar, M.D., Ali Satvat and Jennifer E. Cook, to serve as Class&nbsp;II
directors to hold office until the date of the annual meeting of stockholders following the year ending December&nbsp;31, 2023 and until their successors are duly elected and qualified, or until such director&#146;s earlier death, resignation or
removal. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">To cast <FONT STYLE="white-space:nowrap">a&nbsp;non-binding,&nbsp;advisory</FONT> vote to approve the
compensation of our named executive officers; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">To cast <FONT STYLE="white-space:nowrap">a&nbsp;non-binding,&nbsp;advisory</FONT> vote on the frequency of <FONT
STYLE="white-space:nowrap">future&nbsp;non-binding,&nbsp;advisory</FONT> votes to approve the compensation of our named executive officers; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">To ratify the appointment of Deloitte&nbsp;&amp; Touche LLP as the independent registered public accounting firm
of the Company for its fiscal year ending December&nbsp;31, 2021; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">To transact such other business as may properly come before the meeting or any adjournment or postponement
thereof. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You can attend the Annual Meeting online, vote your shares electronically and submit your questions during the Annual Meeting
by visiting www.virtualshareholdermeeting.com/BBIO2021. You will need to have your <FONT STYLE="white-space:nowrap">16-Digit</FONT> Control Number included on your proxy card to join the Annual Meeting. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Solicitation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This solicitation is made on behalf of the
Board of Directors. We will bear the costs of preparing, mailing, online processing and other costs of the proxy solicitation made by our Board of Directors. Certain of our officers and employees may solicit the submission of proxies authorizing the
voting of shares in accordance with the Board of Directors&#146; recommendations. Such solicitations may be made by telephone, facsimile transmission or personal solicitation. No additional compensation will be paid to such officers, directors or
regular employees for such services. We will reimburse banks, brokerage firms and other custodians, nominees and fiduciaries for reasonable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses
incurred by them in sending proxy materials to stockholders. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Important Notice Regarding the Availability of Proxy Materials </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Proxy Statement and the Company&#146;s 2020 Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> (the &#147;Annual Report&#148;) are
available electronically at www.proxyvote.com. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Voting Rights and Outstanding Shares </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Only holders of record of our common stock as of the close of business on May&nbsp;7, 2021 are entitled to receive notice of, and to vote at, the Annual
Meeting. Each holder of common stock will be entitled to one vote for each share held on all matters to be voted upon at the Annual Meeting. At the close of business on April&nbsp;28, 2021, there were 149,280,583 shares of common stock issued and
outstanding and eligible to vote. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A quorum of stockholders is necessary to take action at the Annual Meeting. Stockholders representing a
majority of the outstanding shares of our common stock (present virtually or represented by proxy) will constitute a quorum. We will appoint an inspector of elections for the meeting to determine whether or not a quorum is present and to tabulate
votes cast by proxy or virtually at the Annual Meeting. Abstentions, withheld votes and broker <FONT STYLE="white-space:nowrap">non-votes</FONT> (which occur when a broker, bank or other nominee holding shares for a beneficial owner does not vote on
a particular matter because such broker, bank or other nominee does not have discretionary authority to vote on that matter and has not received voting instructions from the beneficial owner) are counted as present for purposes of determining the
presence of a quorum for the transaction of business at the Annual Meeting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Votes Required for Each Proposal </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To elect our directors and approve the other proposals being considered at the Annual Meeting, the voting requirements are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="71%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="17%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Proposal</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Vote<BR>Required</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Discretionary<BR>Voting<BR>Permitted?</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Election of Directors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">Plurality</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">No</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-binding,&nbsp;advisory</FONT> vote to approve the
compensation of our named executive officers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">Majority</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">No</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-binding,&nbsp;advisory</FONT> vote on the frequency of future
<FONT STYLE="white-space:nowrap">non-binding,</FONT> advisory votes to approve the compensation of our named executive officers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">Highest&nbsp;Number&nbsp;of Affirmative Votes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">No</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ratification of Deloitte&nbsp;&amp; Touche LLP</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">Majority</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">Yes</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>&#147;Discretionary Voting Permitted&#148;</I> means that brokers will have discretionary voting authority with respect to
shares held in street name for their clients, even if the broker does not receive voting instructions from their client. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>&#147;Majority&#148;</I>
means a majority of the votes properly cast for and against such matter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>&#147;Plurality&#148;</I> means a plurality of the votes properly cast on
such matter. For the election of directors, the three (3)&nbsp;nominees receiving the plurality of votes entitled to vote and cast will be elected as directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The vote required and method of calculation for the proposals to be considered at the Annual Meeting are as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Proposal <FONT STYLE="white-space:nowrap">One-Election</FONT> of Directors.</I> If a quorum is present, the director nominees receiving the highest number
of votes, submitted virtually at the Annual Meeting or by proxy, will be elected as directors. You may vote &#147;FOR&#148; all nominees, &#147;WITHHOLD&#148; for all nominees, or &#147;WITHHOLD&#148; for any nominee by specifying the name of the
nominee on your proxy card. Proposal One is <U>not</U> considered to be a routine item, so if you do not instruct your broker how to vote with respect to this proposal, your broker may not vote on this proposal, and those votes will be counted as
broker <FONT STYLE="white-space:nowrap">&#147;non-votes.&#148;</FONT> Withheld votes and broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will have no effect on the outcome of the election of the directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Proposal <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Two-Non-binding,</FONT></FONT></I><I></I><I>&nbsp;advisory vote to approve the
compensation of our named executive officers.</I> Approval of this proposal requires the affirmative vote of a majority of the votes properly cast for and against such matter. You may vote &#147;FOR,&#148; &#147;AGAINST&#148; or &#147;ABSTAIN&#148;
from voting on this proposal. If you abstain from voting on this matter, your shares will not be counted as &#147;votes cast&#148; with respect to such matter, and the abstention will have no effect on the proposal. Proposal Two is <U>not</U>
considered to be a routine item, so if you do not instruct your broker how to vote with respect to this proposal, your broker may not vote on this proposal, and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
those votes will be counted as broker <FONT STYLE="white-space:nowrap">&#147;non-votes.&#148;</FONT> Withheld votes and broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will have no
effect on the outcome of the <FONT STYLE="white-space:nowrap">non-binding,</FONT> advisory vote to approve the compensation of our named executive officers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Proposal <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Three-Non-binding,</FONT></FONT></I><I></I><I>&nbsp;advisory vote on the
frequency of future</I><I></I><I><FONT STYLE="white-space:nowrap">&nbsp;non-binding,</FONT></I><I></I><I>&nbsp;advisory votes to approve the compensation of our named executive officers.</I> The frequency of &#147;one year,&#148; &#147;two
years,&#148; or &#147;three years&#148; that receives the highest number of affirmative votes properly cast on this proposal will be deemed the preferred frequency with which we
<FONT STYLE="white-space:nowrap">hold&nbsp;a&nbsp;non-binding,&nbsp;advisory&nbsp;vote</FONT> on the compensation of our named executive officers. You may vote for &#147;ONE YEAR,&#148; &#147;TWO YEARS,&#148; &#147;THREE YEARS&#148; or
&#147;ABSTAIN&#148; from voting on this proposal. If you abstain from voting on this matter, your shares will not be counted as &#147;votes cast&#148; with respect to such matter, and the abstention will have no effect on the proposal. Proposal
Three is <U>not</U> considered to be a routine item, so if you do not instruct your broker how to vote with respect to this proposal, your broker may not vote on this proposal, and those votes will be counted as broker
<FONT STYLE="white-space:nowrap">&#147;non-votes.&#148;</FONT> Withheld votes and broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will have no effect on the outcome of <FONT STYLE="white-space:nowrap">non-binding,&nbsp;advisory</FONT> vote
on the frequency of <FONT STYLE="white-space:nowrap">future&nbsp;non-binding,&nbsp;advisory</FONT> votes to approve the compensation of our named executive officers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Proposal Four-Approval of the Ratification of Deloitte</I><I></I><I>&nbsp;&amp; Touche LLP as Independent Registered Public Accounting Firm.</I> Approval
of this proposal requires the affirmative vote of a majority of the votes properly cast for and against such matter. You may vote &#147;FOR,&#148; &#147;AGAINST&#148; or &#147;ABSTAIN&#148; from voting on this proposal. If you abstain from voting on
this matter, your shares will not be counted as &#147;votes cast&#148; with respect to such matter, and the abstention will have no effect on the proposal. Proposal Four is considered to be a routine item, and your broker will be able to vote on
this proposal even if it does not receive instructions from you. Accordingly, we do not anticipate that there will be any broker <FONT STYLE="white-space:nowrap">non-votes</FONT> on this proposal; however, any broker
<FONT STYLE="white-space:nowrap">non-votes</FONT> will not be counted as &#147;votes cast&#148; and will therefore have no effect on the proposal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We
request that you vote your shares by proxy following the methods as instructed by the Notice: over the Internet, by telephone or by mail. If you choose to vote by mail, your shares will be voted in accordance with your voting instructions if the
proxy card is received prior to the Annual Meeting. If you sign and return your proxy card but do not give voting instructions, your shares will be voted FOR: (i)&nbsp;the election of each of the Company&#146;s three (3)&nbsp;nominees as directors;
(ii)&nbsp;the <FONT STYLE="white-space:nowrap">non-binding,&nbsp;advisory</FONT> vote to approve the compensation of our named executive officers; (iii)&nbsp;the <FONT STYLE="white-space:nowrap">non-binding,&nbsp;advisory</FONT> vote on the
frequency of <FONT STYLE="white-space:nowrap">future&nbsp;non-binding,&nbsp;advisory</FONT> votes to approve the compensation of our named executive officers every ONE YEAR; (iv)&nbsp;the ratification of the appointment of Deloitte&nbsp;&amp; Touche
LLP as the independent registered public accounting firm for the Company for the fiscal year ending December&nbsp;31, 2021; and (v)&nbsp;as the proxy holders deem advisable, in their discretion, on other matters that may properly come before the
Annual Meeting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Voting by Proxy Over the Internet or by Telephone </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stockholders whose shares are registered in their own names may vote by proxy by mail, over the Internet or by telephone. Instructions for voting by proxy over
the Internet or by telephone are set forth on the Notice. The Internet and telephone voting facilities will close at 11:59 p.m. Eastern Time on Wednesday, June&nbsp;16, 2021. The Notice will also provide instructions on how you can elect to receive
future proxy materials electronically or in printed form by mail. If you choose to receive future proxy materials electronically, you will receive an email next year with instructions containing a link to the proxy materials and a link to the proxy
voting site. Your election to receive proxy materials electronically or in printed form by mail will remain in effect until you terminate such election. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If your shares are held in street name, the voting instruction form sent to you by your broker, bank or other nominee should indicate whether the institution
has a process for beneficial holders to provide voting instructions over the Internet or by telephone. A number of banks and brokerage firms participate in a program that also permits stockholders whose shares are held in street name to direct their
vote over the Internet or by telephone. If your bank or brokerage firm gives you this opportunity, the voting instructions from the bank or brokerage firm that accompany this Proxy Statement will tell you how to use the Internet or telephone to
direct the vote of shares held </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
in your account. If your voting instruction form does not include Internet or telephone information, please complete and return the voting instruction form in the self-addressed, postage-paid
envelope provided by your broker. Stockholders who vote by proxy over the Internet or by telephone need not return a proxy card or voting instruction form by mail, but may incur costs, such as usage charges, from telephone companies or Internet
service providers. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Revocability of Proxies </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any
proxy may be revoked at any time before it is exercised by filing an instrument revoking it with the Company&#146;s Secretary or by submitting a duly executed proxy bearing a later date prior to the time of the Annual Meeting. Stockholders who have
voted by proxy over the Internet or by telephone or have executed and returned a proxy and who then virtually attend the Annual Meeting and desire to vote are requested to notify the Secretary in writing prior to the time of the Annual Meeting. We
request that all such written notices of revocation to the Company be addressed to Brian C. Stephenson, Secretary, c/o BridgeBio Pharma, Inc., at the address of our principal executive offices at 421 Kipling Street, Palo Alto, CA 94301. Our
telephone number is (650) <FONT STYLE="white-space:nowrap">391-9740.</FONT> Stockholders may also revoke their proxy by entering a new vote over the Internet or by telephone. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Stockholder Proposals to be Presented at the Next Annual Meeting </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any stockholder who meets the requirements of the proxy rules under the Exchange Act may submit proposals to the Board of Directors to be presented at the 2022
annual meeting. Such proposals must comply with the requirements of Rule <FONT STYLE="white-space:nowrap">14a-8</FONT> under the Exchange Act and be submitted in writing by notice delivered or mailed by first-class United States mail, postage
prepaid, to our Secretary at our principal executive offices at the address set forth above no later than January&nbsp;12, 2022 in order to be considered for inclusion in the proxy materials to be disseminated by the Board of Directors for such
annual meeting. If the date of the 2022 annual meeting is moved by more than 30 days from the date contemplated at the time of the previous year&#146;s proxy statement, then notice must be received within a reasonable time before we begin to print
and send proxy materials. If that happens, we will publicly announce the deadline for submitting a proposal in a press release or in a document filed with the SEC. A proposal submitted outside the requirements of Rule
<FONT STYLE="white-space:nowrap">14a-8</FONT> under the Exchange Act will be considered untimely if received after March&nbsp;28, 2022. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Amended and
Restated Bylaws (&#147;Bylaws&#148;) also provide for separate notice procedures to recommend a person for nomination as a director or to propose business to be considered by stockholders at a meeting. To be considered timely under these provisions,
the stockholder&#146;s notice must be received by our Secretary at our principal executive offices at the address set forth above no earlier than February&nbsp;17, 2022 and no later than March&nbsp;19, 2022. Our Bylaws also specify requirements as
to the form and content of a stockholder&#146;s notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board of Directors, a designated committee thereof or the chairman of the meeting may refuse
to acknowledge the introduction of any stockholder proposal if it is not made in compliance with the applicable notice provisions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc131567_2"></A>PROPOSAL 1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ELECTION OF DIRECTORS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation provides for a Board of Directors that is divided into three classes. The term for each class is
three years, staggered over time. The terms of the Class&nbsp;II directors are scheduled to expire on the date of the upcoming Annual Meeting. Based on the recommendation of the Nominating and Corporate Governance Committee of the Board of
Directors, or the Nominating and Corporate Governance Committee, the Board of Directors&#146; nominees for election by the stockholders are the current Class&nbsp;II members: Eric Aguiar, M.D., Ali Satvat and Jennifer E. Cook. If elected, each
nominee will serve as a director until the date of the annual meeting of stockholders following the year ending December&nbsp;31, 2023 and until their successors are duly elected and qualified, or until such director&#146;s earlier death,
resignation or removal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Board of Directors is currently comprised of eleven (11)&nbsp;members. If each of the Class&nbsp;II director nominees is
elected at the Annual Meeting, the composition of our Board of Directors will be as follows: <FONT STYLE="white-space:nowrap">Class&nbsp;I-</FONT> James C. Momtazee, Richard H. Scheller, Ph.D., Brenton L. Saunders and Randal W. Scott; <FONT
STYLE="white-space:nowrap">Class&nbsp;II-</FONT> Eric Aguiar, M.D., Ali Satvat and Jennifer E. Cook; and <FONT STYLE="white-space:nowrap">Class&nbsp;III-</FONT> Neil Kumar, Ph.D., Charles Homcy, M.D., Ronald J. Daniels and Andrew Lo. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the absence of instructions to the contrary, the persons named as proxy holders in the accompanying proxy intend to vote in favor of the election of the
nominees designated below to serve until the date of the annual meeting of stockholders following the year ending December&nbsp;31, 2023 and until their successors are duly elected and qualified, or until such director&#146;s earlier death,
resignation or removal. Each nominee is currently a director. The Board of Directors expects that each nominee will be available to serve as a director, but if any such nominee should become unavailable or unwilling to stand for election, it is
intended that the shares represented by the proxy will be voted for such substitute nominee as may be designated by the Board of Directors. The biographies of our directors and their ages as of March&nbsp;31, 2021 are set forth below. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="39%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="51%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Age</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Position</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Neil Kumar, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Chief Executive Officer and Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Eric Aguiar, M.D.(1)(2)(3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Director</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard H. Scheller, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ali Satvat(2)(3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Director</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Charles Homcy, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Director and Lead Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James C. Momtazee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Director</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jennifer E. Cook</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Andrew Lo</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Director</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Brenton L. Saunders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Randal W. Scott(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Director</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ronald J. Daniels(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Director</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Member of the Audit Committee. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Member of the Compensation Committee. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Member of the Nominating and Corporate Governance Committee. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Nominees for Director </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Class&nbsp;II: </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The persons listed below are nominated for election to Class&nbsp;II of the Board of Directors to serve a three-year term ending on the date of the annual
meeting of stockholders following the year ending December&nbsp;31, 2023 and until their successors are elected and qualified, or until such director&#146;s earlier death, resignation or removal. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Board of Directors recommends that you vote FOR the following nominees. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Eric Aguiar, M.D.</I></B> has served as a member of our Board of Directors since March 2019. Dr.&nbsp;Aguiar has been a partner at Aisling Capital since
January 2016 and prior to that was a partner at Thomas, McNerney and Partners, a healthcare venture capital and growth equity fund, since 2007. Prior to joining that firm, he was a Managing Director of HealthCare Ventures, a healthcare focused
venture capital firm, from 2001 to 2007. Dr.&nbsp;Aguiar currently serves on the board of directors of Invitae Corporation (NYSE: NVTA) since September 2010. He also serves on the board of directors of Biomea Fusion, a biopharmaceutical company
(Nasdaq: BMEA). He served on the board of directors of Eidos Therapeutics, Inc. (formerly Nasdaq: EIDX) from March 2018 to August 2020. He served on the board of directors of Biohaven Corporation (NYSE: BHVN) from October 2016 to January 2020.
Dr.&nbsp;Aguiar is a member of the Board of Overseers of the Tufts School of Medicine and a member of the Council on Foreign Relations. Dr.&nbsp;Aguiar received his medical degree with honors from Harvard Medical School. He graduated with honors
from Cornell University as a College Scholar. He was also a Luce Fellow and is a Chartered Financial Analyst. Dr.&nbsp;Aguiar&#146;s qualifications to serve on our Board of Directors include his medical and finance background and experience as an
investor in life science companies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Ali Satvat</I></B> has served as a member of our Board of Directors since March 2016. Mr.&nbsp;Satvat joined
Kohlberg Kravis Roberts&nbsp;&amp; Co. L.P., a global investment firm, in January 2012 and is a Partner, <FONT STYLE="white-space:nowrap">Co-Head</FONT> of the Health Care industry team within KKR&#146;s Americas Private Equity platform, and Global
Head of KKR Health Care Strategic Growth. Mr.&nbsp;Satvat is a member of the Investment Committee for KKR&#146;s Americas Private Equity platform and chairs the Investment Committee for KKR Health Care Strategic Growth. Mr.&nbsp;Satvat has served as
a member of the boards of directors of Coherus BioSciences, Inc. (Nasdaq: CHRS), a biopharmaceutical company, since May 2014, Eidos Therapeutics, Inc. (formerly Nasdaq: EIDX), a biopharmaceutical company, from June 2018 through January 2021, PRA
Health Sciences, Inc. (Nasdaq: PRAH), a global contract research organization, from September 2013 through April 2018, and numerous privately held companies. Prior to joining KKR, Mr.&nbsp;Satvat was a Principal with Apax Partners, a global private
equity firm, where he invested in health care from 2006 to 2012. Previously, Mr.&nbsp;Satvat held various positions with Johnson&nbsp;&amp; Johnson Development Corporation, a venture capital subsidiary of Johnson&nbsp;&amp; Johnson, Audax Group, a
private equity firm, and The Blackstone Group, a global investment firm. Mr.&nbsp;Satvat holds an A.B. in History and Science from Harvard College and an M.B.A. in Health Care Management and Entrepreneurial Management from the Wharton School of the
University of Pennsylvania. Mr.&nbsp;Satvat previously served as a member of the board of directors of the Healthcare Private Equity Association. Mr.&nbsp;Satvat&#146;s qualifications to serve on our Board of Directors include his expertise in
corporate governance, financing, and financial matters and his extensive investment experience in the health care industry. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Jennifer E.
Cook</I></B> has served as a member of our Board of Directors since December 2019. She is currently the owner and principal of Jennifer Cook Consulting since July 2019. Ms.&nbsp;Cook has served as a member of the board of directors of Denali
Therapeutics, Inc. (Nasdaq: DNLI) since November 2018, Ambys Medicines since March 2020, Gyroscope Therapeutics Limited since November 2020, and Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) since November 2020. Ms.&nbsp;Cook served as the Chief
Executive Officer of GRAIL from January 2018 to June 2019. Previously, Ms.&nbsp;Cook was at Roche Pharmaceuticals and Genentech, where she held a number of senior management positions; from January 2017 to December 2017, Ms.&nbsp;Cook served as
Senior Vice President, Global Head of Clinical Operations for Roche Pharmaceuticals; from September 2013 to December 2016, Ms.&nbsp;Cook served as Head of Region Europe Pharma for Roche Pharmaceuticals; and from July 2010 to September 2013,
Ms.&nbsp;Cook served as the Senior Vice President, Business Unit Head Immunology and Ophthalmology for Genentech. Ms.&nbsp;Cook holds a B.A. in human biology and an M.S. in biology from Stanford University, as well as an M.B.A. from the Haas School
of Business at University of California, Berkeley. Ms.&nbsp;Cook&#146;s qualifications to serve on our Board of Directors include her extensive experience as a senior management executive of healthcare and biotechnology companies, including as the
senior vice president of one of the world&#146;s largest healthcare companies. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Current Directors </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Class&nbsp;I: Currently Serving Until the 2023 Annual Meeting </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Richard H. Scheller, Ph.D.</I></B> has served as a member of our Board of Directors since January 2018 and as our Chairman of Research&nbsp;&amp;
Development effective as of January 2019. Dr.&nbsp;Scheller served as the Chief Science Officer and Head of Therapeutics at 23andMe, a personal genetics company, from 2015 to April 2019. Previously, Dr.&nbsp;Scheller was the Executive Vice President
of Research and Early Development and a member of the Executive Committee at Genentech, Inc., a biotechnology corporation, from February 2001 to December 2014. From January 2009 to December 2014, Dr.&nbsp;Scheller was also a member of the Enlarged
Executive Committee at <FONT STYLE="white-space:nowrap">Hoffmann-La</FONT> Roche Ltd, a pharmaceutical company. Dr.&nbsp;Scheller currently serves as a member of the board of directors ORIC Pharmaceuticals, Inc., a biopharmaceutical company, since
February 2015, Alector, Inc., a biopharmaceutical company (Nasdaq: ALEC), since October 2018, DiCE Molecules, a biopharmaceutical company, and Maze Therapeutics, a biopharmaceutical company, since July 2019. Dr.&nbsp;Scheller holds a B.Sc. in
Biochemistry from the University of Wisconsin-Madison and a Ph.D. in Chemistry from the California Institute of Technology. He completed his post-doctorate in Molecular Neurobiology at Columbia University and was also a post-doctorate fellow at
California Institute of Technology. Dr.&nbsp;Scheller&#146;s qualifications to serve on our Board of Directors include his scientific background and his senior management experience in the pharmaceutical industry. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>James C. Momtazee</I></B> has served as a member of our Board of Directors since March 2016 and as our Senior Advisor &#150; Transactions from February
2020 until January 2021. He is the Chairman of the Board, CEO and President of Montes Archimedes Acquisition Corp. He is the Managing Partner of Patient Square Capital, LP, a dedicated health care investment firm. He was previously a Member of KKR
and had been employed by Kohlberg Kravis Roberts&nbsp;&amp; Co. L.P., a private equity and alternative asset management firm, since 1996 until July 2019. Mr.&nbsp;Momtazee currently serves as Lead Independent Director on the board of directors of
PRA Health Sciences, Inc. (Nasdaq: PRAH), a global contract research organization. He previously served on the boards of directors of Jazz Pharmaceuticals plc (Nasdaq: JAZZ), a biopharmaceutical company, from 2004 to 2014, HCA Healthcare Inc.
(formerly HCA Holdings Inc.; NYSE: HCA), a health care services company, from 2006 to 2014, and Entellus Medical, Inc., a medical technology company, from 2017 to 2018. He received an A.B. from Stanford University and an M.B.A. from the Stanford
Graduate School of Business. Mr.&nbsp;Momtazee&#146;s qualifications to serve on our Board of Directors include his expertise in corporate governance, the healthcare industry and in financing and financial matters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Brenton L. Saunders</I></B> has served as a member of our Board of Directors since June 2020. Mr.&nbsp;Saunders is currently Chairman and <FONT
STYLE="white-space:nowrap">Co-Founder</FONT> of Vesper Healthcare Acquisitions Corp. Mr.&nbsp;Saunders served as the President and Chief Executive Officer of Allergan from 2014 and as Chairman from 2016 to May 2020. Prior to its acquisition by
Allergan, Mr.&nbsp;Saunders served as the Chief Executive Officer, President, and director of Forest Laboratories, Inc. Before joining Forest Laboratories, Inc. Mr.&nbsp;Saunders served as Chief Executive Officer of Bausch + Lomb Incorporated, from
2010 to 2013. Mr.&nbsp;Saunders currently serves on the board of directors of Cisco Systems, a technology conglomerate (Nasdaq: CSCO). Mr.&nbsp;Saunders holds a B.A. in Economics and Eastern Asian Studies from University of Pittsburg, a JD from
Temple School of Law and an M.B.A. from Temple University School of Business. We believe Mr.&nbsp;Saunders&#146; extensive experience building and leading successful biopharmaceutical companies qualifies him to serve on our Board of Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Randal W. Scott</I></B> has served as a member of our Board of Directors since June 2020. Dr.&nbsp;Scott is the cofounder of Invitae Corporation, a
genetic information company (NYSE: NVTA), where he served as the Chairman and CEO from 2012 to 2017 and the Executive Chairman from 2017 to 2019. Dr.&nbsp;Scott served on the board of Invitae from 2010 until August 2019. Prior to that,
Dr.&nbsp;Scott cofounded Genomic Health, Inc., a genetic research company (Nasdaq: GHDX), where he served as the Chairman and CEO from 2000 to 2009 and the Executive Chairman from 2009 to 2012. Dr.&nbsp;Scott holds a B.S. in Chemistry from Emporia
State University and a Ph.D. in Biochemistry from the University of Kansas. We believe Dr.&nbsp;Scott&#146;s significant experience building and leading successful biopharmaceutical companies and his scientific expertise, qualifies him to serve on
our Board of Directors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Class&nbsp;III: Currently Serving Until the 2022 Annual Meeting </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Neil Kumar, Ph.D.</I></B> is a <FONT STYLE="white-space:nowrap">co-founder</FONT> and has served as our Chief Executive Officer and a member of our Board
of Directors since April 2015. Dr.&nbsp;Kumar has also served as the Chief Executive Officer of our subsidiary, Eidos Therapeutics (Nasdaq: EIDX), a clinical stage biopharmaceutical company, and a member of Eidos Therapeutics&#146; board of
directors since March 2016. Prior to that, he served as the interim vice president of business development at MyoKardia, Inc. (Nasdaq: MYOK), a clinical stage biopharmaceutical company, from 2012 to 2014. Prior to that, Dr.&nbsp;Kumar served as a
principal at Third Rock Ventures, a venture capital firm, from 2011 to 2014. Before joining Third Rock Ventures, he served as an associate principal at McKinsey&nbsp;&amp; Company, a worldwide management consulting firm, from 2007 to 2011.
Dr.&nbsp;Kumar has served as a member of the board of directors of LianBio since August 2020. He received his B.S. and M.S. degrees in chemical engineering from Stanford University and received his Ph.D. in chemical engineering from the
Massachusetts Institute of Technology. Dr.&nbsp;Kumar&#146;s qualifications to serve on our Board of Directors include his role as our principal executive officer and his extensive experience as an executive officer of biotechnology companies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Charles Homcy, M.D.</I></B> has served as a member of our Board of Directors since November 2018, our Chairman of Pharmaceuticals since February 2019,
and our Lead Director since February 2020. In 2010, Dr.&nbsp;Homcy joined Third Rock Ventures, a venture capital firm, where he is currently a partner. He served as president and chief executive officer of Portola Pharmaceuticals, a clinical
biotechnology company, and he served as their president and chief executive officer since <FONT STYLE="white-space:nowrap">co-founding</FONT> the company in 2003 until 2010. Prior to that, Dr.&nbsp;Homcy served as the president of research and
development at Millennium Pharmaceuticals, Inc. (currently, Takeda Oncology), a biopharmaceutical company, following its acquisition of COR Therapeutics, Inc. in 2002. He joined COR Therapeutics, Inc., a biopharmaceutical company, in 1995 as
executive vice president of research and development, and he served as a director of the company from 1998 to 2002. Dr.&nbsp;Homcy was a clinical professor of medicine at the University of California, San Francisco Medical School, and attending
physician at the San Francisco Veterans Affairs Hospital from 1997 to 2011. He was previously president of the medical research division of American Cyanamid-Lederle Laboratories, a division of Wyeth-Ayest Laboratories. He currently serves on the
board of directors of Maze Therapeutics, a biopharmaceutical company, and was formerly a director of Portola Pharmaceuticals, Inc. (Nasdaq: PTLA) from 2004 until March 2019, Global Blood Therapeutics, Inc. (Nasdaq: GBT) from 2012 until June 2019.
Dr.&nbsp;Homcy holds a B.A. and an M.D. from Johns Hopkins University and currently serves on its board of trustees. Dr.&nbsp;Homcy&#146;s qualifications to serve on our Board of Directors include his significant experience building and leading
successful biotechnology companies and his scientific expertise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Ronald J. Daniels</I></B> has served as a member of our Board of Directors since
February 2020. Mr.&nbsp;Daniels has been the president of Johns Hopkins University since March 2009. He is a member of the Board of Managers of the Johns Hopkins Applied Physics Laboratory and the chair of the Executive Committee of Johns Hopkins
Health System. A law and economics scholar, Mr.&nbsp;Daniels is author or editor of seven books and dozens of scholarly articles. Before joining Johns Hopkins University, he served as Provost and a Professor of Law at the University of Pennsylvania
and Dean and James M. Tory Professor of Law of the Faculty of Law at the University of Toronto. Mr.&nbsp;Daniels earned an L.L.M. from Yale University in 1988 and a J.D. in 1986 from the University of Toronto. He received a B.A. from the University
of Toronto in 1982 in political science and economics. Mr.&nbsp;Daniels&#146; qualifications to serve on our Board of Directors include his extensive experience as a professor and now a leader at of one of the world&#146;s premier science
institutions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Andrew Lo</I></B> has served as a member of our Board of Directors since June 2020. Dr.&nbsp;Lo is the Charles E. and Susan T. Harris
Professor at the MIT Sloan School of Management, director of the MIT Laboratory for Financial Engineering, a principal investigator at the MIT Computer Science and Artificial Intelligence Laboratory, and an affiliated faculty member of the MIT
Department of Electrical Engineering and Computer Science, and has served as a professor at the MIT Sloan School of Management and MIT Department of Electrical Engineering and Computer Science since 1988. He is also an external faculty member of the
Santa Fe Institute and a research associate of the National Bureau of Economic Research. Dr.&nbsp;Lo currently serves on the board of directors of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Roivant Sciences, Inc., a clinical-stage biopharmaceutical company. Dr.&nbsp;Lo holds a B.A. in Economics from Yale University and a Ph.D. in Economics from Harvard University. Dr.&nbsp;Lo&#146;s
qualifications to serve on our Board of Directors include his extensive experience as a professor and a leader at two premier educational institutions. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board of Directors&#146; Role in Risk Management </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Risk is
inherent with every business, and how well a business manages risk can ultimately determine its success. We face a number of risks, including risks relating to our financial condition, development and commercialization activities, strategic
direction, clinical and regulatory matters, operations and intellectual property. Management is responsible for the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> management of risks we face, while our
Board of Directors, as a whole and through its committees, has responsibility for the oversight of risk management. In its risk oversight role, our Board of Directors has the responsibility to satisfy itself that the risk management processes
designed and implemented by management are adequate and functioning as designed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The role of our Board of Directors in overseeing the management of our
risks is conducted primarily through committees of the Board of Directors, as disclosed in the descriptions of each of the committees below and in the charters of each of the committees. The full Board of Directors (or the appropriate committee of
the Board of Directors in the case of risks that are under the purview of a particular committee) discusses with management our major risk exposures, their potential impact on our company, and the steps we take to manage them. When a Board committee
is responsible for evaluating and overseeing the management of a particular risk or risks, the chairman of the relevant committee reports on the discussion to the full Board of Directors during the committee reports portion of the next Board of
Directors meeting. This enables our Board of Directors and its committees to coordinate the risk oversight role, particularly with respect to risk interrelationships. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Compensation Risk Assessment </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe that although a
portion of the compensation provided to our executive officers and other employees is performance-based, our executive compensation program does not encourage excessive or unnecessary risk taking. This is primarily due to the fact that our
compensation programs are designed to encourage our executive officers and other employees to remain focused on both short-term and long-term strategic goals, in particular in connection with our <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">pay-for-performance</FONT></FONT> compensation philosophy. As a result, we do not believe that our compensation programs are reasonably likely to have a material adverse effect on the Company. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board of Directors and Committees of the Board </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During
2020, our Board of Directors held a total of ten meetings. All directors attended at least 75% of the aggregate of the number of Board meetings and meetings of the Board committees on which each such director served during the time each such
director served on the Board of Directors or such committees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Board of Directors has determined that all of our directors, except for Drs. Kumar,
Homcy and Scheller, Mr.&nbsp;Momtazee and Ms.&nbsp;Cook, are independent, as determined in accordance with the rules of The Nasdaq Stock Market (&#147;Nasdaq&#148;) and the SEC. In making such independence determination, the Board of Directors
considered the relationships that each <FONT STYLE="white-space:nowrap">non-employee</FONT> director has with us and all other facts and circumstances that the Board of Directors deemed relevant in determining their independence, including the
beneficial ownership of our capital stock by each <FONT STYLE="white-space:nowrap">non-employee</FONT> director. In considering the independence of the directors listed above, our Board of Directors also considered the association of our directors
with the holders of more than 5% of our common stock. There are no family relationships among any of our directors or executive officers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board of
Directors has a standing Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee, each of which has the composition and responsibilities described below. Copies of our Audit Committee, Amended and Restated
Compensation Committee and Nominating and Corporate Governance Committee charters and our corporate governance guidelines are available, free of charge, on our website at https://bridgebio.com, under the &#147;For Investors/Corporate
Governance/Documents&nbsp;&amp; Charters&#148; link. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Audit Committee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Aguiar, Mr.&nbsp;Daniels and Dr.&nbsp;Scott currently serve on the Audit Committee, which is chaired by Dr.&nbsp;Aguiar. All of the members of our
Audit Committee meet the enhanced independence standards established by the Sarbanes-Oxley Act of 2002 and related rulemaking of the SEC. In addition, our Board of Directors has determined that Dr.&nbsp;Aguiar is an &#147;Audit Committee financial
expert,&#148; as defined under the applicable rules of the SEC. The Audit Committee&#146;s responsibilities include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">appointing, approving the compensation of, and assessing the independence of our independent registered public
accounting firm; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">pre-approving</FONT> auditing and permissible
<FONT STYLE="white-space:nowrap">non-audit</FONT> services, and the terms of such services, to be provided by our independent registered public accounting firm; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing the overall audit plan with our independent registered public accounting firm and members of management
responsible for preparing our financial statements; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and discussing with management and our independent registered public accounting firm our annual and
quarterly financial statements and related disclosures as well as critical accounting policies and practices used by us; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">coordinating the oversight and reviewing the adequacy of our internal control over financial reporting;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establishing policies and procedures for the receipt and retention of accounting-related complaints and concerns;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">recommending, based upon the Audit Committee&#146;s review and discussions with management and our independent
registered public accounting firm, whether our audited financial statements shall be included in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K;</FONT> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">monitoring the integrity of our financial statements and our compliance with legal and regulatory requirements as
they relate to our financial statements and accounting matters; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">preparing the Audit Committee report required by SEC rules to be included in our annual proxy statement;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing all related person transactions for potential conflict of interest situations and approving all such
transactions; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing quarterly earnings releases and scripts. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During 2020, the Audit Committee held six meetings. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Compensation Committee </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Aguiar and
Mr.&nbsp;Satvat currently serve on the Compensation Committee, which is chaired by Dr.&nbsp;Aguiar. All of the members of our Compensation Committee are independent, as defined under and required by Rule <FONT STYLE="white-space:nowrap">10C-1</FONT>
of the Exchange Act and the Nasdaq rules. The Compensation Committee&#146;s responsibilities include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">annually reviewing and approving corporate goals and objectives relevant to the compensation of our Chief
Executive Officer; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">evaluating the performance of our Chief Executive Officer in light of such corporate goals and objectives and
determining the compensation of our Chief Executive Officer; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and approving the compensation of our other executive officers; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and establishing our overall management compensation structure, policies and programs;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">overseeing and administering our compensation and similar plans; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">evaluating and assessing potential and current compensation advisors in accordance with the independence
standards identified in the applicable Nasdaq rules; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">retaining and approving the compensation of any compensation advisors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and approving our policies and procedures for the grant of equity-based awards; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">acting as administrator of our equity and incentive plans; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and making recommendations to our Board of Directors with respect to director compensation;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and discussing with management the compensation disclosure to be included in our annual proxy statement
or Annual Report on Form <FONT STYLE="white-space:nowrap">10-K;</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and approving the peer group of companies used to inform our evaluation of compensation for our
employees and directors; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and discussing with the Board of Directors the corporate succession plan for the Chief Executive
Officer and other key officers. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During 2020, the Compensation Committee held five meetings. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Nominating and Corporate Governance Committee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Satvat and Dr.&nbsp;Aguiar currently serve on the Nominating and Corporate Governance Committee, which is chaired by Mr.&nbsp;Satvat. All of the
members of our Nominating and Corporate Governance Committee, Dr.&nbsp;Aguiar and Mr.&nbsp;Satvat, are independent, as defined under and required by current Nasdaq rules. The Nominating and Corporate Governance Committee&#146;s responsibilities
include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">developing and recommending to the Board of Directors criteria for board and committee membership;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establishing procedures for identifying and evaluating Board of Director candidates, including nominees
recommended by stockholders; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing the size and composition of the Board of Directors to ensure that it is composed of members containing
the appropriate skills and expertise to advise us; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">identifying individuals qualified to become members of the Board of Directors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">recommending to the Board of Directors the persons to be nominated for election as directors and to each of the
Board&#146;s committees; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">developing and recommending to the Board of Directors a code of business conduct and ethics and a set of
corporate governance guidelines; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">developing a mechanism by which violations of the code of business conduct and ethics can be reported in a
confidential manner; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">overseeing the evaluation of the Board of Directors and management. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During 2020, the Nominating and Corporate Governance Committee held two meetings. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board Leadership </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We do not currently have a Chairman of
the Board of Directors; however, we have designated Dr.&nbsp;Homcy as our Lead Director. We believe that separating the positions of Chief Executive Officer and Lead Director has the potential to allow our Chief Executive Officer to focus on our <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> business, while allowing our Lead Director to lead our Board of Directors in its fundamental role of providing advice to and oversight of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
management. Our Board of Directors recognizes the time, effort and energy that the Chief Executive Officer is required to devote to his position in the current business environment, as well as
the commitment required to serve as a Lead Director, particularly as our Board of Directors&#146; oversight responsibilities continue to grow. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While our
Bylaws and corporate governance guidelines do not require that we appoint a separate Chairman of the board or lead independent director and Chief Executive Officer, our Board of Directors believes that having a Chief Executive Officer and a separate
Lead Director may provide the appropriate leadership structure for us and would demonstrate our commitment to good corporate governance. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Director
Nominations </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The director qualifications developed to date focus on what our Board of Directors believes to be essential competencies to effectively
serve on the Board of Directors. The Nominating and Corporate Governance Committee must reassess such criteria from time to time and submit any proposed changes to the Board of Directors for approval. Presently, at a minimum, the Nominating and
Corporate Governance Committee must be satisfied that each nominee it recommends (i)&nbsp;has experience at a strategic or policymaking level in a business, government, <FONT STYLE="white-space:nowrap">non-profit</FONT> or academic organization of
high standing, (ii)&nbsp;is highly accomplished in his or her respective field, with superior credentials and recognition, (iii)&nbsp;is well regarded in the community and has a long-term reputation for high ethical and moral standards,
(iv)&nbsp;has sufficient time and availability to devote to the affairs of the Company, particularly in light of the number of boards of directors on which such nominee may serve, and (v)&nbsp;to the extent such nominee serves or has previously
served on other boards, the nominee has a demonstrated history of actively contributing at board meetings. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to those minimum qualifications,
the Nominating and Corporate Governance Committee recommends that our Board of Directors select persons for nomination to help ensure that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a majority of our Board of Directors is &#147;independent&#148; in accordance with Nasdaq standards;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each of the Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee be
comprised entirely of independent directors; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at least one member of the Audit Committee shall have the experience, education and other qualifications
necessary to qualify as an &#147;Audit Committee financial expert&#148; as defined by the rules of the SEC. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to other
standards the Nominating and Corporate Governance Committee may deem appropriate from time to time for the overall structure and compensation of the Board of Directors, the Nominating and Corporate Governance Committee may consider the following
factors when recommending that our Board of Directors select persons for nomination: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether a nominee has direct experience in the biotechnology or pharmaceuticals industry or in other fields
relevant to the Company&#146;s operations; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the nominee, if elected, assists in achieving a mix of Board members that represents a diversity of
background and experience. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although the Nominating and Corporate Governance Committee may consider whether nominees assist in achieving
a mix of Board members that represents a diversity of background and experience, which is not only limited to race, gender or national origin, we have no formal policy regarding board diversity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Nominating and Corporate Governance Committee adheres to the following process for identifying and evaluating nominees for the Board of Directors. First,
it solicits recommendations for nominees from <FONT STYLE="white-space:nowrap">non-management</FONT> directors, our Chief Executive Officer, other executive officers, third-party search firms or any other source it deems appropriate. The Nominating
and Corporate Governance Committee then reviews and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
evaluates the qualifications of proposed nominees and conducts inquiries it deems appropriate; all proposed nominees are evaluated in the same manner, regardless of who initially recommended such
nominee. In reviewing and evaluating proposed nominees, the Nominating and Corporate Governance Committee may consider, in addition to the minimum qualifications and other criteria for Board membership approved by our Board of Directors from time to
time, all facts and circumstances that it deems appropriate or advisable, including, among other things, the skills of the proposed nominee, his or her depth and breadth of business experience or other background characteristics, his or her
independence and the needs of the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the Nominating and Corporate Governance Committee decides to retain a third-party search firm to identify
proposed nominees, it has sole authority to retain and terminate such firm and to approve any such firm&#146;s fees and other retention terms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each
nominee for election as director at the 2021 Annual Meeting is recommended by the Nominating and Corporate Governance Committee and is presently a director and stands for election by the stockholders. From time to time, the Company may pay fees to
third-party search firms to assist in identifying and evaluating potential nominees, although no such fees have been paid in connection with nominations to be acted upon at the 2021 Annual Meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to our Bylaws, stockholders who wish to nominate persons for election to the Board of Directors at an annual meeting must be a stockholder of record
at the time of giving the notice, entitled to vote at the meeting, present (in person or by proxy) at the meeting and must comply with the notice procedures in our Bylaws. A stockholder&#146;s notice of nomination to be made at an annual meeting
must be delivered to our principal executive offices not less than 90 days nor more than 120 days before the anniversary date of the immediately preceding annual meeting. However, if an annual meeting is more than 30 days before or more than 60 days
after such anniversary date, the notice must be delivered no later than the later of the 90th day prior to such annual meeting or the 10th day following the day on which the first public announcement of the date of such annual meeting was made. A
stockholder&#146;s notice of nomination may not be made at a special meeting unless such special meeting is held in lieu of an annual meeting. The stockholder&#146;s notice must include the following information for the person making the nomination:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">name and address; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the class and number of shares of the Company owned beneficially or of record; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">disclosure regarding any derivative, swap or other transactions which give the nominating person economic risk
similar to ownership of shares of the Company or provide the opportunity to profit from an increase in the price of value of shares of the Company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any proxy (other than a revocable proxy given in response to a public proxy solicitation made pursuant to, and in
accordance with, the Exchange Act), agreement, arrangement, understanding or relationship that confers a right to vote any shares of the Company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any agreement, arrangement, understanding or relationship engaged in for the purpose of acquiring, holding,
disposing or voting of any shares of any class or series of capital stock of the Company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any rights to dividends or other distributions on the shares that are separate from the underlying shares;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any performance-related fees that the nominating person is entitled to based on any increase or decrease in the
value of any shares of the Company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a description of all agreements, arrangements or understandings by and between the proposing stockholder and
another person relating to the proposed business (including an identification of each party to such agreement, arrangement or understanding and the names, addresses and class and number of shares owned beneficially or of record of other stockholders
known by the proposing stockholder support such proposed business); </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a statement whether or not the proposing stockholder will deliver a proxy statement and form of proxy to holders
of, in the case of a business proposal, at least the percentage of voting power of all shares of capital stock required to approve the proposal or, in the case of director nominations, at least the percentage of voting power of all of the shares of
capital stock reasonably believed by the proposing stockholder to be sufficient to elect the nominee; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other information relating to the nominating person that would be required to be disclosed in a proxy
statement filed with the SEC. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With respect to proposed director nominees, the stockholder&#146;s notice must include all information
required to be disclosed in a proxy statement in connection with a contested election of directors or otherwise required pursuant to Regulation 14A under the Exchange Act (including such person&#146;s written consent to being named in the proxy
statement as a nominee and to serving as a director if elected). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For matters other than the election of directors, the stockholder&#146;s notice must also
include a brief description of the business desired to be brought before the meeting, the reasons for conducting such business at the meeting and any material interest in such business of the stockholder(s) proposing the business. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The stockholder&#146;s notice must be updated and supplemented, if necessary, so that the information required to be provided in the notice is true and correct
as of the record date for the meeting and as of the date that is ten business days prior to the meeting. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board of Directors, a designated committee
thereof or the chairman of the meeting will determine if the procedures in our Bylaws have been followed, and if not, declare that the proposal or nomination be disregarded. The nominee must be willing to provide any other information reasonably
requested by the Nominating and Corporate Governance Committee in connection with its evaluation of the nominee&#146;s independence. There have been no material changes to the process by which stockholders may recommend nominees to our Board of
Directors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Stockholder Communications with the Board of Directors </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stockholders may send correspondence to the Board of Directors at our principal executive offices at the address set forth above. The Company will forward all
correspondence addressed to the Board of Directors or any individual Board member. Stockholders may also communicate online with our Board of Directors as a group by accessing our website (https://bridgebio.com) and selecting the &#147;For
Investors&#148; tab and &#147;Contact IR&#148;. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Director Attendance at Annual Meetings </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Directors are encouraged to attend the Annual Meeting. All of our eight directors then serving on our Board of Directors attended our 2020 annual meeting of
stockholders. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Compensation Committee Interlocks and Insider Participation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During 2020, the members of our Compensation Committee included Dr.&nbsp;Aguiar, Mr.&nbsp;Satvat and Mr.&nbsp;Momtazee. Mr.&nbsp;Momtazee resigned from our
Compensation Committee in February 2020, when he became an employee of the Company, which employment continued through January 2021. None of the members of our Compensation Committee was an officer or employee of the Company while serving on the
Compensation Committee during 2020, a former officer of the Company, or had any other relationships with us requiring disclosure herein, except that Mr.&nbsp;Satvat serves as a Partner of Kohlberg Kravis Roberts&nbsp;&amp; Co. L.P., which is an
affiliate of KKR Genetic Disorder L.P., a holder of more than 5% of our outstanding common stock, and which is an affiliate of KKR Capital Markets LLC, which acted as an initial purchaser in connection with certain of our note offerings and as
underwriter in connection with a registered sale of our common stock. See the section titled &#147;Certain Relationships and Related Party Transactions - Agreements and Transactions with 5% Stockholders and Their Affiliates - Participation in Our
Offerings&#148; for more information. None of our executive officers currently </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
serves, or in the past fiscal year has served, as a member of the Board of Directors or compensation committee of any entity that has one or more executive officers serving on our Board of
Directors or Compensation Committee. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Director Compensation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our directors are eligible to receive the following cash retainers and equity awards pursuant to our formal policy: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="83%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annual Retainer for Board Membership</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Initial <FONT STYLE="white-space:nowrap">Non-Statutory</FONT> Stock Option Grant upon
Election</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annual <FONT STYLE="white-space:nowrap">Non-Statutory</FONT> Stock Option Grant</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Annual Retainer for Board Membership </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our policy provides that, each director who is not serving as our Chief Executive Officer (an &#147;Outside Director&#148;) shall receive a cash retainer in
the amount of $50,000 for general availability and participation in meetings and conference calls of our Board of Directors. No additional compensation is paid for attending individual Board meetings, serving on committees of the Board of Directors
or attending committee meetings. Cash retainers owing to Outside Directors shall be annualized, meaning that with respect to directors who join the Board of Directors during the calendar year, such amounts shall be
<FONT STYLE="white-space:nowrap">pro-rated</FONT> based on the number of calendar days served by such director. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Initial Equity Grant Upon Election
</I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our policy provides that, upon initial election to our Board of Directors, each Outside Director will receive an initial, <FONT
STYLE="white-space:nowrap">one-time</FONT> grant of a <FONT STYLE="white-space:nowrap">non-statutory</FONT> stock option with a value of $1,200,000, with an exercise price per share equal to the closing price of a share of our common stock on the
date of grant and a term of ten years, that vests in three equal annual installments over three years; provided, however, that all vesting ceases if the director resigns from our Board of Directors or otherwise ceases to serve as a director, unless
the Board of Directors determines that the circumstances warrant continuation of vesting (the &#147;Initial Grant&#148;). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Annual Equity Grant </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our policy provides that, on the date of each of our annual meetings of stockholders, each Outside Director who will continue as a member of our Board of
Directors following such annual meeting and who has not received an Initial Grant in the same calendar will receive a grant of a <FONT STYLE="white-space:nowrap">non-statutory</FONT> stock option on the date of such annual meeting with a value of
$1,200,000, with an exercise price per share equal to the closing price of a share of our common stock on the date of grant and a term of ten years, that vests in three equal annual installments over three years; provided, however, that all vesting
ceases if the director resigns from our Board of Directors or otherwise ceases to serve as a director, unless the Board of Directors determines that the circumstances warrant continuation of vesting (the &#147;Annual Grant&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Initial Grants and Annual Grants are subject to full accelerated vesting upon a &#147;sale event,&#148; as defined in the Amended and Restated BridgeBio
Pharma, Inc. 2019 Stock Option and Incentive Plan (the &#147;2019 Plan&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The policy also provides that the aggregate amount of compensation,
including both equity compensation and cash compensation, paid to any Outside Director in a calendar year will not exceed $1,250,000 (or such other limit as may be set forth in the 2019 Plan or any similar provision of a successor plan).<B> </B>
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Chief Executive Officer will receive no additional compensation for his service as a director. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will reimburse all reasonable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses incurred by our
Outside Directors for their attendance at meetings of our Board of Directors or any committee thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table presents the total compensation for each person who served as an Outside Director during
the year ended December&nbsp;31, 2020, other than Dr.&nbsp;Homcy, which is presented in &#147;Executive Compensation-Summary Compensation Table&#148; below. The compensation received by Dr.&nbsp;Kumar as Chief Executive Officer is also presented in
&#147;Executive Compensation-Summary Compensation Table&#148; below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="40%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name(1)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fees&nbsp;earned<BR>or paid in<BR>cash ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock<BR>awards&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>awards<BR>($)(2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All other<BR>compensation&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Eric Aguiar, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">93,539</TD>
<TD NOWRAP VALIGN="bottom">(4)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,860,304</TD>
<TD NOWRAP VALIGN="bottom">(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,953,843</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jennifer E. Cook</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,199,992</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">100,000</TD>
<TD NOWRAP VALIGN="bottom">(9)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,349,992</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James C. Momtazee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">294,213</TD>
<TD NOWRAP VALIGN="bottom">(5)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,493,632</TD>
<TD NOWRAP VALIGN="bottom">(5)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46,042</TD>
<TD NOWRAP VALIGN="bottom">(6)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,883,887</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ali Satvat</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">105,571</TD>
<TD NOWRAP VALIGN="bottom">(7)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,860,304</TD>
<TD NOWRAP VALIGN="bottom">(8)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,965,875</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Brenton L. Saunders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26,099</TD>
<TD NOWRAP VALIGN="bottom">(10)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,199,999</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,226,098</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard H. Scheller, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,199,992</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">600,000</TD>
<TD NOWRAP VALIGN="bottom">(11)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,849,992</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Andrew Lo</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26,099</TD>
<TD NOWRAP VALIGN="bottom">(10)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,199,999</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,226,098</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Randal Scott</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26,099</TD>
<TD NOWRAP VALIGN="bottom">(10)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,199,999</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,226,098</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ronald Daniels</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44,253</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,200,273</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,244,526</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As of December&nbsp;31, 2020: Dr.&nbsp;Aguiar held outstanding options to purchase an aggregate of 195,300
shares of our common stock; Ms.&nbsp;Cook held outstanding options to purchase an aggregate of 212,384 shares of our common stock; Mr.&nbsp;Momtazee held outstanding options to purchase an aggregate of 220,227 shares of our common stock;
Mr.&nbsp;Satvat held outstanding options to purchase an aggregate of 86,112 shares of common stock of Eidos Therapeutics, Inc. (&#147;Eidos&#148;) and 195,300 shares of our common stock; Mr.&nbsp;Saunders held outstanding options to purchase an
aggregate of 101,223 shares of our common stock; Dr.&nbsp;Scheller held outstanding options to purchase an aggregate of 248,688 shares of our common stock; Mr.&nbsp;Lo held outstanding options to purchase an aggregate of 101,223 shares of our common
stock; Mr.&nbsp;Scott held outstanding options to purchase an aggregate of 101,223 shares of our common stock; and Mr.&nbsp;Daniels held outstanding options to purchase an aggregate of 91,554 shares of our common stock. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In accordance with SEC rules, this column reflects the aggregate grant date fair value of the option awards
granted by the Company and by Eidos during 2020 computed in accordance with Financial Accounting Standard Board Accounting Standards Codification Topic 718 for stock-based compensation transactions (&#147;FASB ASC Topic 718&#148;). Such aggregate
grant date fair values do not take into account any estimated forfeitures related to service-vesting conditions. Assumptions used in the calculation of these amounts are included in Note 15 to our financial statements included in our Annual Report
on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2020. These amounts do not reflect the actual economic value that may be realized by the directors upon the exercise of the stock options or the sale of
the common stock underlying such stock options. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes the aggregate grant date fair value of an option grant from Eidos equal to $660,312.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes fees equal to $43,539 paid by Eidos as of December&nbsp;31, 2020. All cash payments to Dr.&nbsp;Aguiar
were made payable to Aisling Capital Management LP. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes an option to purchase shares of the Company&#146;s common stock valued at $293,640 on the date of
grant and RSAs valued at $294,213 granted to Mr.&nbsp;Momtazee in his role as Senior Advisor to the Company pursuant to the Offer Letter with the Company, effective as of February&nbsp;12, 2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes compensation and Company matching of 401(k) contributions paid to Mr. Momtazee in his role as Senior
Advisor to the Company. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes the aggregate grant date fair value of an option grant from Eidos equal to $660,312.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes fees equal to $55,571 paid by Eidos. All cash payments to Mr.&nbsp;Satvat were made payable to KKR
Genetic Disorder L.P. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes fees accrued and paid to Ms.&nbsp;Cook in connection with consulting services rendered to the Company.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes pro-rated annual retainer for membership on the Board of Directors commencing June 2020.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes compensation paid to Dr. Scheller in his role as our Chairman of Research and Development.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Required Vote </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The three (3)&nbsp;nominees receiving the highest number of affirmative votes of all the votes properly cast shall be elected as directors to serve until the
date of the annual meeting of stockholders following the year ending December&nbsp;31, 2023 and until their successors are duly elected and qualified, or until such director&#146;s earlier death, resignation or removal. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recommendation of the Board of Directors </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Board of
Directors recommends that the stockholders vote FOR the election of the three (3)&nbsp;director nominees listed above. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc131567_6"></A>EXECUTIVE OFFICERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following is information for our executive officers, as of December 31, 2020. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="63%"></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Brian C. Stephenson, Ph.D., CFA</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>40</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Chief&nbsp;Financial&nbsp;Officer&nbsp;and&nbsp;Secretary</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Michael Henderson, M.D.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>31</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Chief Business Officer</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Cameron Turtle, Ph.D.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>31</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Chief Strategy Officer</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Biographical information for Neil Kumar and Charles Homcy is included above with the director biographies under the caption
&#147;Current Directors.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Brian C. Stephenson, Ph.D., CFA</I></B><B> </B>has served as our Chief Financial Officer since October 2018. Prior
to joining us, Dr.&nbsp;Stephenson served as Partner and the Head of Life Sciences for Capital IP Investment Partners, a special situation investment fund, from 2015 to 2018. From 2011 to 2014, Dr.&nbsp;Stephenson was a Director/Vice President
Leerink Partners, an investment bank. Prior to that, Dr.&nbsp;Stephenson was an Engagement Manager at McKinsey&nbsp;&amp; Company, a worldwide management consulting firm. He received his Ph.D. and M.S. degrees in chemical engineering from the
Massachusetts Institute of Technology and his B.S. in chemical engineering from Brigham Young University. Dr.&nbsp;Stephenson is also a Chartered Financial Analyst charterholder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Michael Henderson, M.D. </I></B>has served as our Chief Business Officer since January 2020. Prior to that, he served as our Senior Vice President,
Asset Acquisition, Strategy and Operations from December 2017 to December 2019. Dr.&nbsp;Henderson joined BridgeBio as our Vice President of Asset Acquisition, Strategy and Operations in April 2016. Dr.&nbsp;Henderson serves as the Chief Executive
Officer of certain of our subsidiaries, including QED Therapeutics, Inc. since December 2017 and Origin Biosciences, Inc. from December 2017 to December 2019 and commencing again in March 2020. Dr.&nbsp;Henderson also serves on the board of
directors for certain of our subsidiaries, including TheRas, Inc. since September 2016 and Adrenas Therapeutics, Inc. since July 2017. Prior to BridgeBio, Dr.&nbsp;Henderson worked as a Senior Associate at McKinsey&nbsp;&amp; Company from January
2015 to April 2016 and prior to that, he <FONT STYLE="white-space:nowrap">co-founded</FONT> PellePharm, Inc., in August 2011. Dr.&nbsp;Henderson received his B.A. with high honors in global health with a citation in Spanish from Harvard University
and his M.D. with a scholarly concentration in health services and policy from Stanford University where he was a member of both the Ignite and Leadership in Health Disparities Programs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cameron Turtle, Ph.D.</I></B> has served as our Chief Strategy Officer since January 2021. Prior to that, he served as our Senior Vice President,
Portfolio Management and Corporate Development, from January 2018 until December 2020 and served as a Director, Portfolio Management, from February 2017 to December 2017. Mr.&nbsp;Turtle has also worked for our subsidiary, Eidos Therapeutics, since
February 2017, currently as the chief business officer, and currently serves as a director of certain of our subsidiaries, including Aspa Therapeutics, since June 2018, CoA Therapeutics, Inc. since January 2018, Dermecular since July 2017 and
Fortify Therapeutics since December 2017. Mr.&nbsp;Turtle previously worked as vice president of business development and operations for our subsidiary, Navire Pharmaceuticals, Inc., from February 2017 to March 2018. From August 2016 to January
2017, Mr.&nbsp;Turtle was a consultant at McKinsey&nbsp;&amp; Company. Mr.&nbsp;Turtle received his B.S. with honors in bioengineering from the University of Washington and his D. Phil. in cardiovascular medicine from University of Oxford, St.
John&#146;s College, where he was a Rhodes Scholar. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc131567_7"></A>EXECUTIVE COMPENSATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Compensation Discussion and Analysis </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following
Compensation Discussion and Analysis (&#147;CD&amp;A&#148;) describes the philosophy, objectives and structure of our 2020 executive compensation program and includes discussion and background information regarding the compensation of our named
executive officers (&#147;NEOs&#148;). This CD&amp;A is intended to be read in conjunction with the tables immediately following this section, which provide further historical compensation information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following executive officers are our Named Executive Officers for 2020: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="85%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="46%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Title</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Neil Kumar, Ph.D.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Executive Officer and President</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Brian Stephenson, Ph.D., CFA</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Financial Officer and Secretary</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Michael Henderson, M.D.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Business Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Cameron Turtle, Ph.D.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Strategy Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Charles Homcy, M.D.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chairman of Pharmaceuticals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Brian Stolz<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Former Chief Operating Officer</TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><I><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Mr.&nbsp;Stolz resigned from the Company effective October&nbsp;22, 2020.</I> </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Executive Summary </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BridgeBio is a team of
experienced drug discoverers, developers and innovators working to create life-altering medicines that target well-characterized genetic diseases at their source. BridgeBio was founded in 2015 to identify and advance transformative medicines to
treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. BridgeBio&#146;s pipeline of over 30 development programs ranges from early science to advanced
clinical trials and its commercial organization is focused on delivering the Company&#146;s first approved therapy.</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>2020 Business and Financial
Highlights </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2020 was a year of significant progress for us. Clinical, regulatory and corporate performance highlights for 2020 include: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Laying the groundwork to complete in the first quarter of 2021 our acquisition of all of the outstanding shares
of Eidos Therapeutics, Inc. (&#147;Eidos&#148;) that we did not already own, allowing BridgeBio to deploy its full clinical and commercial infrastructure to develop and plan for potential global commercialization upon regulatory approval of
Eidos&#146; product candidate, acoramidis, a potential <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">best-in-class</FONT></FONT> therapy for patients with amyloidosis cardiomyopathy
<FONT STYLE="white-space:nowrap">(ATTR-CM)</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Acceptance of our New Drug Application (&#147;NDA&#148;) for infigratinib for the treatment of cholangiocarcinoma
by the U.S. Food and Drug Administration (&#147;FDA&#148;) and granting of Priority Review designation under the Real-Time Oncology Review (RTOR) pilot program, designed to expedite the delivery of safe and effective cancer treatments to patients
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Acceptance of our NDA for NULIBRY<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> (fosdenopterin) by
the FDA, leading to NULIBRY&#146;s approval in the first quarter of 2021 as the first and only approved therapy to reduce the risk of mortality for patients with Molybdenum cofactor deficiency (MoCD) Type A, an ultra-rare, life-threatening genetic
disorder that progresses rapidly </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Initiation of two new clinical trials and progress in additional 17 ongoing clinical trials
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Implementation and completion of an equity exchange program (the &#147;Exchange Program&#148;) pursuant to which
certain employees and individual independent contractors who provide services to our affiliates had the opportunity to exchange some or all of the unregistered equity they held in our subsidiaries for shares of registered common stock or
milestone-related equity awards exercisable or convertible into shares of our common stock that are registered on The Nasdaq Global Select Market </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Ending 2020 with $607.1&nbsp;million in cash, cash equivalents and marketable securities </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Increasing our stock price value in 2020 by 103% </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Overview of 2020 Pay Outcomes </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We continue to reward our
NEOs with competitive compensation packages that directly align pay with performance. The caliber of our performance in the areas of research, clinical and regulatory milestones drives our compensation structure, specifically the degree to which
NEOs are granted equity and earn bonuses. Our Compensation Committee regularly examines our compensation program both from a design and pay outcome perspective. In line with our strong growth in 2020, the Compensation Committee considered how our
incentives provided appropriate levels of compensation considering our performance and growth stage. Key decisions include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Annual Bonuses</B> &#150;<B> </B>An annual bonus was paid to our CEO at 250% of target and to our CFO at 216%
based on strong achievement of corporate goals that included advancing our affiliate programs, securing financing through 2021, strengthening internal operations and controls, and building cross-organization and cross-function capabilities. Bonuses
for our other NEOs were paid at levels ranging from 146% to 150% of target based on strong achievement of corporate goals. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Long-term Equity Incentives</B> &#150; The annual stock option grant and restricted stock unit grants to our
CEO in 2020 reflect our <FONT STYLE="white-space:nowrap">&#147;go-forward&#148;</FONT> equity guidelines as compared to the <FONT STYLE="white-space:nowrap">pre-IPO</FONT> grants awarded in 2019. Factors influencing our equity grants to our NEOs in
2020 were based on market data provided to us by our compensation consultant, Radford. See &#147;Compensation Determination Process&#151;Use of Compensation Consultant.&#148; </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Compensation Philosophy&nbsp;&amp; Objectives </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our
compensation programs are designed to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Harness the power of top performers<B> </B>to drive outsized impact relative to the investment, which increases
our probability of success in technical programs and maximizes value for shareholders; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Attract and retain top performers at all levels who contribute to our long-term success; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Focus total rewards on what really matters to our team; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Directly tie rewards to performance through a long-term incentive program that pays out when the company hits
value inflection points. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Compensation Determination Process </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Role of the Compensation Committee </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Compensation
Committee is responsible for the executive compensation programs for our executive officers and reports to Board of Directors on its discussions, decisions and other actions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Compensation Committee, or the Board of Directors upon recommendation from the Compensation Committee, establishes the annual compensation, including
salaries, bonuses and equity awards for our CEO and our executives. For executives other than the CEO, the Compensation Committee solicits and considers evaluations and recommendations by the CEO. In the case of the CEO, the evaluation of his
performance is conducted by the Board of Directors upon recommendation from the Compensation Committee, which determines any adjustments to his compensation as well as awards to be granted. For all executives, as part of its deliberations, the
Compensation Committee may review and consider, as appropriate, materials such as financial reports and projections, operational data, tax and accounting information, company stock performance data, analyses of historical executive compensation
levels and current Company-wide compensation levels and recommendations of Radford, including analyses of executive compensation paid at other companies identified by the consultant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Role of CEO&nbsp;&amp; Management </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our CEO makes recommendations for the respective executive officers that report to him to our Compensation Committee and typically attends Compensation
Committee meetings. Our CEO makes such recommendations (other than with respect to himself) regarding base salary, and short-term and long-term compensation, including equity incentives, for our executive officers based on our results, an executive
officer&#146;s individual contribution toward these results, the executive officer&#146;s role and performance of his or her duties and his or her achievement of individual goals. Our Compensation Committee then reviews the recommendations and other
data, including various compensation survey data and publicly-available data of our peers, and recommends the target total direct compensation, which our CEO has the authority to approve in consultation with our Compensation Committee, for our
executive officers who are not &#147;officers&#148; (as defined in Section&nbsp;16 of the Exchange Act). Our Board of Directors, at the recommendation of our Compensation Committee, has also delegated to our CEO the authority to determine and
approve the cash and equity compensation payable to employees and consultants of the Company and our subsidiaries who are not &#147;officers&#148; (as defined in Section 16 of the Exchange Act). The aggregate amount of compensation our CEO has the
authority to approve in calendar year 2021 pursuant to the foregoing delegations shall not exceed approximately $142.4 million, and the aggregate number of shares of our common stock issuable pursuant to equity awards under our Amended and Restated
2019 Stock Option and Incentive Plan shall not exceed 4,500,000 shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While our CEO typically attends meetings of the Compensation Committee, the
Compensation Committee meets outside the presence of our CEO when discussing his compensation and when discussing certain other matters, as well. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Use
of Compensation Consultant </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Compensation Committee is authorized to retain the services of one or more executive compensation advisors, as it sees
fit, in connection with the establishment of our executive compensation programs and related policies. In fiscal year 2020, the Compensation Committee engaged the services of Radford, which is part of the Rewards Solutions practice at Aon plc, to
conduct a review and analysis of our executive compensation compared with current market practices and a peer group of companies, to be used for setting 2020 executive compensation levels. Radford&#146;s review, which consisted of an analysis of our
compensation practices against prevailing market practices of identified peer group companies and broader industry trends, analyzed total direct compensation of our executive officers and was based on an assessment of market trends through analysis
of available public information in addition to proprietary data provided by Radford. Radford reports directly to the Compensation Committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During 2020,
Radford did not provide services to us other than the services to our Compensation Committee described herein. The Compensation Committee has assessed the independence of Radford according to the six factors mandated by SEC and Nasdaq listing
standards. After conducting this assessment and considering any potential conflicts of interest, the Compensation Committee concluded that the continued engagement of Radford did not raise any conflict of interest and did not adversely affect
Radford&#146;s independence. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Peer Group </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prior to
2020, the Company did not use a peer group. In early 2020, we developed a peer group, with the assistance of Radford, to provide a broad perspective on competitive pay levels and practices for 2020. For this peer group, the Compensation Committee,
reviewed similar companies with respect to sector, stage of development and market capitalization that was ultimately chosen based on these characteristics and others including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Sector</B> &#150;<B> </B>publicly-traded <FONT STYLE="white-space:nowrap">pre-commercial</FONT> or early-stage
commercial biopharma companies </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Market Capitalization</B> &#150; $1B to $13B market capitalization range </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Size</B> &#150; companies with under 450 employees </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on the above market data, Radford compiled the following peer group of companies in early 2020: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center">Acceleron Pharma</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">FibroGen</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center">Aimmune Therapeutics</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Global Blood Therapeutics</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center">Ackea Therapeutics</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">MyoKardia</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center">Axsome Therapeutics</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Nektar Therapeutics</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center">bluebird bio</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Principia Biopharma</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center">Blueprint Medicines</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Ra Pharmaceuticals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center">Deciphera Pharmaceuticals</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Sage Therapeutics</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center">Dicerna Pharmaceuticals</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Tricida</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center">Epizyme</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Ultragenyx Pharmaceutical</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In light of the Company&#146;s rapid growth, the Compensation Committee conducts an annual review of peers to ensure that the
underlying criteria for peer selection remains appropriate, ensuring that we consider companies that have profiles similar to us and removing companies that have been acquired in the interim. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As guidelines for our executives, we set target cash compensation, when considering salary and bonus potential, and equity compensation, delivered through
equity-based awards, after generally referencing the compensation paid to executives within our compensation peer group. We target equity compensation for our executives at or above the 50th percentile of equity compensation paid to executives in
our compensation peer group, however our own performance and individual performance informs decisions on equity compensation. We believe that our emphasis on equity compensation serves to retain our executives and directors and align their interests
with those of our stockholders. We also believe that these references appropriately reflect our position and performance, which has been very strong since our IPO in June 2019. We may deviate from setting actual compensation levels at these target
levels with respect to our executives to reflect experience, performance levels, existing equity holdings, and market factors as deemed appropriate by the Compensation Committee or the Board of Directors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Pay Components </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Compensation Committee has
developed an executive compensation program that consists of three main components. The relative mix of these components is weighted more on incentives, particularly long-term incentives, rather than fixed compensation. The focus on incentive
compensation is intended to ensure that the interests of our executives are aligned with those of our stockholders. Our compensation program is made up of the following three key compensation components: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="76%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Base Salary</B></P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:1pt">


<IMG SRC="g131567g26a01.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Base salaries are fixed annual cash compensation established and reviewed annually with consideration for responsibilities, experience, market data and individual contributions. Base salaries are set to be competitive within our
industry and are important in attracting and retaining talented executives.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Annual Performance-based Bonus</B></P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:1pt">


<IMG SRC="g131567g26b02.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The annual performance-based bonus opportunity is a variable, cash incentive program. It is intended to motivate and reward our executives
for the achievement of key strategic goals of the Company.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">In 2020, our annual
incentives were based on key corporate objectives and individual performance.</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="76%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Long-Term Equity Incentives</B></P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:1pt">


<IMG SRC="g131567g26c03.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Long-term equity awards incentivize executives to deliver long-term shareholder value, while also providing a retention vehicle for our
top executive talent and promoting an ownership culture at the Company.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Equity
awards are delivered as time-vested stock options and restricted stock units. These awards are typically granted on an annual basis.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">From time to time, the Compensation Committee may determine it in the Company&#146;s best interest to use other award types, such as PSUs and milestone
achievement grants, to drive the achievement of specific performance outcomes.</P></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Overview of Compensation Program Governance </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>What We Do</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>What We Don&#146;t Do</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Pay for performance - structure a substantial portion of pay to be &#147;at risk&#148; and based on Company and individual performance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">No excise tax or other gross ups</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Maintain a long-term strategic plan for equity compensation and avoid undue emphasis on short-term value</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">No significant fringe benefits or perquisites that are not available to all employees</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Retain an independent compensation consultant</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Hedging and pledging are prohibited</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Review peer group and peer pay regularly as reference point</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">No retirement programs other than our 401K</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Maintain an independent compensation committee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In prior years, we were an &#147;emerging growth company&#148; as defined in the Jumpstart Our Business Startups Act of 2012
and were not required to hold a&nbsp;non-binding,&nbsp;advisory vote on the compensation of our NEOs (a&nbsp;&#147;Say-on-Pay&nbsp;Vote&#148;). At this Annual Meeting of Stockholders, we will hold our first&nbsp;Say-on-Pay&nbsp;Vote as described in
Proposal 2 of this Proxy Statement. Our board of directors and compensation committee will consider the result of the&nbsp;Say-on-Pay&nbsp;vote, and the related&nbsp;&#147;Say-on-Frequency&#148;&nbsp;vote, as described in Proposal 3 of this Proxy
Statement, as well as feedback received throughout the year, when making compensation decisions for our executive officers in the future because we value the opinions of our stockholders. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Base Salary </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Base salaries for our NEOs consider
such executive&#146;s qualifications, experience, the scope of his responsibilities, and competitive market compensation paid by other companies for similar positions within the industry. Base salaries were initially established at the time of our
IPO in 2019 and were adjusted in 2020. In making decisions regarding salary increases, we draw upon the experience of members of our Compensation Committee with other companies and considering individual responsibilities, performance and experience.
We also we draw upon the expertise of Radford, who provides comparative compensation data from similar sized companies in our industry. The Compensation Committee does not apply specific formulas to determine base salary increases. This strategy is
consistent with our intent of offering base salaries that are cost-effective while remaining competitive. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="63%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019 Base<BR>Salary</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020&nbsp;Base<BR>Salary</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>%&nbsp;Increase</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Neil Kumar, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">450,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">550,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Brian Stephenson, Ph.D., CFA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">420,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">550,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael Henderson, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">410,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">515,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cameron Turtle, Ph.D.<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">350,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">400,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Charles Homcy, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Brian Stolz</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">625,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">625,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="font-size:6.5pt"><I>(1)&nbsp;</I></FONT></SUP></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Dr. Turtle is paid through our subsidiary, Eidos Therapeutics, Inc.</I> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For 2020, our Board of Directors approved increases in base salary ranging from 14% to 31% based on evaluation of the third-party market compensation data and
recommendations from Radford, as necessary to be competitive with our peer group. The 2020 base salary increases were effective as of January&nbsp;1, 2020. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Annual Performance-Based Bonus </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to
base salaries, certain of our NEOs are eligible to receive annual cash bonuses, which are designed to provide appropriate incentives to our executives to achieve corporate goals and individual accomplishments, and to reward our executives who
significantly impact our results. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each NEO has a target bonus represented as a percentage of base salary, or a target bonus percentage, each of which is
set forth below. These bonus targets were set by the Compensation Committee based on recommendations from Radford as necessary to be competitive with our peer group: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="61%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020 Base</B><br><B>Salary</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020&nbsp;Target</B><br><B>Bonus&nbsp;(%&nbsp;of<BR>base salary)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020&nbsp;Target</B><br><B>Bonus</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Neil Kumar, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">550,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">330,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Brian Stephenson, Ph.D., CFA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">550,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">330,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael Henderson, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">515,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">206,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cameron Turtle, Ph.D.<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">400,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">140,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Charles Homcy, M.D.<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Brian Stolz<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">625,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">375,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="font-size:6.5pt"><I>(1)&nbsp;</I></FONT></SUP></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Dr. Turtle was paid through our subsidiary, Eidos Therapeutics, Inc.</I> </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><I><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Dr.&nbsp;Homcy does not have a defined target bonus pursuant to his offer letter with the Company.</I>
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="font-size:6.5pt"><I>(3)</I></FONT></SUP><FONT STYLE="font-size:6.5pt">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Mr.&nbsp;Stolz resigned from the Company effective October&nbsp;22, 2020.</I> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our performance goals vary from&nbsp;year to&nbsp;year. For the FY 2020 bonus, these goals included advancing our affiliate programs, securing financing
through 2021, strengthening internal operations and controls, and building cross-organization and cross-function capabilities. The corporate performance goals are generally tied to achievement of clinical and regulatory milestones related to our
preclinical and clinical development programs across our affiliates. The Compensation Committee determines whether any weighting will be applied to each of the goals that comprise the established corporate performance goals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Compensation Committee and our Board of Directors reviews the Company&#146;s achievement of the corporate goals in their totality, considering the
Company&#146;s overall performance for the year and comes to a general, subjective conclusion as to whether the corporate goals were met, and whether there were any other extraordinary factors that should be considered in determining the amount of
bonus earned for the year. In sum, the actual amount of bonus compensation that is earned by our NEOs is a subjective, discretionary, determination made by our CEO in consultation with the Compensation Committee following the Board of
Directors&#146; and the Compensation Committee&#146;s review of the Company&#146;s achievement of the corporate goals, other than for our CEO and CFO, whose compensation is determined by the Board of Directors. The Board of Directors believes that
maintaining discretion to evaluate corporate performance at the close of the year based on the totality of the circumstances, and the discretion to award or fail to award bonus compensation without reliance on rote calculations under set formulas,
is appropriate in responsibly discharging its duties. Payouts of earned bonuses, if any, are generally made in the year following the year of performance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For 2020, our Board of Directors determined that the corporate goals were achieved. Based on the achievement of corporate performance goals, our NEOs received
bonuses ranging from 146% to 250% of their targets. Mr.&nbsp;Stolz </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
left the company prior to the Company bonus being paid out and therefore was not eligible for a 2020 fiscal year performance bonus. Overall, bonus payments are outlined in the table below: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="59%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020&nbsp;Target</B><br><B>Bonus</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020&nbsp;Bonus<BR>Payout</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020&nbsp;Bonus<BR>Payout&nbsp;(%&nbsp;of<BR>bonus&nbsp;target)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Neil Kumar, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">330,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">825,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">250</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Brian Stephenson, Ph.D., CFA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">330,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">712,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">216</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael Henderson, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">206,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">300,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">146</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cameron Turtle, Ph.D.<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">140,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">210,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">150</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Charles Homcy, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">100,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Brian Stolz</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">375,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">682,777</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><I><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I></I><I>Dr. Turtle was paid through our subsidiary, Eidos Therapeutics, Inc.</I> </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><I><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Mr.&nbsp;Stolz did not receive a bonus based on 2020 performance given his resignation from the Company in
October 2020. Pursuant to our severance agreement with Mr. Stolz, he received a target bonus payment of $375,000 and a pro-rated bonus payment for the fiscal year ended December 31, 2020, in the amount of $307,377.</I> </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Long-term Incentive Program </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our long-term,
equity-based incentive awards are designed to align the interests of our NEOs with the interests of our stockholders. We believe that equity compensation is an integral component of our efforts to attract and retain exceptional executives, senior
management and other employees at this critical point on our growth and both a newly public, <FONT STYLE="white-space:nowrap">pre-commercial</FONT> stage company. In 2020, we structured this in a mix of 75% stock options and 25% in RSUs. Because
vesting is generally subject to continued service over a period of several years following the date of grant, our equity-based incentives also serve as a retention device for NEOs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The stock option grants are intended to create a direct link between our NEOs&#146; compensation and our stock price appreciation. Because the executive must
pay a cash exercise price equal to the value of the stock on the date the option is granted, the executive will only receive value from the option grant if the value of our stock increases following the option grant date. Likewise, the value of RSUs
increase as our stock price increases. Accordingly, we believe stock options and RSUs provide meaningful incentives to our executives to achieve increases in the value of our stock over time. In addition, the vesting feature of our equity grants
contributes to executive retention by providing an incentive to our executives to remain employed by us during the vesting period. We also believe that if our executives own shares of our common stock with value that is significant to them, but
which value cannot be immediately realized, they will have an incentive to act to maximize longer-term stockholder value instead of short-term gain. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
June 2020, in connection with the annual compensation review, the Company granted stock options and RSUs to most of our NEOs. The size of the awards to any individual is determined based on several factors including performance as well as the total
number of shares available for grant under our Amended and Restated 2019 Stock Option and Incentive Plan, and the levels of equity compensation, both from the perspective of grant date values and as a percent of common shares outstanding, provided
by our peer companies to their executives. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes the equity grants to our NEOs in 2020: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020&nbsp;RSU</B><br><B>(#&nbsp;Shares)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020&nbsp;Stock<BR>Options</B><br><B>(# Shares)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Neil Kumar, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">82,069</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">590,551</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Brian Stephenson, Ph.D., CFA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27,356</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">196,850</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael Henderson, M.D.<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">205,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cameron Turtle, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,745</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Charles Homcy, M.D.<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Brian Stolz</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25,532</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">183,727</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="font-size:6.5pt"><I>(1)&nbsp;</I></FONT></SUP></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Dr. Henderson received an option award from a subsidiary of the Company in 2020. Please refer to the Summary
Compensation Table.</I> </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="font-size:6.5pt"><I>(2)&nbsp;</I></FONT></SUP></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Dr. Homcy received an option award for service on our Board of Directors. Please refer to the Summary
Compensation Table</I><I>.</I> </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All of our stock option grants made to our NEOs vest monthly in equal increments over a four-year period
subject to the NEO&#146;s continued services with us. All of our RSUs vest quarterly in equal increments over a four-year period subject to the NEO&#146;s continued services with us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, in March 2020, the Compensation Committee approved our implementation of the Exchange Program pursuant to which certain employees and individual
independent contractors who provide services to our subsidiaries were offered the opportunity to exchange some or all of the equity held by these individuals in our subsidiaries for (i)&nbsp;vested shares of our common stock, (ii)&nbsp;shares of our
restricted common stock subject to vesting on the same terms and conditions as the unvested shares of restricted common stock held by them in our subsidiaries, (iii)&nbsp;options to purchase shares of our common stock, and/or (iv)&nbsp;the right to
receive notional units in our common stock that will pay out an applicable fixed dollar amount upon the achievement of certain designated performance milestones (the &#147;Milestone Program&#148;). We and our Compensation Committee determined that
the Exchange Program is critical to our retention of high-performing employees and individual independent contractors who provide services to our subsidiaries because it provides them with the opportunity to receive shares of our common stock (or
equity awards exercisable or convertible into shares of our common stock) that will be registered and listed on the Nasdaq Stock Market in exchange for unregistered equity in our privately held subsidiaries. Additionally, the ability for certain of
these individuals to participate in the Milestone Program creates an incentive for them to contribute to the achievement of defined milestones at the subsidiary level while aligning their long-term interests with those of our stockholders. We
successfully completed the Exchange Program in 2020 and continue to incentivize employees with grants under the Milestone Program. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Additional
Compensation Policies and Practices </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Perquisites, Health and Welfare Benefits </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our NEOs are eligible to participate in all our employee benefit plans, including our medical, dental, vision, group life and disability insurance plans, in
each case on the same basis as our other employees. We pay the premiums for term life insurance and disability insurance for all our employees, including our NEOs. Our Board of Directors may elect to adopt qualified or
<FONT STYLE="white-space:nowrap">non-qualified</FONT> benefit plans in the future if it determines that doing so is in our best interests. None of our NEOs participate in or have account balances in qualified or
<FONT STYLE="white-space:nowrap">non-qualified</FONT> defined benefit, <FONT STYLE="white-space:nowrap">non-qualified</FONT> defined contribution plans or defined benefit pension plans sponsored by us. We provide a 401(k) plan for all our eligible
employees, including our NEOs, and make matching contributions, as described in the section below entitled &#147;401(k) Plan.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We also provided
limited perquisites to our named executive officers in 2020, consisting primarily of commuting expenses and other <I>de minimis</I> benefits. We believe that providing such perquisites were appropriate to assist our NEOs in the performance of his
duties. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>401(k) Plan </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All of our full-time employees in the United States, including our NEOs, are eligible to participate in our 401(k) plan, which is a retirement savings defined
contribution plan established in accordance with Section&nbsp;401(a) of the Code. The 401(k) plan provides that each participant may contribute up to the lesser of 100% of his or her compensation or the statutory limit, which is $19,500 for calendar
year 2020. Participants that are 50&nbsp;years or older can also make <FONT STYLE="white-space:nowrap">&#147;catch-up&#148;</FONT> contributions, which in calendar year 2020 may be up to an additional $6,500 above the statutory limit. In 2020, we
made matching contributions into the 401(k) plan on behalf of participants, matching 100% of participant contributions up to 3% of eligible compensation and 50% of participant contributions above that level up to 5% of eligible compensation.
Participant contributions are held and invested, pursuant to the participant&#146;s instructions, by the plan&#146;s trustee. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Anti-Hedging and
Pledging Policy </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Insider Trading policy expressly prohibits each of our directors, officers and employees from engaging in any speculative
transaction designed to decrease the risks associated with holding our securities, including hedging or similar transactions. We also prohibit any pledging of our securities as collateral for loans and the holding of our securities in margin
accounts without <FONT STYLE="white-space:nowrap">pre-approval.</FONT> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Accounting for Share-Based Compensation </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We account for share-based compensation in accordance with the requirements of FASB ASC Topic 718. This accounting treatment has not significantly affected our
executive compensation decisions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Report of the Compensation Committee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>The material in this report is not &#147;soliciting material,&#148; is not deemed &#147;filed&#148; with the SEC and is not to be incorporated by reference
in any filing of the Company under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), or the Exchange Act, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing.
</I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Compensation Committee of the Company has reviewed and discussed the Compensation Discussion and Analysis required by Item 402(b) of Regulation <FONT
STYLE="white-space:nowrap">S-K</FONT> with management and, based on such review and discussions, the Compensation Committee recommended to the Board of Directors that the CD&amp;A be included in this Proxy Statement for the Annual Meeting and
incorporated by reference in the Company&#146;s Annual Report on Form 10-K for the fiscal year ended December 31, 2020. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Compensation Committee</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Eric Aguiar, M.D., Chair</I></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Ali Satvat</I></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2020 Summary Compensation Table </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table provides information regarding the total compensation awarded to, earned by, and paid to our named executive officers for services rendered
to us in all capacities for the years ended set forth below. Please note that in certain years Drs. Stephenson, Henderson and Turtle were not NEOs and as such we are not including their compensation for those years. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Name and Principal Position</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Year</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Salary<BR>($)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Bonus<BR>($)(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Stock<BR>Awards<BR>($)(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Option<BR>Awards<BR>($)(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">All Other<BR>Compensation<BR>($)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Total ($)</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Neil Kumar, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">550,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">825,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,368,511</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,299,998</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,054,909</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Chief Executive Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">502,765</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">360,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,863,445</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,573,049</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34,804</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26,334,063</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">450,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">450,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Brian Stephenson, Ph.D., CFA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">550,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">712,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">789,494</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,099,996</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,943</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>(7)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,163,933</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Chief Financial Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">420,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">189,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">132,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,430,781</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26,586</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,198,967</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">74,375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">(4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">330,240</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,942,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,347,115</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Michael Henderson, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">515,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">300,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,072,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">91,899</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>(5)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,843</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>(7)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,991,241</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Chief Business Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Cameron Turtle, Ph.D.*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">400,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">210,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,940,081</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>(6)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>(7)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,561,482</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Chief Strategy Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Charles Homcy, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">100,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,199,992</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>(8)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">55,812</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>(9)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,855,805</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Chairman of Pharmaceuticals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">513,808</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,111,579</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,128,716</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">221,737</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,975,842</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Brian Stolz</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">511,362</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right">(10)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">736,854</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,992,182</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>(11)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,975,453</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>(12)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,240,851</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Chief Operating Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">146,780</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">93,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,860,780</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,045,003</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,146,313</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Dr. Turtle is employed through our subsidiary, Eidos Therapeutics, Inc. In 2020, his salary and bonus were paid
by Eidos Therapeutics, Inc. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The bonus amounts reported reflect the discretionary cash bonuses earned by the named executive officers, and
determined by our Board of Directors, for the applicable fiscal year, based on the named executive officers&#146; performance during such fiscal year. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In accordance with SEC rules, these columns reflect the aggregate grant date fair values of the stock awards
and option awards, as applicable, granted during the applicable fiscal year, computed in accordance with FASB ASC Topic 718 for stock-based compensation transactions. Such aggregate grant date fair values do not take into account any estimated
forfeitures related to service vesting conditions. Assumptions used in the calculation of these amounts are included in Note 15 to our audited financial statements included in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT>
for the fiscal year ended December&nbsp;31, 2020. These amounts do not reflect the actual economic value that will be realized by the named executive officers upon the exercise of the options, the lapse of our repurchase right on any shares of
restricted stock or the sale of shares of our common stock underlying such awards. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes employer matching contributions received under the Company&#146;s 401(k) plan and <I>de minimis</I>
Company-paid travel services. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Dr.&nbsp;Stephenson commenced employment with us on October&nbsp;29, 2018, and his annual base salary
was&nbsp;pro-rated&nbsp;accordingly. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes the grant date fair value of an option grant in a subsidiary of the Company. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes grant date fair value under ASC 718 based on probable outcome of a performance metric, which assumes
maximum achievement of such performance metric. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes employer matching contributions received under the Company&#146;s 401(k) plan. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes the aggregate grant date fair value in the amount of $1,199,992 of an option grant made in connection
with Dr.&nbsp;Homcy&#146;s service on the Board of Directors. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes annual payment of $50,000 in connection with Dr.&nbsp;Homcy&#146;s service on the Board of Directors
and employer matching contributions received under the Company&#146;s 401(k) plan. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes one-time achievement bonus paid in connection with the completion of the Exchange Program.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes $32,182 of incremental expense to the Company related to the modification of the exercise period for
15,310 options to purchase shares of common stock. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(12)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes compensation paid to Mr. Stolz pursuant to his separation agreement with the Company entered into in
November 2020, including: $1,250,000 separation payment; $375,000 target bonus payment; $307,377 pro rated 2020 bonus payment; and $36,329 COBRA reimbursement of payment. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Grants of Plan-Based Awards for Fiscal Year 2020 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth the individual awards made to each of our NEOs during 2020. For a description of the types of awards indicated below, please
see our &#147;Compensation Discussion and Analysis&#148; above. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="36%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:7pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant&nbsp;Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Estimated Future Payouts Under</B><br><B>Equity Incentive Plan Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All Other<BR>Stock&nbsp;Awards<BR>Number&nbsp;of<BR>Shares of<BR>Stock<BR>or&nbsp;Units</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All Other<BR>Option<BR>Awards<BR>Number of<BR>Securities<BR>Underlying<BR>Options</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exercise<BR>or Base<BR>Price of<BR>Option<BR>Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant Date<BR>Fair Value<BR>of Stock<BR>and&nbsp;Options<BR>Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Threshold</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Target</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Maximum</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Neil Kumar, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6/3/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">590,551</TD>
<TD NOWRAP VALIGN="bottom">(1)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28.86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,299,998</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6/3/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">82,069</TD>
<TD NOWRAP VALIGN="bottom">(2)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,368,511</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Brian&nbsp;Stephenson,&nbsp;Ph.D.,&nbsp;CFA</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6/3/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">196,850</TD>
<TD NOWRAP VALIGN="bottom">(1)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28.86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,099,996</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6/3/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27,356</TD>
<TD NOWRAP VALIGN="bottom">(2)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">789,494</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Michael&nbsp;Henderson,&nbsp;M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5/19/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">205,000</TD>
<TD NOWRAP VALIGN="bottom">(2)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,072,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4/3/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,456</TD>
<TD NOWRAP VALIGN="bottom">(5)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.07</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,609</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7/21/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,137</TD>
<TD NOWRAP VALIGN="bottom">(5)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.07</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,571</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9/30/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,199</TD>
<TD NOWRAP VALIGN="bottom">(5)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42.80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68,719</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Cameron Turtle, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9/1/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,745</TD>
<TD NOWRAP VALIGN="bottom">(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">75,817</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5/19/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,805,649</TD>
<TD NOWRAP VALIGN="bottom">(4)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,864,264</TD>
<TD NOWRAP VALIGN="bottom">(6)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Charles Homcy, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6/2/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">112,422</TD>
<TD NOWRAP VALIGN="bottom">(8)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,199,992</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Brian Stolz</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6/3/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">183,727</TD>
<TD NOWRAP VALIGN="bottom">(1)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28.86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,992,182</TD>
<TD NOWRAP VALIGN="bottom">(7)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6/3/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25,532</TD>
<TD NOWRAP VALIGN="bottom">(2)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">736,854</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">1/48th of the shares underlying option grant vest on a monthly basis. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">6.25% of the RSUs vested on August 16, 2020 and 6.25% will continue to vest in quarterly installments.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">This award was fully vested upon grant pursuant to the achievement of performance-based milestone, whose vesting
was contingent upon meeting certain regulatory milestones. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Milestone awards related to achievement of performance-based milestones whose vesting is contingent upon meeting
regulatory and development milestones. There is no threshold for this award and the maximum is equal to the target. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Option award granted by a subsidiary, vests 1/48 monthly one year cliff </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">6</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Performance milestone award that was probable on the date the Board of Directors approved participation in the
milestone program. Note that $2.6 million was no longer probable as of December 31, 2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">7</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Includes $32,182 incremental expense related to the modification of exercise period. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">8</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Option grant made in connection with Dr. Homcy&#146;s service on the Board of Directors. 1/3rd of the shares
vest annually. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Outstanding Equity Awards at Fiscal Year End </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth information regarding outstanding equity awards held by our NEOs as of December&nbsp;31, 2020: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant<BR>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options (#)<BR>Exercisable</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options (#)<BR>Unexercisable</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Exercise<BR>Price<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Expiration<BR>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number<BR>of shares<BR>or units<BR>of stock<BR>that have<BR>not&nbsp;vested<BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Market<BR>value of<BR>shares or<BR>units of<BR>stock that<BR>have not<BR>vested<BR>($)(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Equity<BR>incentive<BR>plan<BR>awards:<BR>number<BR>of<BR>unearned<BR>shares,<BR>units or<BR>other<BR>rights<BR>that have<BR>not<BR>vested<BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Equity<BR>incentive<BR>plan<BR>awards:<BR>market or<BR>payout<BR>value of<BR>unearned<BR>shares,<BR>units or<BR>other<BR>rights that<BR>have
not<BR>vested<BR>($)(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Neil Kumar</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>06/26/19</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">653,580</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,089,302</TD>
<TD NOWRAP VALIGN="bottom">(2)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">06/26/29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>07/01/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>07/01/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">133,516</TD>
<TD NOWRAP VALIGN="bottom">(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,494,323</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>07/01/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">914,820</TD>
<TD NOWRAP VALIGN="bottom">(4)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65,052,850</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>07/01/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,207,832</TD>
<TD NOWRAP VALIGN="bottom">(5)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">85,888,934</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>06/03/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">73,818</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">516,733</TD>
<TD NOWRAP VALIGN="bottom">(6)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28.86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">06/02/30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>06/03/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">71,811</TD>
<TD NOWRAP VALIGN="bottom">(7)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,106,480</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Brian Stolz</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>12/12/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>06/03/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,310</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28.86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10/21/21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>06/03/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>11/13/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25,520</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26.28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10/21/21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>11/13/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>11/13/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>11/20/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Brian&nbsp;Stephenson</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>06/26/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">193,751</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">322,919</TD>
<TD NOWRAP VALIGN="bottom">(8)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">06/25/29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>07/01/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">167,001</TD>
<TD NOWRAP VALIGN="bottom">(9)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,875,441</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>07/01/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,552</TD>
<TD NOWRAP VALIGN="bottom">(10)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">821,463</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>06/03/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24,606</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">172,244</TD>
<TD NOWRAP VALIGN="bottom">(11)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28.86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">06/02/30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>06/03/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23,937</TD>
<TD NOWRAP VALIGN="bottom">(12)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,702,160</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Charles Homcy</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>06/26/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">78,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">181,540</TD>
<TD NOWRAP VALIGN="bottom">(13)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">06/25/29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>07/01/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>07/01/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,337</TD>
<TD NOWRAP VALIGN="bottom">(14)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,446,164</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>07/01/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">139,339</TD>
<TD NOWRAP VALIGN="bottom">(15)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,908,396</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>07/01/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">183,968</TD>
<TD NOWRAP VALIGN="bottom">(16)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,081,964</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>12/12/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27,626</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">55,252</TD>
<TD NOWRAP VALIGN="bottom">(17)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12/11/29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>06/02/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">112,422</TD>
<TD NOWRAP VALIGN="bottom">(18)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">06/01/30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Michael&nbsp;Henderson</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>06/26/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24,338</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40,565</TD>
<TD NOWRAP VALIGN="bottom">(19)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">06/26/29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>07/01/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">422</TD>
<TD NOWRAP VALIGN="bottom">(20)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30,008</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>07/01/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,825</TD>
<TD NOWRAP VALIGN="bottom">(21)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">129,776</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>07/01/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">85,886</TD>
<TD NOWRAP VALIGN="bottom">(22)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,107,353</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>07/01/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,398</TD>
<TD NOWRAP VALIGN="bottom">(23)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">241,632</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>05/19/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">179,375</TD>
<TD NOWRAP VALIGN="bottom">(24)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,755,356</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>05/19/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19,271</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">06/24/28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>05/19/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,778</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">05/28/29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>05/19/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,932</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">09/24/29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>05/19/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,586</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">08/26/28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>05/19/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">05/07/28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>05/19/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,282</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.05</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">09/24/29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>05/19/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11/13/27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>05/19/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.05</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12/17/29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>05/19/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,044</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">307</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">06/10/29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant<BR>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options (#)<BR>Exercisable</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options (#)<BR>Unexercisable</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Exercise<BR>Price<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Expiration<BR>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number<BR>of shares<BR>or units<BR>of stock<BR>that have<BR>not&nbsp;vested<BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Market<BR>value of<BR>shares or<BR>units of<BR>stock that<BR>have not<BR>vested<BR>($)(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Equity<BR>incentive<BR>plan<BR>awards:<BR>number<BR>of<BR>unearned<BR>shares,<BR>units or<BR>other<BR>rights<BR>that have<BR>not<BR>vested<BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Equity<BR>incentive<BR>plan<BR>awards:<BR>market or<BR>payout<BR>value of<BR>unearned<BR>shares,<BR>units or<BR>other<BR>rights that<BR>have
not<BR>vested<BR>($)(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>12/15/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,456</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.07</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">04/01/30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>12/15/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,137</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.07</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">07/20/30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>12/15/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,199</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42.80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">09/29/30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>05/19/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,096.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">789,036.56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>05/19/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,063.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">215,889.96</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>05/19/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>05/19/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,796</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">269,933.56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>05/19/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,233</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">229,898.63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>05/19/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,477</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">247,249.47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>05/19/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,035</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">429,148.85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>05/19/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,968</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">139,944.48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Cameron Turtle</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>06/26/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">187,500</TD>
<TD NOWRAP VALIGN="bottom">(25)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">06/26/29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>07/01/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">786</TD>
<TD NOWRAP VALIGN="bottom">(26)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">55,892.46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>07/01/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,249</TD>
<TD NOWRAP VALIGN="bottom">(27)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">373,256.39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>05/19/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">56,042</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">05/23/29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>05/19/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,082</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">08/23/27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>05/19/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31,766</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">07/14/29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>09/01/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Based on a price of $71.11 per share, which was the closing price per share of our common stock as reported by
the Nasdaq Global Select Market on December 31, 2020, the last trading day of 2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The shares underlying this stock option award vest as follows: 1/48th of the shares vest on a monthly basis
from the vesting commencement date of June 26, 2019, such that all of the shares will be fully vested on June&nbsp;26, 2023, subject to Dr.&nbsp;Kumar&#146;s continuous service through each such vesting date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents shares of restricted common stock that were issued in exchange for common units in BridgeBio Pharma
LLC (the &#147;LLC&#148;) in connection with the reorganization of our corporate structure on July&nbsp;1, 2019 (the &#147;Reorganization&#148;). The shares are subject to vesting at a rate of 1/60 per monthfrom a vesting commencement date of
July&nbsp;26, 2019, such that the shares shall be fully vested on March&nbsp;26, 2021, subject to Dr.&nbsp;Kumar&#146;s continuous service through each such vesting date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents shares of restricted common stock that were issued in exchange for common units in the LLC in
connection with the Reorganization. The shares are subject to vesting at a rate of 1/60 per month from a vesting commencement date of July&nbsp;15, 2019, such that the shares shall be fully vested on August&nbsp;15, 2022, subject to
Dr.&nbsp;Kumar&#146;s continuous service through each such vesting date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents shares of restricted common stock that were issued in exchange for common units in the LLC in
connection with the Reorganization. The shares are subject to vesting at a rate of 1/60 per month from a vesting commencement date of July&nbsp;12, 2019, such that the shares shall be fully vested on February&nbsp;12, 2024, subject to
Dr.&nbsp;Kumar&#146;s continuous service through each such vesting date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The shares underlying this stock option award vest as follows: 1/48th of the shares vest on a monthly basis
from the vesting commencement date of June 3, 2020, such that all of the shares will be fully vested on June 03, 2024, subject to Dr.&nbsp;Kumar&#146;s continuous service through each such vesting date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents restricted stock units that vest quarterly for four years such that shares fully vest on
May&nbsp;16, 2024 subject to Dr.&nbsp;Kumar&#146;s continuous service through each such vesting date. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The shares underlying this stock option award vest as follows: 1/48th of the shares vest on a monthly basis
from the vesting commencement date of June&nbsp;26, 2019, such that all of the shares will be fully vested on June&nbsp;26, 2023, subject to Mr.&nbsp;Stephenson&#146;s continuous service through each such vesting date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents shares of restricted common stock that were issued in exchange for common units in BridgeBio Pharma
LLC (the &#147;LLC&#148;) in connection with the reorganization of our corporate structure on July&nbsp;1, 2019 (the &#147;Reorganization&#148;). The shares are subject to vesting at a rate of 1/60 per month from a vesting commencement date of
July&nbsp;29, 2019, such that the shares shall be fully vested on October&nbsp;29, 2023, subject to Dr.&nbsp;Stephenson&#146;s continuous service through each such vesting date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents shares of restricted common stock that were issued in exchange for common units in BridgeBio Pharma
LLC (the &#147;LLC&#148;) in connection with the reorganization of our corporate structure on July&nbsp;1, 2019 (the &#147;Reorganization&#148;). The shares are subject to vesting at a rate of 1/60 per month from a vesting commencement date of
July&nbsp;12, 2019, such that the shares shall be fully vested on February&nbsp;12, 2024, subject to Dr.&nbsp;Stephenson&#146;s continuous service through each such vesting date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The shares underlying this stock option award vest as follows: 1/48th of the shares vest on a monthly basis
from the vesting commencement date of June 03, 2020, such that all of the shares will be fully vested on June 3, 2024, subject to Dr.&nbsp;Stephenson&#146;s continuous service through each such vesting date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(12)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents restricted stock units that vest quarterly for four years such that shares fully vest on
May&nbsp;16, 2024 subject to Dr.&nbsp;Stephenson&#146;s continuous service through each such vesting date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(13)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The shares underlying this stock option award vest as follows: 1/48th of the shares vest on a monthly basis
from the vesting commencement date of June&nbsp;26, 2019, such that all of the shares will be fully vested on June&nbsp;26, 2023, subject to Dr.&nbsp;Homcy&#146;s continuous service through each such vesting date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(14)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents shares of restricted common stock that were issued in exchange for common units in the LLC in
connection with the Reorganization. The shares are subject to vesting at a rate of 1/60 per month from a vesting commencement date of March&nbsp;26, 2016, such that the shares shall be fully vested on March&nbsp;26, 2021, subject to
Dr.&nbsp;Homcy&#146;s continuous service through each such vesting date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(15)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents shares of restricted common stock that were issued in exchange for common units in the LLC in
connection with the Reorganization. The shares are subject to vesting at a rate of 1/60 per month from a vesting commencement date of August&nbsp;15, 2017, such that the shares shall be fully vested on August&nbsp;15, 2022, subject to
Dr.&nbsp;Homcy&#146;s continuous service through each such vesting date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(16)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents shares of restricted common stock that were issued in exchange for common units in the LLC in
connection with the Reorganization. The shares are subject to vesting at a rate of 1/60 per month from a vesting commencement date of February&nbsp;12, 2019, such that the shares shall be fully vested on February&nbsp;12, 2024, subject to
Dr.&nbsp;Homcy&#146;s continuous service through each such vesting date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(17)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The shares underlying this stock option agreement vests in three annual installments after December&nbsp;12,
2019, subject to Dr.&nbsp;Homcy&#146;s continuous service as a director through each such vesting date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(18)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The shares underlying this stock option agreement vests in three annual installments after June 02, 2020,
subject to Dr.&nbsp;Homcy&#146;s continuous service as a director through each such vesting date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(19)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The shares underlying this stock option award vest as follows: 1/48th of the shares vest on a monthly basis
from the vesting commencement date of June 26, 2019, such that all of the shares will be fully vested on June&nbsp;26, 2023, subject to Mr.&nbsp;Henderson&#146;s continuous service through each such vesting date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(20)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents shares of restricted common stock that were issued in exchange for common units in the LLC in
connection with the Reorganization. The shares are subject to vesting at a rate of 1/60 per month from a vesting commencement date of July&nbsp;22, 2019, such that the shares shall be fully vested on March&nbsp;22, 2021, subject to
Dr.&nbsp;Henderson&#146;s continuous service through each such vesting date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(21)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents shares of restricted common stock that were issued in exchange for common units in the LLC in
connection with the Reorganization. The shares are subject to vesting at a rate of 1/60 per month from a vesting commencement date of August&nbsp;1, 2019, such that the shares shall be fully vested on January 01, 2022, subject to
Dr.&nbsp;Henderson&#146;s continuous service through each such vesting date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(22)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents shares of restricted common stock that were issued in exchange for common units in the LLC in
connection with the Reorganization. The shares are subject to vesting at a rate of 1/60 per month from a vesting commencement date of July&nbsp;31, 2019, such that the shares shall be fully vested on October&nbsp;31, 2023, subject to
Dr.&nbsp;Henderson&#146;s continuous service through each such vesting date. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(23)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents shares of restricted common stock that were issued in exchange for common units in the LLC in
connection with the Reorganization. The shares are subject to vesting at a rate of 1/60 per month from a vesting commencement date of July&nbsp;12, 2019, such that the shares shall be fully vested on February&nbsp;12, 2024, subject to
Dr.&nbsp;Henderson&#146;s continuous service through each such vesting date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(24)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents restricted stock units that vest quarterly for four years such that shares fully vest on
May&nbsp;16, 2024 subject to Dr.&nbsp;Henderson&#146;s continuous service through each such vesting date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(25)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The shares underlying this stock option award vest as follows: 1/48th of the shares vest on a monthly basis
from the vesting commencement date of June 26, 2019, such that all of the shares will be fully vested on June&nbsp;26, 2023, subject to Dr.&nbsp;Turtle&#146;s continuous service through each such vesting date </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(26)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents shares of restricted common stock that were issued in exchange for common units in the LLC in
connection with the Reorganization. The shares are subject to vesting at a rate of 1/60 per month from a vesting commencement date of July 06, 2019, such that the shares shall be fully vested on February 06, 2022, subject to Dr.&nbsp;Turtle&#146;s
continuous service through each such vesting date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(27)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents shares of restricted common stock that were issued in exchange for common units in the LLC in
connection with the Reorganization. The shares are subject to vesting at a rate of 1/60 per month from a vesting commencement date of July&nbsp;31, 2019, such that the shares shall be fully vested on October&nbsp;31, 2023, subject to
Mr.&nbsp;Turtle&#146;s continuous service through each such vesting date. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Option Exercises and Stock Vested in Fiscal Year 2020
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth the number of shares acquired and the value realized upon exercises of stock options and vesting of RSUs during the
fiscal year ended December&nbsp;31, 2020 by each of our NEOs. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of<BR>Shares<BR>Acquired&nbsp;on<BR>Exercise&nbsp;(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Value&nbsp;Realized&nbsp;on<BR>Exercise&nbsp;($)&nbsp;(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of<BR>Shares<BR>Acquired&nbsp;on<BR>Vesting&nbsp;(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Value&nbsp;Realized&nbsp;on<BR>Vesting ($) (2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Neil Kumar, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,550,210</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">55,113,334</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Brian C. Stephenson, Ph.D., CFA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">66,008</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,401,397</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael Henderson, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">98,365</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(3</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,590,744</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">111,278</TD>
<TD NOWRAP VALIGN="bottom">(4)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,008,092</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cameron Turtle, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">136,794</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(5</TD>
<TD NOWRAP VALIGN="bottom">)(6)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,495,487</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,271</TD>
<TD NOWRAP VALIGN="bottom">(7)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">166,827</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Charles Homcy, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30,256</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">636,144</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">234,068</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,322,307</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Brian Stolz</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,595</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45,505</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The value realized upon exercise of stock options is determined by multiplying (i) the difference between the
trade price of our common stock on the date of exercise and the converted exercise price, by (ii)&nbsp;the number of shares exercised. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The value realized upon vesting of restricted stock and RSUs is calculated by multiplying the number of shares
of restricted stock and RSUs vested by the closing price of our common stock on the vesting date and does not necessarily reflect actual proceeds received. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Shares acquired from exercise of Options Awards granted pursuant to the 2020 Stock and Equity Award Exchange
Program (&#147;Exchange Program&#148;). The value realized is determined by multiplying (i)&nbsp;the difference between the trade price of our common stock on the date of exercise and the converted exercise price, by (ii)&nbsp;the number of shares
exercised. The converted price is based on the volume weighted average closing price of our common stock on The Nasdaq Global Select Market (&#147;Nasdaq&#148;) over the <FONT STYLE="white-space:nowrap">7-day</FONT> trading period immediately prior
to the award exchange date and the fair value of the applicable subsidiary&#146;s stock based on its 409A valuation. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 50,900 shares acquired from vesting of awards granted pursuant to the Exchange Program.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 56,294 shares acquired from exercise of Options Awards granted from Eidos&#146; 2018 Stock Option and
Incentive Plan with value realized of $3,724,017. The value realized is determined by multiplying (i)&nbsp;difference between the trade price of Eidos&#146; stock on Nasdaq on date of exercise and exercise price, by (ii)&nbsp;the number of shares
exercised. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 36,000 shares acquired from the exercise of options granted pursuant to the Exchange Program. The
value realized of $1,675,100 was determined by multiplying (i)&nbsp;the difference between the trade price of BridgeBio stock on date of exercise and the converted exercise price, by (ii)&nbsp;the number of shares exercised. The converted price is
based on the volume weighted average closing price of our common stock on Nasdaq over the <FONT STYLE="white-space:nowrap">7-day</FONT> trading period immediately prior to the award exchange date and the fair value of the applicable
subsidiary&#146;s stock based on its 409A valuation. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 2,745 shares of restricted stock awards acquired related to performance-based milestone that were
achieved during fiscal year 2020 due to completion of regulatory milestones. The value realized of $75,817 is calculated by multiplying the number of shares of restricted stock by the closing price of our common stock on Nasdaq on the vesting date.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Employment Arrangements with our Named Executive Officers </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have entered into a written employment offer letter with each of our NEOs. These agreements set forth the basic terms and conditions of employment,
including initial base salary, initial equity awards, eligibility to participate in our standard employee benefits plans, the at-will employment relationship and, in certain cases, a one-time signing bonus. These agreements also require that each
NEO execute our standard employee confidentiality and assignment agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Neil Kumar </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On December 14, 2017, we, through our wholly-owned subsidiary, BridgeBio Services, Inc. (&#147;Services Company&#148;), entered into an offer letter with Dr.
Kumar, who currently serves as our Chief Executive Officer. The offer letter provided for Dr. Kumar&#146;s at-will employment and set forth his initial annual base salary, initial target annual bonus opportunity, and his eligibility to participate
in our employee benefit plans generally. In the event of a termination of his employment by the Services Company without &#147;cause&#148; or Dr. Kumar&#146;s resignation from employment with the Services Company for &#147;good reason&#148; (as such
terms are defined in the offer letter), in either case subject to Dr. Kumar&#146;s execution of an effective release of claims in favor of the Company, Dr. Kumar will be entitled to the following severance benefits: (i) a lump sum payment equal to
twelve months of his then-current base salary; (ii) a pro-rated bonus based on Company and individual performance for the year of termination; and (iii) up to twelve months of COBRA reimbursements for Dr. Kumar and his dependents. Dr. Kumar is
subject to the Service Company&#146;s standard proprietary information and inventions agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Brian C. Stephenson, Ph.D., CFA </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On October&nbsp;28, 2018, we, through Services Company, entered into an offer letter with Dr.&nbsp;Stephenson, Ph.D., CFA, who currently serves as our Chief
Financial Officer. The offer letter provided for Dr.&nbsp;Stephenson&#146;s <FONT STYLE="white-space:nowrap">at-will&nbsp;employment</FONT> and set forth his initial annual base salary, initial target annual bonus
opportunity,&nbsp;one-time&nbsp;sign-on&nbsp;bonus equal to $300,000 (subject to repayment if Dr.&nbsp;Stephenson voluntarily resigned from the Company within his first year of employment), initial equity grant, and his eligibility to participate in
our employee benefit plans generally. Dr. Stephenson is subject to the Service Company&#146;s standard proprietary information and inventions agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Michael Henderson, M.D. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March 22, 2016, we,
through BridgeBio Pharma LLC, entered into an offer letter with Dr. Henderson, who currently serves as our Chief Business Officer. The offer letter provided for Dr. Henderson&#146;s at-will employment and set forth his initial annual base salary,
initial target annual bonus opportunity, initial equity grant, and his eligibility to participate in our employee benefit plans generally. Dr. Henderson is subject to the Service Company&#146;s standard proprietary information and inventions
agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cameron Turtle, Ph.D. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On December 13, 2016, we, through BridgeBio Pharma LLC, entered into an offer letter with Dr. Turtle, who currently serves as our Chief Strategy Officer. The
offer letter provided for Dr. Turtle&#146;s at-will employment and set forth his initial annual base salary, initial target annual bonus opportunity, initial equity grant, and his eligibility to participate in our employee benefit plans generally.
Dr. Turtle is subject to the Service Company&#146;s standard proprietary information and inventions agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Charles Homcy, M.D. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On February&nbsp;20, 2019, we, through Services Company, entered into an offer letter with Dr. Homcy, who currently serves as our Senior Advisor, Chair of
Pharmaceuticals. The offer letter provided for Dr. Homcy&#146;s at-will employment and set forth his initial annual base salary and his eligibility to participate in our employee benefit plans generally. Dr. Homcy is subject to the Service
Company&#146;s standard proprietary information and inventions agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Brian Stolz </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr. Stolz resigned from the Company effective as of October 22, 2020 (the &#147;Termination Date&#148;). We had entered into an offer letter with Mr. Stolz on
September 19, 2019, which set forth the terms and conditions of his employment with us. Pursuant to the severance agreement into which we entered with Mr. Stolz on November 2, 2020, Mr. Stolz received: (i) $1,250,000.00, which was equivalent to 24
months of Mr. Stolz&#146;s base salary as in effect prior to the Termination Date; (ii) a target bonus payment of $375,000; (iii) a pro-rated bonus payment for the fiscal year ended December 31, 2020, in the amount of $307,377; and (iv) 12 months of
COBRA reimbursements for Mr. Stolz and his dependents. There was no acceleration of vesting of Mr. Stolz&#146;s stock options or RSUs in connection with his resignation. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Potential Payments on Termination or Change in Control </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The table below quantifies the potential payments and benefits that would have become due to our NEOs assuming that a qualifying termination occurred on
December&nbsp;31, 2020. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="58%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Base<BR>Salary<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Bonus<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accelerated<BR>Vesting of<BR>Equity<BR>Awards ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Continuation<BR>of Insurance<BR>Coverage ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Neil Kumar, Ph.D.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Termination Without Cause or Resignation for Good Reason</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">550,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">825,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,984</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,405,984</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Termination Without Cause or Resignation for Good Reason in Connection with a Change in
Control</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">550,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">825,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,984</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,405,984</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Brian Stephenson, Ph.D., CFA</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Termination Without Cause or Resignation for Good Reason</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Termination Without Cause or Resignation for Good Reason in Connection with a Change in
Control</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Michael Henderson, M.D.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Termination Without Cause or Resignation for Good Reason</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Termination Without Cause or Resignation for Good Reason in Connection with a Change in
Control</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="58%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Base<BR>Salary<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Bonus<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accelerated<BR>Vesting of<BR>Equity<BR>Awards ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Continuation<BR>of Insurance<BR>Coverage ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cameron Turtle, Ph.D.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Termination Without Cause or Resignation for Good Reason</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Termination Without Cause or Resignation for Good Reason in Connection with a Change in
Control</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Charles Homcy, M.D.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Termination Without Cause or Resignation for Good Reason</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Termination Without Cause or Resignation for Good Reason in Connection with a Change in
Control</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr. Stolz resigned from the Company effective October 22, 2020. Pursuant to the terms of his separation agreement with the
Company, dated November 2, 2020, Mr. Stolz received a $1,250,000 separation payment, a $375,000 target bonus payment, a $307,377 pro rated 2020 bonus payment, and $36,329 COBRA reimbursement payment. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Equity Compensation Plan Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table
provides information as of December 31, 2020 regarding shares of common stock that may be issued under our equity compensation plans, consisting of our Amended and Restated 2019 Employee Stock Purchase Plan (the &#147;ESPP&#148;), our Amended and
Restated 2019 Stock Option and Incentive Plan (the &#147;2019 Plan&#148;) and the Inducement Plan. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Plan category</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of&nbsp;securities<BR>to be issued upon<BR>exercise of<BR>outstanding options,<BR>warrants&nbsp;and&nbsp;rights(a)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted&nbsp;average<BR>exercise price of<BR>outstanding options,<BR>warrants&nbsp;and&nbsp;rights(b)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of&nbsp;securities<BR>remaining&nbsp;available&nbsp;for<BR>future issuance under<BR>equity compensation<BR>plan (excluding<BR>securities
referenced in<BR>column(a))(c)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity compensation plans approved by security holders(1):</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,009,722</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20.82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,943,791</TD>
<TD NOWRAP VALIGN="bottom">(3)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity compensation plans not approved by security holders(4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">752,761</TD>
<TD NOWRAP VALIGN="bottom">(2)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29.99</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">204,664</TD>
<TD NOWRAP VALIGN="bottom">(6)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,762,483</TD>
<TD NOWRAP VALIGN="bottom">(5)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50.80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,148,455</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes grants under the ESPP and our 2019 Plan. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 7,139,820 shares of common stock issuable upon the exercise of outstanding options and 869,902 RSUs.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As of December 31, 2020, a total of 14,000,000 shares of our common stock were reserved for issuance pursuant
to the 2019 Plan, which number excludes the 6,142,469 and 6,182,914 shares that were added to the 2019 Plan as a result of the automatic annual increase on January 1, 2021 and January 1, 2020, respectively. On June 2, 2020, our stockholders approved
an amendment and restatement of the 2019 Plan to, among other things, increase the number of shares of common stock reserved for issuance thereunder by 2,500,000 shares. The 2019 Plan provides that the number of shares reserved and available for
issuance under the 2019 Plan will automatically increase each January 1, beginning on January 1, 2020, by 5% of the outstanding number of shares of our common stock on the immediately preceding December 31 or such lesser number of shares as
determined by the plan administrator. This number will be subject to adjustment in the event of a stock split, stock dividend or other change in our capitalization. The shares of common stock underlying any awards that are forfeited, cancelled, held
back upon exercise or settlement of an award to satisfy the exercise price or tax withholding, reacquired by us prior to vesting, satisfied without the </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
issuance of stock, expire or are otherwise terminated, other than by exercise, under the 2019 Plan will be added back to the shares of common stock available for issuance under the 2019 Plan. As
of December 31, 2020, a total of 2,000,000 shares of our common stock have been reserved for issuance pursuant to the ESPP, which number excludes the 1,228,493 and 1,236,582 shares that were added to the ESPP as a result of the automatic annual
increase on January 1, 2021 and January 1, 2020, respectively. The ESPP provides that the number of shares reserved and available for issuance under the ESPP will automatically increase each January 1, beginning on January 1, 2020, by the lesser of
2,000,000 shares of our common stock, 1% of the outstanding number of shares of our common stock on the immediately preceding December 31 or such lesser number of shares as determined by our Compensation Committee. This number will be subject to
adjustment in the event of a stock split, stock dividend or other change in our capitalization.</TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes grants under the Inducement Plan. For more information about the Inducement Plan, please see Note 15
to our Annual Report on Form 10-K for the year ended December 31, 2020 filed with the SEC on February 25, 2021.</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 493,141 shares of common stock issuable upon the exercise of outstanding options.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As of December 31, 2020, there were 204,664 shares available for grants under the Inducement Plan.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc131567_8"></A>CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other than the compensation agreements and other arrangements described under &#147;Executive Compensation&#148; and the transactions described below, since
January&nbsp;1, 2020, there has not been and there is not currently proposed, any transaction or series of similar transactions to which we were, or will be, a party in which the amount involved exceeded, or will exceed, $120,000 and in which any
director, executive officer, holder of five percent or more of any class of our capital stock or any member of the immediate family of, or entities affiliated with, any of the foregoing persons, had, or will have, a direct or indirect material
interest. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Agreements and Transactions with 5% Stockholders and Their Affiliates </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Intercompany Services Agreements with BridgeBio Services Inc. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have received consulting and management services pursuant to two Intercompany Services Agreements with BridgeBio Services Inc., or, collectively, the
BridgeBio Agreements. BridgeBio Services Inc. is affiliated with BridgeBio Pharma Inc., which has a controlling interest in us. The initial BridgeBio Agreement was entered into on March&nbsp;1, 2016 and was superseded by the subsequent BridgeBio
Agreement, effective as of May&nbsp;1, 2017. During the year ended December&nbsp;31, 2019, we incurred an aggregate of $0 for these services, which included, among other things, the services of Dr.&nbsp;Kumar, as well as other personnel, and the
supervision of our strategic, financial, legal, personnel and executive recruitment activities. Dr.&nbsp;Kumar is our Chief Executive Officer and a member of our Board of Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We also provided services to BridgeBio Pharma, Inc. and its affiliates. During the year ended December&nbsp;31, 2020, BridgeBio Pharma, Inc. incurred an
aggregate of $0 for these services. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Agreements with Entities Affiliated with Perceptive Advisors LLC </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>License and Exclusivity Agreements </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In October 2019, our
subsidiary, QED Therapeutics, Inc. (&#147;QED&#148;), entered into an exclusive license agreement (the &#147;License Agreement&#148;) with LianBio, a licensee entity in which Perceptive Life Sciences Master Fund, Ltd. (&#147;Perceptive Master
Fund&#148;) and certain of its affiliated funds hold a majority of the outstanding voting securities. Perceptive Master Fund directly holds shares of our common stock representing a greater than 5% ownership interest. Perceptive Advisors LLC
(&#147;Perceptive Advisors,&#148; and collectively with Perceptive Master Fund and its affiliated funds, &#147;Perceptive&#148;) serves as the investment manager to the Master Fund and may be deemed to beneficially own the securities directly held
by Perceptive Master Fund. Mr.&nbsp;Joseph Edelman is the managing member of Perceptive Advisors and may be deemed to beneficially own the securities directly held by Perceptive Master Fund. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the License Agreement, QED granted to LianBio an exclusive, sublicensable license under the licensed patent rights and <FONT
STYLE="white-space:nowrap">know-how</FONT> to develop, manufacture and commercialize infigratinib for any and all human prophylactic and therapeutic uses in all cancer indications (including in combination with other therapies) in certain
territories outside the United States. Under the License Agreement, QED received a nonrefundable upfront payment of $10.0&nbsp;million and was granted certain equity rights in an affiliate of LianBio. Additionally, QED is entitled to receive
payments from LianBio totaling an aggregate of up to $132.5&nbsp;million upon the achievement of specified development and sales milestones and tiered royalties on net sales ranging from the low to mid teens. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In October 2019, our subsidiary, BBP LLC, concurrently entered into an exclusivity agreement with LianBio, pursuant to which BBP LLC received equity in the
entity representing a 10% ownership interest, valued at approximately $3.8&nbsp;million at the time of the transaction. The equity interest was issued in consideration for certain rights of first negotiation and rights of first offer granted by BBP
LLC to LianBio with respect to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
specified transactions covering intellectual property rights owned or controlled by BBP LLC or its affiliates in certain territories outside the United States. Pursuant to the exclusivity
agreement, BBP LLC also received a warrant to purchase 10% of the then-fully diluted shares of one of the subsidiaries of LianBio upon achievement of certain contingent milestones. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Exclusive License Agreement </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In August 2020, our
subsidiary, Navire Pharma, Inc. (&#147;Navire&#148;) entered into an Exclusive License Agreement with LianBio (the &#147;Navire-LianBio License Agreement&#148;). Under the terms of the Navire-LianBio License Agreement, LianBio will receive
commercial rights in China and selected Asian markets and participate in clinical development activities for <FONT STYLE="white-space:nowrap">BBP-398.</FONT> In consideration for the rights granted to LianBio, we received a nonrefundable
$8.0&nbsp;million upfront payment. We will also receive future development and sales milestone payments of up to $382.1&nbsp;million, and tiered royalty payments from single-digit to <FONT STYLE="white-space:nowrap">low-teens</FONT> on net sales of
the product in licensed territories. As part of the Navire-LianBio License Agreement, our CEO, Neil Kumar, was appointed to the board of directors of LianBio. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Participation in Our Offerings </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Convertible
Note Offerings </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">KKR Capital Markets LLC (&#147;KCM&#148;), an affiliate of KKR Genetic Disorder L.P. (&#147;KKR&#148;), acted as (i)&nbsp;an initial
purchaser in connection with our offering in March 2020 of our 2.50% convertible senior notes due 2027, in which KCM received fees of $0.6&nbsp;million for such services, (ii)&nbsp;an initial purchaser in connection with our offering in January 2021
of our 2.25% convertible senior notes due 2029, in which KCM received fees of $0.5&nbsp;million for such services, and (iii)&nbsp;an underwriter in connection with a registered sale of our common stock by affiliates of KKR in February 2021, in which
KCM received fees of $1.9&nbsp;million for such services. KKR Genetic Disorder L.P. is a holder of more than 5% of our outstanding common stock. Ali Satvat, a member of our Board of Directors, serves as a Partner of Kohlberg Kravis
Roberts&nbsp;&amp; Co. L.P., an affiliate of KKR Genetic Disorder L.P. See footnote (2) to the beneficial ownership table under &#147;Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters&#148; for more
information. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Selling Stockholder Offering </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
February 2021, KKR sold an aggregate of $208,617,188 of net proceeds of its shares of our common stock in a registered offering. Certain of our directors and executive officers participated in the offering, in each case at the public offering price
per share and on the same terms as the other purchasers in the offering, in the following purchase amounts that exceeded $120,000: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="44%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Relationship</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares&nbsp;Purchased&nbsp;in<BR>Offering</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Aggregate&nbsp;Purchase<BR>Price ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Neil Kumar, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Executive&nbsp;officer,&nbsp;director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Brian Stephenson, Ph.D., CFA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Executive officer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Randal Scott</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Consulting Agreements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Jennifer E. Cook </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In October 2019, we entered into a
consulting agreement with Jennifer E. Cook, a member of our Board of Directors. Pursuant to the consulting agreement. Ms.&nbsp;Cook provides expert consulting services to the Company regarding matters relating to commercial activities as Senior
Advisor. The consulting agreement has a <FONT STYLE="white-space:nowrap">two-year</FONT> term. Pursuant to the consulting agreement, in 2020, the Company paid Ms. Cook an aggregate of $100,000 for consulting services. In addition, in accordance with
the terms of the consulting agreement, the Company previously granted to Ms.&nbsp;Cook on December&nbsp;2, 2019 an option to purchase 17,084 shares of the Company&#146;s </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
common stock at an exercise price equal to $31.14, 50% of which options vested on October&nbsp;14, 2020 and the remaining 50% of which options will vest on October&nbsp;14, 2021, subject to
Ms.&nbsp;Cook&#146;s continuous service under the consulting agreement through such date; and an award of 7,152 restricted stock units of the Company (the &#147;RSUs&#148;), 50% of which RSUs vested on October&nbsp;14, 2020 and the remaining 50% of
which RSUs will vest on October&nbsp;14, 2021, subject to Ms.&nbsp;Cook&#146;s continuous service under the consulting agreement through such date. Ms.&nbsp;Cook is also entitled to reimbursement for expenses incurred in the course of rendering
services under the consulting agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>QLS Advisors, LLC </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In December 2020, the Company entered into a consulting agreement with BioSF Global (the &#147;BioSF Agreement&#148;), a joint collaboration of QLS Advisors
LLC (&#147;QLS&#148;), of which Andrew Lo, a member of our Board of Directors, is the <FONT STYLE="white-space:nowrap">co-founder</FONT> and chairman, and Ram Island Strategies LLC to provide certain consulting, legal and other services to BridgeBio
Pharma, Inc. The Company will pay an aggregate of $125,000 to QLS under the BioSF Agreement, and up to $199,000 if a transaction occurs resulting from services under the BioSF Agreement, provided that no other payments shall have been made to QLS
during such calendar year. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Employment Agreements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
February 2020, we entered into an employment agreement with James C. Momtazee, a member of our Board of Directors, which was terminated in January 2021. Pursuant to the employment agreement, Mr.&nbsp;Momtazee served as the Senior
Advisor&nbsp;-&nbsp;Transactions. The position was part-time. Pursuant to the employment agreement, the Company paid Mr.&nbsp;Momtazee an annual salary of $50,000. In addition, in accordance with the terms of the employment agreement, the Company
previously granted to Mr.&nbsp;Momtazee an option to purchase shares of the Company&#146;s common stock valued at $1,493,632 on the date of grant and restricted stock units valued at $294,213. Mr.&nbsp;Momtazee was also eligible to participate in or
receive benefits under the Company&#146;s employee benefit plans in effect from time to time (including, without limitation, any group health care plan, paid time off, and 401(k)), subject to the terms of such plans. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are party to an employment offer letter agreement with Richard H. Scheller, Ph.D., a member of our Board of Directors, pursuant to which Dr.&nbsp;Scheller
serves as Senior Advisor, Chairman of R&amp;D. The position is part-time and requires Dr.&nbsp;Scheller to devote 40% of his full working time and efforts to the business and affairs of the Company. Pursuant to the agreement, Dr.&nbsp;Scheller is
entitled to a salary at the annual rate of $500,000 and is eligible to participate in or receive benefits under the Company&#146;s employee benefit plans in effect from time to time (including, without limitation, any group health care plan, paid
time off, and 401(k)), subject to the terms of such plans. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">See the section titled &#147;Proposal 1&nbsp;-&nbsp;Election of Directors&nbsp;-&nbsp;Director
Compensation&#148; for information regarding employment compensation received by Mr.&nbsp;Momtazee and Dr.&nbsp;Scheller in 2020. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Executive Officer
and Director Compensation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">See the sections titled &#147;Executive Compensation&#148; and &#147;Proposal 1&nbsp;-&nbsp;Election of
Directors&nbsp;-&nbsp;Director Compensation&#148; for information regarding compensation of our executive officers and directors, respectively. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Indemnification Agreements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have entered into
agreements to indemnify our directors and executive officers. These agreements will, among other things, require us to indemnify these individuals for certain expenses (including attorneys&#146; fees), judgments, fines and settlement amounts
reasonably incurred by such person in any action or proceeding, including any action by or in our right, on account of any services undertaken by such person on behalf of our company or that person&#146;s status as a member of our Board of Directors
to the maximum extent allowed under Delaware law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Procedures for Approval of Related Person Transactions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Audit Committee conducts an appropriate review of all related party transactions for potential conflict of interest situations on an ongoing basis, and the
approval of the Audit Committee is required for all such transactions. The Audit Committee follows the policies and procedures set forth in our Related Person Transaction Policy in order to facilitate such review. The Related Person Transaction
Policy is written. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc131567_9"></A>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
AND RELATED STOCKHOLDER MATTERS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth the beneficial ownership information of our common stock by: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each person known to us to be the beneficial owner of more than 5% of our common stock as of March&nbsp;31, 2021;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each named executive officer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each of our directors; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all of our executive officers and directors as a group. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have based our calculation of the percentage of beneficial ownership of 149,114,600 shares of common stock outstanding on March&nbsp;31, 2021. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each individual or entity shown in the table has furnished information with respect to beneficial ownership. The information with respect to our executive
officers and directors is as of March&nbsp;31, 2021 unless otherwise noted. The information with respect to certain significant stockholders is based on filings by the beneficial owners with the SEC pursuant to section 13(d) and 13(g) of the
Exchange Act. We have determined beneficial ownership in accordance with the SEC&#146;s rules. These rules generally attribute beneficial ownership of securities to persons who possess sole or shared voting power or investment power with respect to
those securities. In addition, the rules include shares of common stock issuable pursuant to the exercise of stock options that are either immediately exercisable or exercisable on or before May&nbsp;30, 2021, which is 60 days after March&nbsp;31,
2021. These shares are deemed to be outstanding and beneficially owned by the person holding those options for the purpose of computing the percentage ownership of that person, but they are not treated as outstanding for the purpose of computing the
percentage ownership of any other person. Unless otherwise indicated, the persons or entities identified in this table have sole voting and investment power with respect to all shares shown as beneficially owned by them, subject to applicable
community property laws. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="67%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name of Beneficial Owner(1)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares of<BR>Beneficially<BR>Owned</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage&nbsp;of<BR>Shares<BR>Beneficially<BR>Owned</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B></B><B><I>5% Stockholders:</I></B><B></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">KKR Genetic Disorder L.P.(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31,060,971</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20.8</TD>
<TD NOWRAP VALIGN="bottom">%</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Viking Global Entities(3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26,620,991</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17.9</TD>
<TD NOWRAP VALIGN="bottom">%</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B></B><B><I>Directors and Named Executive Officers</I></B><B></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Neil Kumar, Ph.D.(4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,511,944</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.7</TD>
<TD NOWRAP VALIGN="bottom">%</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Brian C. Stephenson, Ph.D., CFA(5)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">599,803</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael Henderson, M.D.(6)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">341,498</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cameron Turtle, Ph.D.(7)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">98,590</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Charles Homcy, M.D.(8)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,341,314</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Brian Stolz(9)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">59,123</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Eric Aguiar, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27,626</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jennifer E. Cook(10)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39,744</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ronald J. Daniels</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30,518</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Andrew Lo, Ph.D.(11)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">246,182</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James C. Momtazee(12)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">61,044</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ali Satvat(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31,248,001</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20.9</TD>
<TD NOWRAP VALIGN="bottom">%</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Brent Saunders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard H. Scheller, Ph.D.(13)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">83,819</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Randal Scott, Ph.D.(14)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All directors and executive officers as a group (15&nbsp;persons)(15)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42,710,206</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28.3</TD>
<TD NOWRAP VALIGN="bottom">%</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents beneficial ownership of less than one percent of the shares of BridgeBio common stock.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Unless otherwise indicated, the address of all listed stockholders is 421 Kipling Street, Palo Alto, California
94301. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Based on a Schedule 13D/A filed with the SEC on February 17, 2021 by KKR Genetic Disorder L.P. Consists of
31,060,971 shares of BridgeBio common stock directly owned by KKR Genetic Disorder L.P. KKR Genetic Disorder GP LLC, as the general partner of KKR Genetic Disorder L.P., KKR Group Partnership L.P., as the sole member of KKR Genetic Disorder GP LLC,
KKR Group Holdings Corp., as the general partner of KKR Group Partnership L.P., KKR&nbsp;&amp; Co. Inc., as the sole shareholder of KKR Group Holdings Corp., KKR Management LLP, as the Series&nbsp;I preferred stockholder of KKR&nbsp;&amp; Co. Inc.,
and Messrs. Henry R. Kravis and George R. Roberts, as the founding partners of KKR Management LLP, may be deemed to be the beneficial owners having shared voting and investment power with respect to the shares described above. The principal business
address of each of the entities and persons identified in the immediately preceding sentence, except Mr.&nbsp;Roberts, is c/o Kohlberg Kravis Roberts&nbsp;&amp; Co. L.P., 30&nbsp;Hudson Yards, New York, NY 10001. The principal business address for
Mr.&nbsp;Roberts is c/o Kohlberg Kravis Roberts&nbsp;&amp; Co. L.P., 2800 Sand Hill Road, Suite&nbsp;200, Menlo Park, CA 94025. Mr.&nbsp;Satvat is a member of the BridgeBio board and serves as an executive of Kohlberg Kravis Roberts&nbsp;&amp; Co.
L.P. and/or one or more of its affiliates. Each of Messrs. Kravis, Roberts and Satvat disclaims beneficial ownership of the shares held by KKR Genetic Disorder L.P. The principal business address of Mr.&nbsp;Satvat is c/o Kohlberg Kravis
Roberts&nbsp;&amp; Co. L.P., 2800&nbsp;Sand Hill Road, Suite 200, Menlo Park, CA 94025. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Based on a Schedule 13D filed with the SEC on July&nbsp;8, 2019 by Viking Global Investors LP. Consists of (i)
631,167 shares of BridgeBio common stock held by Viking Global Equities Master Ltd. (&#147;VGE Master&#148;); (ii) 251,204 shares of BridgeBio common stock held by Viking Long Fund Master Ltd. (&#147;VLF&#148;) and (iii) 25,738,620 shares of
BridgeBio common stock held by Viking Global Opportunities Illiquid Investments Sub-Master LP (&#147;Viking Opportunities,&#148; and together with VGE Master, VLF and Viking Opportunities, the &#147;Viking Global Entities&#148;). VGE Master has the
power to dispose of and vote the shares directly owned by it, which power may be exercised by its investment manager, Viking Global Performance LLC (&#147;VGP&#148;), and by Viking Global Investors LP (&#147;VGI&#148;), which provides managerial
services to VGE Master. VLF has the power to dispose of and vote the shares directly owned by it, which power may be exercised by its investment manager, Viking Long Fund GP LLC (&#147;VLFGP&#148;), and by VGI, which provides managerial services to
VLF. Viking Opportunities has the power to dispose of and vote the shares directly owned by it, which power may be exercised by its general partner, Viking Global Opportunities Portfolio GP LLC (&#147;Viking Opportunities GP&#148;), and by VGI,
which provides managerial services to Viking Opportunities. O. Andreas Halvorsen, David C. Ott and Rose S. Shabet, as Executive Committee members of Viking Global Partners LLC (the general partner of VGI), VGP, VLFGP and Viking Opportunities GP,
have shared power to direct the voting and disposition of investments beneficially owned by VGI, VGP, VLFGP and Viking Opportunities GP. The business address of each of the Viking Global Entities is c/o Viking Global Investors LP, 55 Railroad
Avenue, Greenwich, Connecticut 06830. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of: (i) 7,519,833 shares of BridgeBio common stock, of which 4,711,425 shares are held by
Dr.&nbsp;Kumar, of which 1,890,074 shares are subject to our right of repurchase as of March 31, 2021, 1,612,722 shares are held by the Kumar Haldea Revocable Trust and 1,195,686 shares are held by the Kumar Haldea Family Irrevocable Trust
(Dr.&nbsp;Kumar disclaims beneficial ownership of the shares held in the trusts) and (ii) 984,587 shares of BridgeBio common stock underlying exercisable options that are vested as of March 31, 2021 or exercisable within 60 days thereafter.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of (i) 300,043 shares of BridgeBio common stock held by Dr.&nbsp;Stephenson, of which 162,905 shares
are subject to our right of repurchase as of March 31, 2021 and (ii) 297,272 shares of BridgeBio common stock underlying exercisable options that are vested as of March 31, 2021 or exercisable within 60 days thereafter. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Based on a Form 4 filed with the SEC on December 17, 2020, consists of (i) 274,211 shares of BridgeBio common
stock held by Dr.&nbsp;Henderson, of which 97,025 shares are subject to our right of repurchase as of March 31, 2021 and (ii) 43,427 shares of BridgeBio common stock underlying exercisable options that are vested as of March 31, 2021 or exercisable
within 60 days thereafter. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Based on a Form 4 filed with the SEC on December 29, 2020, consists of (i) 12,568 shares of BridgeBio common
stock held by Dr. Turtle of which 5,404 shares are subject to our right of repurchase as of March </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
31, 2021 and (ii) 86,940 shares of common stock issuable upon the exercise of options that are vested as of March 31, 2021 or exercisable within 60 days thereafter. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of (i) 1,204,764 shares of BridgeBio common stock held by Dr.&nbsp;Homcy, of which 287,882 shares are
subject to our right of repurchase as of March 31, 2021 and (ii)&nbsp;136,550 shares of BridgeBio common stock underlying exercisable options that are vested as of March 31, 2021 or exercisable within 60 days thereafter. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of (i) 24,615 shares of BridgeBio common stock held by Mr. Stolz and (ii) 30,830 shares of BridgeBio
common stock underlying exercisable options that are vested as of March 31, 2021 or exercisable within 60 days thereafter. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of (i) 3,576 shares of BridgeBio common stock held by Ms. Cook, and (ii) 36,168 shares of BridgeBio
common stock underlying exercisable options that are vested as of March 31, 2021 or exercisable within 60 days thereafter. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of 246,182 shares of BridgeBio common stock, of which 40,599 shares are held by Dr. Lo and 205,583
shares are held in trust by Andrew W. Lo and Nancy N. Lo JTWROS. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(12)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of (i) 8,491 shares of BridgeBio common stock held by Mr. Momtazee and (ii) 52,553 shares of BridgeBio
common stock issuable upon the exercise of options that are vested as of March 31, 2021 or exercisable within 60 days thereafter. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(13)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of (i) 45,860 shares of BridgeBio common stock held by Dr.&nbsp;Scheller, of which 36,646 shares are
subject to our right of repurchase as of March 31, 2021, and (ii) 37,959 shares of BridgeBio common stock issuable upon the exercise of options that are vested as of March 31, 2021 or exercisable within 60 days thereafter. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(14)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of 21,000 shares of BridgeBio common stock held by Dr. Scott. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(15)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of the number of shares beneficially owned by the named executive officers and directors listed in the
table above. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc131567_10"></A>DELINQUENT SECTION 16(A) REPORTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;16(a) of the Exchange Act requires our officers and directors, and persons who own more than 10% of a registered class of our equity securities,
to file reports of ownership and changes in ownership (Forms 3, 4 and 5) with the SEC. Officers, directors and greater than 10% stockholders are required to furnish us with copies of all such forms which they file. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To our knowledge, based solely on our review of such reports or written representations from certain reporting persons, we believe that all of the filing
requirements applicable to our officers, directors, greater than 10% beneficial owners and other persons subject to Section&nbsp;16 of the Exchange Act were complied with during the year ended December&nbsp;31, 2020. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc131567_3"></A>PROPOSAL 2 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">NON-BINDING,</FONT> ADVISORY VOTE TO APPROVE THE </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Board of Directors is committed to excellence in governance. As part of that commitment, and as required by Section&nbsp;14A(a)(1) of the Exchange Act,
our Board of Directors is providing the stockholders with an opportunity to approve, on a <FONT STYLE="white-space:nowrap">non-binding,</FONT> advisory basis, the compensation of our named executive officers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following proposal, commonly known as a &#147;say on pay&#148; proposal, gives our stockholders the opportunity to vote to approve, on a <FONT
STYLE="white-space:nowrap">non-binding,</FONT> advisory basis, the compensation of our named executive officers. This vote is not intended to address any specific item of compensation or the compensation of any particular officer, but rather the
overall compensation of our named executive officers and our compensation philosophy, policies and practices, as discussed in this proxy statement. Accordingly, we are asking our stockholders to vote for the following resolution: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;RESOLVED, that the Company&#146;s stockholders approve, on a <FONT STYLE="white-space:nowrap">non-binding,</FONT> advisory basis, the compensation of
the Company&#146;s named executive officers, as disclosed in this proxy statement, including the Compensation Discussion and Analysis, compensation tables and narrative discussion.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Before you vote, we recommend that you read the Executive Compensation section of this proxy statement for additional details on our executive compensation
programs and philosophy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This vote is advisory, and therefore not binding on us, the Board of Directors or the Compensation Committee. However, our board
of directors and Compensation Committee value the opinions of our stockholders and intend to take into account the outcome of the vote when considering future compensation decisions for our named executive officers. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Approval on a <FONT
STYLE="white-space:nowrap">non-binding,</FONT> advisory basis of the compensation of our named executive officers requires an affirmative vote of a majority of the shares of our common stock present in person or by proxy at the Annual Meeting and
entitled to vote thereon to be approved. Abstentions and broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will have no effect on the outcome of this proposal. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#147;FOR&#148; APPROVAL, ON A <FONT STYLE="white-space:nowrap">NON-BINDING,</FONT> ADVISORY BASIS, OF THE
COMPENSATION OF THE COMPANY&#146;S NAMED EXECUTIVE OFFICERS. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc131567_4"></A>PROPOSAL 3 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">NON-BINDING,</FONT> ADVISORY VOTE ON THE FREQUENCY OF FUTURE
<FONT STYLE="white-space:nowrap">NON-BINDING,</FONT> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ADVISORY VOTES TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;14A of the Exchange Act requires us to submit a <FONT STYLE="white-space:nowrap">non-binding,</FONT> advisory resolution, commonly known
as a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;say-on-frequency&#148;</FONT></FONT> proposal, to stockholders at least once every six years to determine whether <FONT STYLE="white-space:nowrap">non-binding,</FONT>
advisory votes to approve the compensation of our named executive officers, like Proposal 2, should be held every one, two or three years. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">After careful
consideration, our Board of Directors has determined that an annual advisory vote to approve the compensation of our named executive officers will allow our stockholders to provide timely and direct input on our executive compensation philosophy,
policies and practices as disclosed in the proxy statement each year. The Board of Directors believes that an annual vote is therefore consistent with our efforts to engage in an ongoing dialogue with our stockholders on executive compensation and
corporate governance matters. Accordingly, we are asking our stockholders to vote on the following resolution at the Annual Meeting: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;RESOLVED, that
the Company&#146;s stockholders approve, on a <FONT STYLE="white-space:nowrap">non-binding,</FONT> advisory basis, the submission by the Company of a <FONT STYLE="white-space:nowrap">non-binding,</FONT> advisory resolution on the compensation of the
Company&#146;s named executive officers pursuant to Section&nbsp;14A of the Exchange Act every: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">one year; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">two years; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">three years.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This vote is advisory, and therefore not binding on us, the Board of Directors or the Compensation Committee. However, our Board of Directors and our
Compensation Committee value the opinions of our stockholders and intend to take into account the outcome of the vote when considering the frequency of holding future <FONT STYLE="white-space:nowrap">non-binding,</FONT> advisory votes to approve the
compensation of our named executive officers. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The frequency of future <FONT STYLE="white-space:nowrap">non-binding,</FONT> advisory votes to approve the compensation of our named executive officers that
receives the highest number of votes of the shares of our common stock present in person or by proxy at the Annual Meeting thereon shall be approved. Abstentions and broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will have no effect on the
<FONT STYLE="white-space:nowrap">non-binding,</FONT> advisory vote on the frequency of future <FONT STYLE="white-space:nowrap">non-binding,</FONT> advisory votes to approve the compensation of our named executive officers. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR EVERY &#147;ONE YEAR&#148; ON THE FREQUENCY OF FUTURE <FONT STYLE="white-space:nowrap">NON-BINDING,</FONT>
ADVISORY VOTES TO APPROVE THE COMPENSATION OF THE COMPANY&#146;S NAMED EXECUTIVE OFFICERS. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc131567_5"></A>PROPOSAL 4 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RATIFICATION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Audit Committee has appointed Deloitte&nbsp;&amp; Touche LLP (&#147;Deloitte&#148;) as the Company&#146;s independent registered public accounting firm
for 2021. Representatives of Deloitte will attend the Annual Meeting and will have the opportunity to make a statement if they desire to do so. They will also be available to respond to appropriate questions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s organizational documents do not require that the stockholders ratify the selection Deloitte as the Company&#146;s independent registered
public accounting firm, and stockholder ratification is not binding on the Company, the Board of Directors or the Audit Committee. The Company requests such ratification, however, as a matter of good corporate practice. Our Board of Directors,
including our Audit Committee, values the opinions of our stockholders and, to the extent there is any significant vote against the ratification of the selection of Deloitte as disclosed in this Proxy Statement, we will consider our
stockholders&#146; concerns and evaluate what actions may be appropriate to address those concerns, although the Audit Committee, in its discretion, may still retain Deloitte. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Independent Registered Public Accounting Firm Fees And Services </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table represents aggregate fees billed to us for the fiscal years ended December&nbsp;31, 2019 and December&nbsp;31, 2020 by Deloitte. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Fees billed</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019<BR>Deloitte</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020<BR>Deloitte</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,501,147</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,561,166</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit Related Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All Other Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,391</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,391</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,520,538</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,581,156</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Audit Fees. </I>This category consists of fees for professional services rendered in connection with the audit of our
annual financial statements, review of our quarterly financial statements, assistance with registration statements filed with the SEC, services that are normally provided by the independent registered public accounting firm in connection with
statutory and regulatory filings or engagements and other fees in connection with our adoption of new accounting pronouncements. This category also includes fees for services incurred in connection with our initial public offering in 2019 and
nonrecurring transactions closed in each of 2019 and 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Audit-Related Fees</I>. This category consists of fees billed for related services by the
principal accountant that are reasonably related to the performance of the audit or review of the Company&#146;s financial statements and are not reported under the Audit Fees category. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Tax Fees.</I> This category consists of fees for services provided for tax consultation services. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>All Other Fees.</I> This category consists of fees for all other services that are not reported above. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Audit Committee <FONT STYLE="white-space:nowrap">Pre-Approval</FONT> Policies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Audit Committee is directly responsible for the appointment, retention and termination, and for determining the compensation, of the Company&#146;s
independent registered public accounting firm. The Audit Committee shall <FONT STYLE="white-space:nowrap">pre-approve</FONT> all auditing services and the terms thereof and <FONT STYLE="white-space:nowrap">non-audit</FONT> services (other than <FONT
STYLE="white-space:nowrap">non-audit</FONT> services prohibited under Section&nbsp;10A(g) of the Exchange Act or the applicable rules of the SEC or the Public Company </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Accounting Oversight Board), except that <FONT STYLE="white-space:nowrap">pre-approval</FONT> is not required for the provision of <FONT STYLE="white-space:nowrap">non-audit</FONT> services if
the &#147;de minimis&#148; provisions of Section&nbsp;10A(i)(1)(B) of the Exchange Act are satisfied. The Audit Committee may delegate to the Chair of the Audit Committee the authority to grant <FONT STYLE="white-space:nowrap">pre-approvals</FONT>
for audit and <FONT STYLE="white-space:nowrap">non-audit</FONT> services, provided such approvals are presented to the Audit Committee at its next scheduled meeting. All services provided by Deloitte during fiscal year 2019 following our initial
public offering and during fiscal year 2020 were <FONT STYLE="white-space:nowrap">pre-approved</FONT> by the Audit Committee in accordance with the <FONT STYLE="white-space:nowrap">pre-approval</FONT> policy described above. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Required Vote </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The ratification of the selection of
Deloitte&nbsp;&amp; Touche LLP requires the affirmative vote of a majority of the votes cast on the proposal at the Annual Meeting (meaning the number of shares voted &#147;for&#148; the proposal must exceed the number of shares voted
&#147;against&#148; the proposal). Abstentions are not considered votes cast for the foregoing purpose, and will have no effect on the vote for this proposal. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recommendation of the Board of Directors </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Board of
Directors recommends that the stockholders vote FOR the ratification of the appointment of Deloitte&nbsp;&amp; Touche LLP as the independent registered public accounting firm of the Company for its fiscal year ending December&nbsp;31, 2021. </B></P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>The following Audit Committee Report is not considered proxy solicitation material and is not deemed
filed with the Securities and Exchange Commission. Notwithstanding anything to the contrary set forth in any of the Company&#146;s filings made under the Securities Act of 1933 or the Exchange Act that might incorporate filings made by the Company
under those statutes, the Audit Committee Report shall not be incorporated by reference into any prior filings or into any future filings made by the Company under those statutes. </I></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc131567_11"></A>AUDIT COMMITTEE REPORT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Audit Committee of the Board of Directors (the &#147;Audit Committee&#148;) has furnished this report concerning the independent audit of the
Company&#146;s financial statements. Each member of the Audit Committee meets the enhanced independence standards established by the Sarbanes-Oxley Act of 2002 and rulemaking of the Securities and Exchange Commission (the &#147;SEC&#148;) and the
Nasdaq Stock Market regulations. A copy of the Audit Committee Charter is available on the Company&#146;s website at https://bridgebio.com. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Audit
Committee&#146;s responsibilities include assisting the Board of Directors regarding the oversight of the integrity of the Company&#146;s financial statements, the Company&#146;s compliance with legal and regulatory requirements, the independent
registered public accounting firm&#146;s qualifications and independence, and the performance of the Company&#146;s internal audit function and the independent registered public accounting firm. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In fulfilling its oversight responsibilities, the Audit Committee reviewed and discussed the Company&#146;s financial statements for the fiscal year ended
December&nbsp;31, 2020 with the Company&#146;s management and Deloitte&nbsp;&amp; Touche LLP. In addition, the Audit Committee has discussed with Deloitte&nbsp;&amp; Touche LLP, with and without management present, their evaluation of the
Company&#146;s internal accounting controls and overall quality of the Company&#146;s financial reporting. The Audit Committee also discussed with Deloitte&nbsp;&amp; Touche LLP the matters required to be discussed by the applicable requirements of
the Public Company Accounting Oversight Board and the SEC. The Audit Committee also received the written disclosures and the letter from Deloitte&nbsp;&amp; Touche LLP required by the Public Company Accounting Oversight Board Rule 3526 and the Audit
Committee discussed the independence of Deloitte&nbsp;&amp; Touche LLP with that firm. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Based on the Audit Committee&#146;s review and discussions noted
above, the Audit Committee recommended to the Board of Directors, and the Board of Directors approved, that the audited financial statements be included in the Company&#146;s Annual Report for the fiscal year ended December&nbsp;31, 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Audit Committee and the Board of Directors have recommended the selection of Deloitte&nbsp;&amp; Touche LLP as the Company&#146;s independent registered
public accounting firm for the year ending December&nbsp;31, 2021. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>AUDIT COMMITTEE </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ERIC AGUIAR, CHAIRMAN </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">RONALD J. DANIELS </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">RANDAL SCOTT </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc131567_12"></A>HOUSEHOLDING OF PROXY MATERIALS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have made available a procedure approved by the SEC known as &#147;householding.&#148; This procedure allows multiple stockholders residing at the same
address the convenience of receiving a single copy of our Notice, Annual Report and proxy materials, as applicable. This allows us to save money by reducing the number of documents we must print and mail and helps protect the environment as well.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Householding is available to both registered stockholders (i.e., those stockholders with certificates registered in their name) and street name holders
(i.e., those stockholders who hold their shares through a brokerage). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Registered Stockholders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you are a registered stockholder and would like to consent to a mailing of proxy materials and other stockholder information only to one account in your
household, as identified by you, we will deliver or mail a single copy of our Annual Report and proxy materials for all registered stockholders residing at the same address. Your consent will be perpetual unless you revoke it, which you may do at
any time by contacting the Householding Department of Broadridge Corporate Issuer Solutions, Inc. (&#147;Broadridge&#148;), at 1717 Arch Street, Suite 1300, Philadelphia, PA 19103. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Registered stockholders who have not consented to householding will continue to receive copies of Annual Reports and proxy materials for each registered
stockholder residing at the same address. As a registered stockholder, you may elect to participate in householding and receive only a single copy of Annual Reports or proxy statements for all registered stockholders residing at the same address by
contacting Broadridge as outlined above. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Street Name Holders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stockholders who hold their shares through a brokerage may elect to participate in householding or revoke their consent to participate in householding by
contacting their respective brokers. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc131567_13"></A>OTHER MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are not aware of any matters that may come before the meeting other than those referred to in the notice. If any other matter shall properly come before
the Annual Meeting, however, the persons named in the accompanying proxy intend to vote all proxies in accordance with their best judgment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Accompanying
this Proxy Statement is our Annual Report. Copies of our Annual Report are available free of charge on our website at https://bridgebio.com or you can request a copy free of charge by calling Investor Relations at Burns McClennan at (212) <FONT
STYLE="white-space:nowrap">213-0006,</FONT> ext. 362 (attention: John Grimaldi), or sending an <FONT STYLE="white-space:nowrap">e-mail</FONT> request to ir@bridgebio.com. Please include your contact information with the request. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By Order of the Board of Directors,</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BridgeBio Pharma, Inc.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">/s/ Neil Kumar</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Neil Kumar</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Executive Officer</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">April 30, 2021 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g131567g01a10.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">BRIDGEBIO PHARMA, INC. 421 KIPLING STREET PALO ALTO, CA 94301 </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">VOTE BY INTERNET </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Before The Meeting&#151;Go to www.proxyvote.com </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 p.m. Eastern Time on June&nbsp;16, 2021. Have your proxy card in
hand when you access the website and follow the instructions to obtain your records and to create an electronic voting instruction form. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">During The Meeting&#151;Go
to www.virtualshareholdermeeting.com/BBIO2021 </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">You may attend the meeting via the Internet and vote during the meeting. Have the information that is printed in the
box marked by the arrow available and follow the instructions. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">VOTE BY <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">PHONE&#151;1-800-690-6903</FONT></FONT></FONT> </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Use any touch-tone telephone to transmit your voting instructions up until 11:59 p.m.
Eastern Time on June&nbsp;16, 2021. Have your proxy card in hand when you call and then follow the instructions. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">VOTE BY MAIL </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">51 Mercedes Way, Edgewood, NY 11717. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS
FOLLOWS: </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">D54355-P58069 </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">KEEP THIS PORTION FOR YOUR RECORDS </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">DETACH AND RETURN THIS PORTION ONLY </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED.
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">BRIDGEBIO PHARMA, INC. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">The Board of Directors recommends that you vote
&#147;FOR&#148; the nominees listed in Proposal 1, &#147;FOR&#148; Proposal 2, for every &#147;ONE YEAR&#148; in Proposal 3, and &#147;FOR&#148; Proposal 4: </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">1. To
elect three (3)&nbsp;directors, Eric Aguiar, M.D., Ali Satvat and Jennifer E. Cook, to serve as Class&nbsp;II directors to hold office until the date of the Annual Meeting of Stockholders following the year ending December&nbsp;31, 2023 and until
their successors are duly elected and qualified, or until such director&#146;s earlier death, resignation or removal. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Nominees: </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">01) Eric Aguiar, M.D. 02) Ali Satvat 03) Jennifer E. Cook </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">2. To cast a <FONT
STYLE="white-space:nowrap">non-binding,</FONT> advisory vote to approve the compensation of the Company&#146;s named executive officers. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">3. To cast a <FONT
STYLE="white-space:nowrap">non-binding,</FONT> advisory vote on the frequency of future <FONT STYLE="white-space:nowrap">non-binding,</FONT> advisory votes to approve the compensation of the Company&#146;s named executive officers. </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">For All </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Withhold All </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Except For All </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">For Against Abstain </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">One Year </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Two Years </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Three Years </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Abstain </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should
each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized officer. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Signature
[PLEASE SIGN WITHIN BOX] Date </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Signature (Joint Owners) Date </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">To withhold
authority to vote for any individual nominee(s), mark &#147;For All Except&#148; and write the number(s) of the nominee(s) on the line below. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">4. To ratify the
appointment of Deloitte&nbsp;&amp; Touche LLP as the independent registered public accounting firm of the Company for its fiscal year ending December&nbsp;31, 2021.
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">NOTE: To transact such other business as may properly come before the meeting or any adjournment or postponement thereof. </FONT></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g131567g02k20.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting: </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">The Notice and Proxy Statement and Annual Report are available at www.proxyvote.com.
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">D54356-P58069 </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">BRIDGEBIO PHARMA, INC. Annual Meeting of Stockholders
June&nbsp;17, 2021 9:00 a.m. Pacific Time This proxy is solicited by the Board of Directors </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">The undersigned hereby appoints Neil Kumar, Ph.D. and Brian C.
Stephenson, or either of them, as proxies, each with the power to appoint his substitute, and hereby authorizes them to represent and to vote, as designated on the reverse side of this ballot, all of the shares of common stock of BRIDGEBIO PHARMA,
INC. held of record by the undersigned on May&nbsp;7, 2021 at the Annual Meeting of Stockholders to be held at 9:00 a.m. Pacific Time on June&nbsp;17, 2021, at www.virtualshareholdermeeting.com/BBIO2021, and any adjournment or postponement thereof.
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">This proxy, when properly executed, will be voted in the manner directed herein. If no such direction is made, this proxy will be voted in accordance with the
Board of Directors&#146; recommendations. In their discretion, the proxies are authorized to vote upon such other business as may properly come before the Annual Meeting. This proxy, when properly executed, will be voted as directed herein by the
undersigned Stockholder. If no direction is made, this proxy will be voted &#147;FOR&#148; the nominees listed in Proposal 1, &#147;FOR&#148; Proposal 2, for every &#147;ONE YEAR&#148; in Proposal 3 and &#147;FOR&#148; Proposal 4. </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Continued and to be signed on reverse side </FONT></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g131567g01a10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g131567g01a10.jpg
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M/"]X.GAM<&UE=&$^(#P_>'!A8VME="!E;F0](G(B/S[_[@ .061O8F4 9,
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M$D%182)Q@9$#$Z&Q,E(S\,'1X4-"(__:  P# 0 "$0,1 #\ _OXP& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MWI25)5KU2I*M>NE)5K?KK>OX<#ZP& P& P& P& P& P& P& P& P& P& P&
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MW_8W?]E+T7_/9[1_DYXC@?UAX&I/DGX%^%WF'"5#\GO%[B7;'OA^GCG+SS\
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M:=GDR#GM9B1&=/3)CRDMM-N.*TG8<K.,_P!HO^S9WCI\'D5%\TZC"MQ@JR%
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M7&]:7.=TX&JO/_!?@7G]_:TO-[E/DL(;MO+*"4O7:9_/),Z3 &=',4^M<G"
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M1M:>7M+2DKV*E<H_DUP66S(D1NGUQYF(JSJE.-KF*U'ATP0L[:3+W_E/5NN
MQ3>W7R>_0>GT]FGMK_5P;98T;\O^ !:V>M:;W%*":HB>_96AD$J^;',"Q-J*
M$$Q:ZJ V<-$(7Y.G,OPX;#\J.\RO3J$>Q7H-LI-LG9^74Y:VK1=0X*2B,&E;
M@DER(Q%;5AAGYX)+(U;'U[\DPQ5B&HS*&U///1%M)3MWT1L5*QR?(OA\.NR+
M9*Z766*_$=>CRR#DIU/TLV,-AEI(V1%^#ZU@M%A$&=NQ%-ZDM.+TTIO3NMHT
M*E>;#VKEE4?D1+#=1(LA&?AQ'!,CZK9I<TC!'$1T".%:C.%99$C'+Q=1X[3*
MWGWGT,H2IY6D8*E'T?RUX3,DDDQ;M%<'"2L )*+KADFH4XL8#4<T$@U=*X7U
M%S?)M=#%Q])%(EJ9G2$QG=(>VE&QMEFE:[WQ^Y'FZO5+\"/G7Z_(M$6$.=?<
M;F!84&N$Y\J&04PD;)<&0+@)=ELH>4_$02C;>0WIY'J*G/@L0/R;X@><'0H7
M0 ;QDE+ "XP6&Y))S99NPLLO1 XA0V-*8L,N*E].Y6X"I"(C>]./J;;4E6Q4
MO"I^4W";E$A2A5\B1G)P&79T#S@TR *1P4-%S>7/GP"P^)('H?A<\-R6$/:0
MY(BC'WFTJ;;VK!4ODAY0\:B%X *':/Q:<5;LZQ\R&-+)J[RJ=* P[&TNZOP&
MJDRX.E6*.QOW3/:J5I<?6_G0IO0J5<SY-\$?G#AC74*TJ<7*Z$#8_P DM*Y;
MZY(F''G-;7$2C\OS99Z$W&*[WH9*7*:2U(7M>O45+)U=GYBBB#NG+MD-'/RT
MB,P/MBXA- :0B9*7#BD=25P=?$#?<1M:2"])@[8]'OF^'>E[%3=<4<VGRYX'
M5Z=:;EN^#C42JLG5/C J),@N3D5\47+3&1,5YEA,J%MH'*;_ !'W)%MO,K0Y
M)1M"_:*E>#_DES&J7VY42U$Y%==HX:EE"QHG"FH&2I-WC7$I &!],1GY!9P3
M7J/.)$WV4JC#X3:G7EH0V\IL5@OLSO\ QH?42%]F=#KS--&6@E3)-DV^\L4N
MS!GY,8N+@26V%I*K%.P9'U+D7YF6$Q9"EK2F.]M J;KBQ<7Y4\-G)FM3KV&"
M$X+MGTL*0E-/$Y,6M78G1D2AS(Q4]!-ZP$1Z) V''4Z0EQ)<=Q#'HZG!4OT?
MY5<*(23<'=T6.( 2IP1,&F*[9Q11^57B->#3U#1DT.S/)L.G+4/'Q5,MKW-(
M2FXS&G'U:;P5*OC^3/#B+KD<-T>KE9#&@3LC39-J'#8C'9]0A)<65(ZBBOJA
MS5Z%O2HFGOJXZ)K&G&T*=;TH5+\N?DIR*D\Q=ZR2LFWZLZ,L9('J./(LDK0B
ML@BEC() P)\2&_)C;$!WI"9J]-C]1M:?4^EA6G-BINE@*^6W$QI5L6BW#)VH
MRRS=E(,$1[0ZH+"E 0>:DV_)DM*<TL@8<CL+BIDM2)@^5&0O<AE;>A4LD,>3
M7 @$\F,+]6J$.<'C2Y1&/LAMY4=,*4N$_']T=IUMX@J2RYIJ*WM4E_3+BFVU
MI:<VD5*0Z?T&EW^,N93;$.L,=F&(G/N#W%KW&8.P=$A6I;;C;;D61)@JTYME
MS27F];U[TIWO6L)5,QP& P& P& P& P& P& P& P/X</%[[4/WWOMQ^0OFCY
ME>'[WC?<#?=/(B_3RWBATVYMRZ9VSC5@M]KN-,NS-GAEJFU4>E4DD><:8CR2
M(STBD)'K(=3[XKP;:<%^V3]TS[@_W$.#^?\ ]YECB_'>?^'DQNP>.'B)Q8Y"
MMH[5]BD8AP;8CLZ ?NXJ(/:L@L>5GRGSA$B3D"HD/4>)";P-U^E_;G\E+1_:
M(_'O[E H?35^,?./$<YQVS$G[6PS=&KK-"=N'1X\.H[B;D2X"Y%^@;W(T[I&
MD;<WO]*/38;*_?,\.NU>>WVRO(+Q;\>X->)=9Z'.Y-*K,&TGX]8"/MT[K]&N
MAE,HU*:>CQ'$A $A36EZ]''=)1ZZ]WK@:V>;GV:"/GA]HWQ:\-;/;1?*O*'Q
M=Y%P"9RSI423,)5^H]NY3R<-1CXN>2#MH*R:39%,RHCLR&C<B,XF+/::>7%3
M'=#1/5*_M4?D=R;^@KW"K>('#*':@#O+^O>?M<N,*R=-L/,I,-P-:"U5IP"_
M37FN@V^OK>8^KU6 GJZ_[T[%N[^H;"=_M*>$KOVE?LW^6'(/NDP:2'Y$YT/O
M'0>MH S2_4P,S@%YYQSRCE%E8E%#3CTB01C!9S;T:%&=DM-J2YKV[_2D-+?
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M-4*#4L142G?CB_$YO3>G4IT2;XMD,(8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M7],MZ>2PI:V4O>Q/R)96XE#BVM+]?;M6M;WK^'6MX9>V P& P& P& P& P&
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MTI]E&DH2-P%\*0PFP54XN[N2&ZHQ0A\06S4Q\."L9R\(!&4QUAE)-Z.,L")
M+?U\N,VW'E09\V(S%BIE..;&YMASVF#N<T*E<_$+VX+I%4KU3'N[9:CJ>AUX
M3$$L/K89_B6G'VXFEJ2G]72E;],,SC-LPP& P& P& P& P& P& P& P& P&
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MU7&U>BT;_1O6L"KP& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P&!!_>@7,+%50K/4S84*&JUTJ?4X3A;0]YQV
M9R4W#O[_ -)"FH>?E-)'!'DS-QVUNH@N/;_0GW86+X-=CW@L$+$+&1'=0-!B
M9V/T ;"F,5T#,EM5[IV^F:N.C[DA?ON-E:5U::@86F?KCVF&$*:?]\O<HNY=
M^J^-O$3N[SUZ['T!X\0-8))>R$:^+^LK8VM\Y?YG((0I) 8LQI #4)TC#4WI
M7NFJTMCW:6C:A$SE"P4CPW9KW8*MU-5^,6N*NQ&+U>95BU^&E;444!!P>>A"
MU=^@2VRH.:818GG_ )8.F2\1I#$!EEY3;(G5@]9G@M4S!2^';#TDM9BE]U=8
M)6>=!UXBMD/>ZAT&FNM,-R-+AQC$=F[M*3(CM1XKZ13#6XFM*<5L7T6L+X4\
MA*S+:ZJZ)LQ(F7OY)PXR,1/T+.7)OIU7G,M3"!,W7$&*%;[D9_"FH;42<)TT
MU$D;<]B7%#=+-(7A]2ZW7^TQ9]W;V)OP&K09$XI6ZLRW6X//;[?NJB#5LG.H
M3NYEFS=\?5/G$G&U/1(K6_XIS;K[@W,*A^&O$[JH/.KUVT0A4.P#H=EA#XVH
M59L!MAZWV4M,-L5HE7')=D)0>HL+BD4RG?IFV6=ZT^EQQ"A<LTN?B?QOH9^Z
MWAZQ.+,66W%H98_5H867805@*V#@L%X;#/C84PN(+@7N)Q827E*2\.;*2U+V
MVE&MI%RP.)]NKEK8D;!F6>5/B,4"RT*:IY@F]!DNFA%@ "[@/'D+61%0;7&B
MV%22'RM2QI7;#6OHX^TZW@W2O-C\)Z,8U?4.64C+NMD8GFY$N.*%UJ.E9T=V
MT8BNPS*0QEL76"97KDO;T#_SOHQ%90ZRZVXK3HW/JG^)H:T\YK0BWW($@P)Z
MAW&TV2+S!H,BGSFK]<3APUS.3%U"8:4-JEY@@R,M*66'U%ZZA#^MI6_\@O%Z
MU?Q@H4H'V2'_ "K6"[L=7C ^0NRR .(2BULIR.Q7!X7$DC415"IDFMEICL!:
MU-0XRX8Z.VK:I.W)3XOHH+?X3\>9C5TP<NK84>/-0I1"/*;CA*S<BI([U<F0
M62A "U<ED;*97U>0Q ?3*<DL+A,>U+_N=;6+G)GI/Q:Y9U.PG^KJL3QA'4EU
M"S"9B!H5_4(/%;J!';->ESH+DUB':@];::EZ5KU<C2%I4G:=:3@W3&".J1X5
M\A_%CTA=R;MLVK62G13FI0=+6@MCI="J\+090^63E5N(%U%9#EX<=B"EP9)U
MK34G;>_B0-TKQKP Y9^*5J0DU/=$ !" :ZNN&U'!+C,4CF-0T5&# TT0/'V9
M4WE\2<]*D,3H\A4IYEZ,XCX]H&Z5QZ/X7@NGB.<@K'T\PP YQS2%SUL.*$!X
M(F;MFIVJBRC6H/SNPX:; (LRF9L-Y$IA7T$9$;<9.I*9(C53Z#>*_. ?= )T
M/>%1SE0/O==W1U5P$X]!@&2W=1X&  +[C(?JE+:?ZT787"AZUN2\/97M3>ER
M4R!<TQN=X7<I"SZD/G]#*^VT6EX1 BEAH4D5+"!)J'TBCT>GE_IM/5-%,I7,
MHP/4QI*W)]>&_$]ZR=-/H&Z5QY=X@<QB"NBJ$7N98X=TYD<X 3+#XSP<C74U
M^M5GC-LC FF2BZ^.8C?R51%;A_ABD,E&9#K;NV'O@2)U2PTIX><[B3B5.-=L
MCCIW33A95IJ0.HTT&P6,VBF=L9K$82!A)D_E,3&"62S2D(<T[^*.#=>Y_P!6
MGTO%OC3/+KX+\\L;/190\E*BE+2]J4-C#XH )H S%@]/0Q4A91D(1=#UHGKI
MSC,MKZ=]I<6.A"V74*6A1-TJ41X<LG^0#Z5?SM9'G9=Z[U=B"Z=6PSU>AP>^
MA^C58Y7Z_&F08#<;4(%T+2DRVV4;=F,:VXAY+BMK&['!GM+\1J-3.Q0.OAS4
MJ2X/<L[HNN/MNM!ZZ\>L'3"[3518$%!HH+!BL]2*0Y$=V',;E(0RO7PNMJ4L
M7A2-2/V]^5+ BPPFPS*[/@(IBVB8P0''.&WJ+5:&!AQ[&V'_  >:;!%YM"8(
MDH:9+&I,B0[O3C:O8XD;I4DOP@Y+1QUK+NVE\=$61I]@AD9PDK:'J?%K+ V%
M/'-,ESIQI535&%[U"4MA$L,WZ^LUUE&TX-TRPV]^(U%56*O#YE:JZ0N=[CV1
MFJHN4,2BM71VP@;\8DGK0-:JAQNTS:W3[Y+<'MRFFUL(;:<0YK:=M.EC5S;)
MQ^)4+KG-N0A"UK3<JUS-<U 60*C+$1BOT'/;3QQYF5IF2F:E(YPI,>TM*T>^
M0SI.];1K?J9NIM%,+P'J*3PPX3ZI<#+@>!1JD.:=8$,;<I-08@##=!([9UN+
M(#6NJ19863J.Q%D-CI:]J6[*1J3LUNZ)N\:N0T/B(R\T6GV1RS$8%HAN6B;-
M436;9?D5L/(K\>QO32A&&0.;K3T9QZ9%;B-R]+2M3*5^[U,S-ME\(8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8&JGD]Q^C=B_DZKEJL(< :)2^E4^K:GU5%I)E$W_D=UK-GB DHE0Y069!K
MS[L]<SW[CH:A[;>3O3B%)-:9F$>4?@7-.>^20LY&Z:Q)L4$39)56Y<Y'*#6J
MH&LU@ZS8X<*HQA%CA5^#5&1-QFQW8$D=,9>=$QY37TSC+:4"9F8?=@\%ZA9E
M7U\Q9FR4V_%+R\0FE*D-*.MURZB.A0]TU[4P@YJ?719F\,DTL+VEEV8+CKVV
ME>DK;&YA<_PZYY8;B=K\SJPF86)?RF$Q]<'UJ#LFEV:(Z"*?L=X<38)3=GO?
M.'_(P9L:06T/>AP6(3:&-;=U(;&Z5PN_@Q6W:_:*]3N@:YM!Z+*/!S#('G\*
M9&EQ["7DE $/XX!*#('OTB8Y\@J8R]&W#=1O7NTP](8>$:N;PL7@W76(<Q7\
MIE? "91"V1X\$K11NZY]5TZX]/*J.3A^K4*AD.I0#W8%- C2=LK8EQV-_3/N
M.J3L;DUTGQ4K%, ]7KB3\DN.Z_4#E6MBYXF"N64E'[9UJPD+,>><=?:L9^4+
MZ@@8^[);WMZ,)8TK^+VEEH;IE!DWPLK<T+8:?6.IA*Y9+*)(UR_2ZSSL<L:4
M'1Z]Q"+%!%QS-@<? IK0RDQ)8AG9%F9$096N.OX=O:?&[FG6L^,0RK\J/\KC
MV6-N";Z>'Z9),1ZZ@40(RXEKJEP,1K-L::BN&I]F*5U]F20;=AR-Q924_K.L
M_*X29N;8!=/$L^?Y%Q3CD:U50@,Y[9;B^9,V"D:F#&*T?YUU:I XH.G(/M+D
ME*D_>("!TR:4D3$N0$3I3TR5\FW2Q.-K>2\":@29D1WKE-D(E;O4^4^2KT(C
M.(VFW[[ML==C$QV>VHI;*NKM#*XTQQ.GM.@(JF]L_P 7J.-TK2>^W^"-F2I%
MN_OB8<[^4YZ&/#@" =(PET:X7F[RS'L!W$4,*SR)"_RA]@3-B/Q[$%BPXSK3
M#C'U"QN9_,\0(I'AKG%GKK&$QY?0.G7V60J5.:KH-C^4V9T*9,K06JIL,W0H
M$'U?U-QT;FO+4F(G:M^J][2-V-LN-^,->)\T9YM%G"(XT1V/77JFU/J$ F"J
M[[?0I%ZBUT97-3H4>+ '-S7X<5V,]&4QM>G4IUK6VE$M%U.\$ZS2;WS>UB;G
M-T$YRT!_#J4T-)!@;)$%4N>U]=B"MUVU!XXRPV(C0]RB[LEB?')L3G([["_1
M3KI9U7"INWA7'MW2[=T=%U"Q';';X]UT#G<\9*0#DEL/RT*NH=3<1:1RNE<U
M9:YBW+B"%)'+BD9?S_4+^!M&Q&IDO*?$IOET'I,)OHYBP;Z1SP+0I#Y 0AER
MN?E^N2*S"+USXRSOT*B$23\Y%GUW]9*88<^1OXO10G5:.3/@#7MULQ7:1=XU
M%CV. 1#6),"ABY40X"FBN;08@N;':+CY+209*@/$X+T>0P\Q/*R5I5[79290
MW/Q?@"&;^KD#>IV,85+\]Z?0; 7C!XZ9QA_J!NY&)M^>DH*MRF^C5]BS,#QY
M7Y%/,"V9437\3.4ED;F7T+PT'T3H'.+Q$M0A]%#)?CBA^Z@2DD43UTWJ50D@
MJ;93]XL!.D\[FKZ>\3<!ZU.;00C:VRZRRY\+8W8,(LGA&0=LTDP"M\5M-M[!
M/LUH?$A6JE)_DXN'0.D= Z;7[9)CDRCG035F"7Q^I09?Q#UCQBVW?12VM[V-
MV"8.I^)=/ZMT0M>S;H'XC@*M#2@R72QI29,)5&I=QJ8 E),/SF=RHPY':E3&
M8[T=Q3,L2PIMU'OW[!&JE/RWQ7D<LKO91@SIILG9NKCB,)N_%8,TJ?%29:K7
M,@EC T]8S=5LY(&1MKJ8[FH$%3H^-'B2-OH90M))F_!&]:\ :H*BQ$'+O-.$
M8:YNH1=BOLP" &(^CR%>%P:G)GF#LD#'JYGO*)XO]=_<6778+GZSB4+9+NE;
M9O@*Y):7)&]@E4DOMK4^(USZD,5JGAKB #@ ?.K>"J#EG)-CIE3CMV"7+8W*
M<:+D[/*DN;:TVTW@W)5[-XE0.NS.9P?SQ/J]%YJ&8$0*E "LR)B]164P6I,&
MU-DQY6"J0*;;BR&GTS6%MLH4A#;ON6H1JI&TCP5*DC8(R:[H<)O"JFP#)N:J
M$*#,LIJ>?J]RN9TU*AGFVYL>SW@+/+-Q7FGECW3#S+3ZHS3#*1N8]/\ MZ/E
M2[QDIV-!>2XEB$VDIS6 ZQ&A1ZITFF03,2+#M4"%!Z#7@?0VTBC;#3:XSH:(
MZ^Q*=V\M9=R;^)^)P_C723W1$7<Q;9!<22%Q&2Z"\>:):+RPLF:/;=C690"=
M7]+ M2&8SPM4B.0D2Y#<E.I+C6&9FT7@O AB(8*V.Q];+'K)/+H/0#L*IP*_
M-KAURP<B+EK/6D1C$J'7;4?A<K5&E2X#45K_ .+/[;90UK;#A=R?O'+Q_:X
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M1D>#''^R))2!;4IV/M474 7"=?Y$;H,XK<:56>BRX'3S-RMG0Z_T(K)L!R-
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MKI2')=.FN@,361C\DK((C-RG9D5YY#B)L>&S"CJ8=?E$FI5?5:MY!%NCRY=
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MM$43':FQH;[FQ\B5IU<=4="I@O2DWAM>\HQ_1;"4[9;8Y*I2ZO =$ A4"N.
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M.)8)QK7$ 2 IH06G%4#I(R>):<1/CPY$*7#?<3IW3ORJ)A>"*QG!?(KEU?&
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M$^62;3S#N]RBE90F2;&VM#$(]SD1'><=BMAHC3[S$U]F3(C*22(B5ZWY16%
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M_BUJ]=J4W^C]12M[WZ[U^G?K@?OPM>SXOB;^/U]?C]B?9Z^[W^OL]/;Z^_\
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MK*[!K],7ZRQ14HU_]HVSO]&&:BZO! N_+?O^M;W_ *MORZW_ .S5V\,/7?\
M[->OE7K7KO(UMC]H^J?;UUB^U/F-7O@'QRZUT:TGM@/Q7D%2-<;A7VG_ (N+
M?($-GR5RZE5N>2?RU+:3#F?AQR=[Y#B=QOG9TIU-9B(F:M"0KRK[N0*BQ\O[
M=OE<&B3R4"#*,D+GX>NCP\:9+9CR"T]H;Y03R3D$8RXI]Y,9A^0IMM6FVW%^
MU&S6V.<);[3V;HW+B0&#1_%SM'D#%+P9LL@6Y:>X8'@UM^*^PRP.+M];Z_S0
M@_+(-NJ=:5"8ELZ0VK3BT*]J5$B(G.8AB?,?(?KU\NPFK6GPG\BN0 R+9!<S
MH-]M'C,2JH14,?)F1FR,/GG?KQ;G5E)#"8K/THR0E+SJ=N[;:TMQ(G3$1<3$
MG3O(?KU#NQ:K5;PG\BNO@QS8]</H-"M'C,-JIM4P?&F26QT/H??J/;FEBY#Z
MHKWU0R.E3S2MM;<:VAQ0C3$QG#+.*]EZ-U$B>A7CQ=[/X_1A$*#*'E>I'N&&
M(-E?EOR&GQXAODG7^ESV)0YME+CNYK,1E2'4Z;6M6E)2)B(RF)1(5\K.[CRA
M0?$^W;Y7F8D E/@Q3(^Y^'K0\Q%ARWH\<M :)>4$$BW!)LMI?93)88D);<3I
MQMM?N1HNV.<?5-M&ZQ?;9S"SWP]XY]9YU:@/X_\ A7'[::XY-OMP_!Q;$\=^
M $J=U*T\[C?F:6ZJ'#_$3D'V2&U*D_ SM+JC,Q$35V@+7EOW_>M;_P!6WY=:
M_P#9N[>&'KK_ -F_3RKWKUUD:VQ^T?5/-CZW?PG(072!GC=URUW(LV$7/X8$
M-\8C])KBBBMZG-%RI[JH;EKZZ]K7K*^BL4I*]?\ V?;V5FHNKP08QY9]\>D1
MV7/MQ>6T9MZ0PRY)>NOAJIF,VZZAM<EY+/E.Z\IF.A6UKTA"U[2G?M2K?IK9
MK;'[1]4X=KZ[T#EJJXFC>-?7O(/1O139)?+#G%@Z:IL?]!](DWKKO5^9*D;,
M_5N?3_0:F^WZ9SYOB]6_>2(B<YB$><]\D.R7*Y@*Q8_!GR3Y>$,2GV"%_N=K
M\7)]7K+34*5*1,,0Z-Y#6^V/L2'XZ(Z-0ALMS3KR-J2EO2UI$Z8B,X77JWD!
MUGGMSE5BH^&7D'VD)'@#I;5^YY9O&X96)DB:TMR2-CP^E=XH5L3,%K3I#RG!
MK;*E*U\3CFO7>A&F)C&8A>>,=MZ9TX^6$7;Q1[?P(>.$:)1++U"P<#+AS<S<
MUB+L$.8Y-V;I)MHEIAU4CWR8D>+\3:M?-\FTH4)B(RF)1S9?*/N .Q'@HS[?
MGE+;1H@R3&#[4#N'B/'"66% F/18I\/'/^3 4\P++L-)D,(FPXDM+3B=/,M.
M>Y&B[8YPF'F76;[>Z3:[3:?'+K7(3M>=(-B.>WPUQLC:KHB&(9)1GJ],Y[U.
M[U"*V4F.*@LZ)DX"DR4;4[IMCVO;,S$1-6@)/EQW]24JW]MKR[1O:=;VA5V\
M+_<G>]>NTJ]OE6I/JG^#?IO>LC6V/VCZL[Z9)?Z+P^N='MOBWV:Q7,6_LE!X
M$&O7/*SUH3(.[(4HW#FV,+VJO<PFPW:L7DNSHN[3(ARA[JF]H=?]&<J1A-7%
M-8"=R+G'"*CWVF_*&Q1B-<W4$B;%>?$ _7@M65#C0'0%0K1GRWFU^CBI$2$P
MEUD-&@(>^!M2]*4VC>C51^T)Y[+5P_- X631?%/N?:WK6";I9 /Q[J=7J1'F
MM-#Q@\J-6H,CH7>^6PJG5"[\!AJ0.JTCZ:<["3N8TM"6U[,QCQB&%<QO5CE=
M#"QI/VY?)7G<6P1PM'DW:Z7SQHL%+YQ3AVF/I(PVNA?)VY$*I4AZX+#CL&M"
M-;=>::<W'<6VE22S$5G"]=W<35RM2YX(\%>[^1%!J-+%C@3]#OG&(/*X45N&
M0 1JV4HO5?(7GOX\;KPEI.V9<T++U&3(0J-*^72_8(B\;B)6'BE5KG0+HJ!=
M? GN7&H\060,R+YVGH?);R'MI-O4$1!"VQJE>175[->"\(9)7L0X=@RXHAB,
MM,5Z,KXT+$X1G$K.4.D^:7=8JH?;C\I[\/Y[:BTNK7<9U;Q_)UBT$U1FQ+5_
MBC>D^5PX\5)*$,-11\XZ-;+P(++4=K4=IIMM(JXQF&W'(>LW[I 2T%;EXX];
MX9. /-M"J]TDUQHJ5N*%P7)2GP#W+>I]#$1FFGT:CJT2DP%[=7K>M;;]5Z,S
M$1E-H$3Y<=_WK6]_;:\NT[WK6]IW=O##UU_[-^GE7O7KK(UMC]H^J?(_6;\]
MQ5_J+GCCUN+>&F7W6_'UXUQI74Y*VCWX0W'9,,=3>Y&EV2/_ /B2-KLR$:A_
MJJ4F1_$96:BZO! 2O+COZ4J5K[;7EVO>D[WI";MX7^Y6]:]=)3[O*M*?57\&
MO7>M9&ML?M'U3YU+K-^H%1JECJGCCUOLABPNQ6R]'Y^:XT-L=+1(%+(.O6&5
MT?J=%K$IN'+3J$YH80GJW(5I2-*9]7=5F(B9QFD15;R@[>?LU?!%OM_^4=-%
MF30T81MU@M_B5)!5>#.EM1Y1\S&KGDJ=L+XL2RYM]]$&%,EJ;1O33+B_1.S4
MZ8YPD'LW;^F\QL(L-2?$[N/?!L\,DG*M/,+#P(0%#S=SI478">QUCL_-SKA1
M+$=$C:X\-^)\3R-:>^32T))$1.<Q"U\F[]U?HEQ9K5O\-O(#B85T;/G+O?1;
M+XX%*RQ)AZ9W'$NQ.9=VO]JW.)_*K3*D#E1T_&KY7&_U?43$1&$Q+2KKE")B
M;KTBMU3PJ\O[B -]51U,U:Z39O"8ASCHU]0;3:85V9IW9>MQ)GSC$SEAO?."
MPI4F!%CHDZD;A#Y#)J,8N9A,OC_R45T*PV>T=)\:.P\D<!]9F=F"ANY,^+1V
M):+Q<AMZAEB(Z3Q6R7XF4;K"K,\N*H_*;E0''8R83JFFW4Z,SAE-L$Z!?K_T
M4T8(6O[:_F&99*IY?!(C7+KX12:\4A\<Z*5Z154OBR?DM)U(B$3Y1S4U#VM_
M-$TA"4M+UM>S6V(__4?5E52XO ;XX[T"!P'R#H!>MWJ)T>!XT.F/&W5]-&:%
M;B]DJ8VJV ):RE"IL";,-R$QOHK8'>6*=7#E/-MN.-K)>-7$]49E+'?91.T6
M@3]M_P T*Q?+-T<5U1SH-?N/@<BWC[0$K<6H0(\:82\C)\(G7TUIE^'N 39G
M,?%/D^WVJ6A39:C]H^J4+1PX!S6I@NP53Q[\@^I=5N]>?JMXJ]6M' XG6X(;
MH]:MI*^QKU8;G=:;0I\;5RL2B!!@08E1D6%J*Z/:^A0ZA1(FYJXB$.-P;Q8;
M"IAOP=\[N>MWD?!YQ>;&ST3P>?'RN<E:SSSGI858&]=VLI:*#B Z#%F.R@T9
M!Z.Z[-W"=3M_3.BX<X^J9NA\Y8X#?8)KE/C'Y)]QU9^6]*H1V1RBY>/8:JAA
MM\O[-QDZ-#>L=+YD5>N ]STB"IL)N2RT&:1&E*=4S'^,D8QC,0PWDM-G6FV5
M;GK_ (;^5/CAS1VN4D-;9)NR^'_\F%DC<;D2[-1T74=S?JM]Z!')%"ZMQY+H
M"+#22T\EJ?O<9/J@3AC<3/FN141/X, ZGXX<T\'/)_J7([>":!DK31K1XDC*
MD=V?YH$IUJ+UX?>.ST*R12QEF+M9=4\.VS*-ZDRFVE-O[4X,\9F+\V4\MY\_
MVPU:8'0O'KR4\>:+IF@%3-&Z1;?'HA0^IGJ@#;JE>FM)Y!T+I=P%D:V'K@I4
MIE,P..E*@P5:;=4V^E0G#*8F6NI2MVI9B+(.>!?G7T*P4PQ%_)O1"5\\#M$A
MCM._+8ZC6.K(1W0(R-D@8]0:D09+L!F>_HA*3/T[I[;+9<.<?5L 6XH#[K4>
ML=SN/CEW+E_5[!'EP"/,S!'QO,]%OX2FP* 6K=8'/Q;9T#E$RN&[%SX<]!AG
M333+9!N3N3]/%DN:<)=87%(B=L/5W1-LKJ? KSNAU6[1X$H_5QET^W\+%ZN0
MP77AP[H()R#WQHE5['"?JL"<W%@2& B9\?3NH/HMY+D6HYQ]4IW_ (E"=YY5
M^XEN%^1O6>WD2;%AFU.">\;8';J<<MB.=M%)KY,G:*IQ84]5:WRX< DM@BBX
M\@7)EMI3,7)<?RI$XU<1"#X4/I,P4'JYGPA\^I[6I?+1DRS&[O\ ;\42:K/*
MG'FZ&'8D".VM.54?5)!2=.^O ,0K MZ;)7J6M2FDMQ:CG'U=FLKF8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# T [UY(^0W,O+'Q_X53.=<9L'/>Y5K
MIUGU;[/?[N$N5?B<4@58ST"-NM"J"9!SI)(9;XR0V_Q%M"WVG=2?B1[5;-1$
M3IF<;AH]S7[TF^I.^.L>M<,F*E]BYUXAVJUQC#E_I^JS9O)GOHGBQ6N4R?>>
M=UD5TH-4VB"YD,V.?6*(R$:94\RA7RZEM3[=)NKGW)[E+\$_*GRMMG*Z?6.M
M^-%=M1^U^,LJS=!%7CFY033QMM%\][:BZ\OIQNM6MV-/]VYHD:5!$X6VY@J7
M-CN)7NIM[HCA+76E_>0ZP<[[P?B-@\:JN$?ZS8JF :DN7/IXDGT$);.[="Y&
MWU7B(^W\7K29M &U.@2K?\=M56)Q(9&DL#M2W41UR8LZ(J9M,]/^Y=V>YUWG
M%PB<"YD-KGE/QOR#ZQX@JG]MF))3G>#A&K=$KWD9]50!P/E;'1*8YN:DF+G'
MXM=EIW"GI4O:'5TV1SRG%A0O[P=JLGCUSKS J'C(6M/CYV[HUUXMR8<(M6YO
M9==94/%UCA@'HM-'AIX^F0.S]X@F:DIY<IS\ ;>"D)7N8(O(AC9%[;Q;N="\
MD^XC>S\>\8>:<OY<?[G:N'%.^]7(7CI5EJ?+J/4ZS9:;1C JGD0O/;9;;T>,
M7.TN,P?>.'1HD&)]1+<0X\Q&<,Q$5,SDTSZE]XX%2>D>?G/:W0*=:%^(O&>F
MW_F\U74(;1+K=X\?H%,_I!4FQ56"'GGJ#!HA[I@2%#F_'.46^ HMIK6H*M*-
M1HPCJQ\']UWO=RJ-:LM$\>./63Z?FGFWV*U2Y_:KI4ZS=^>>%G0N:4(T1Y"5
M.\=;.025[EWJ8W%C6X4"T/G!GF92TL.(EX-D7C?#ZMFN^?<+M5"!\4.<1\?[
M'W![N_B;TGR>IM4ARC$*[ZBU$SXVQ!09ZJ5RMW X50S7>^OERS N,0+I9!.1
MX$*=)?;;T2--W<U4LO*^=<*N<$\4?(N=KF5NY1VGJE/YKUOH]"MUC<HO+XEY
M1:ZH'N0V7;:A6CDD6+[&.$UPO$-0@TT4Z1>^H0EZ(ME1-N,QQAJOQ7[PL;IW
M?.2\3L7+ZI3U]6X;OH<>0KJ,*3:P'3;I2;GY \6Y22HTL,/,.:MOBQ5F;&3*
M(_B!IHC'%)0\M:7-FIT5%J_H?W5KU5^(^-?2Z]Q&J$K+Y%>&5.\G(8(S?S$
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M)5TQ,"*_%6-;CZCN"/\ SWRZB_QN#=[G.;2M)^S-]C<76*5;K%X,\ K >^L
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M[=)>TT:V3PR579/N=4[E_8. 4P3056SE/;.<\HZO.[),L-@J<2E4/K_0&:&
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MI;V*F<7A5.V^+(.++L5AX_+J@Z7VZSA[!;88Y$.LU^\$^@0>B0)5J&F+)!M
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M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@<*XG_4A%O^$%!_TK=X=/\
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M;U.;^&;HNX)B+):F-?&U\4K4S:_D3[$^U?KKTU_!AB<V4X# 8# 8# 8# 8#
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MT]WZ?7#"LP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P&!P?_M''^S6E_P"=)X??Z0E&R2Z>U^?E/V=X,KF8# 8#
M X-\-_ZBGSM_X=7BO_E'M>1TG^4>+O)E<S 8%N,-DGA!1D,^S%+NCIS8J3(3
MI3$8DN,ZF"^^G;3VE,LRMI4K7L7ZIUO]7?\ !@:*5Q7F!:Y46R&+!^4*K!:H
MK*AT8GR&=%,(TODP+JIDH6$1;#\$.%%;NA,5J+-8<2_]+MU&O:B&@U@O'C)S
MWN0"R#3?5Y<\@D;RH;299HM8:L:L12UC@'*(9TE8WJNK< P8DVJOG%)G.HW(
MW%TRAWV[]&TB9C@B,!S/S3HE;-%P=R+3[B5 UBJSV^AG^=GOQ:<"K9F!(MT*
M>U&B^ML+'-1(H=+TF+#=1(940C)7IYQLO;*=^HU[R5)^/M5KH N7+=$G"#HW
MHLP!%YM5K>0:)4&Y0P3<-%E*V'GXMV-=I0;\8<BS'5*B-27(*O=M#2B15]$$
M:J_GJW\D^-*U5X],#$H5&K^[;0R%8?+IY)U"L0B5QD;:BD+)2XUF@U8BRW)^
MGGQ24Q_:T/L,+?47M;*R(7D/KB%'8;,'RM_W96)%\F!H?+P?0WJ&^4./LP*X
MDJ8L?)=6^!!>%LR9+LO<.9&9E.L_#(=:0@SA:/:KR+R#A>/_ )&0CMI*QN_=
M36:L0:R5<Y7(4R#8U\MIP,7"J9EP0U#!#HMA"2(\),U"]14JVO2VT*TK1;B^
MC#BU#\UJXA^-S6URHH2TW_H%I,-&HW-+)8*;%L71^K&:U'K<*9.K8LA <'&:
M]+.1915Y6F6I# ]UI7HTH=O%+ODC2O("Y6;FA'DZ S8SEDA'2GD$+J4J2;K>
MH!H-$A4]4(3!(ZG@YU!_,<&0R3=9'_5&H4C2]N0MK0(F(S87&K'FNW'%[=O,
MF0\R*CVP@B2URI+DVX;@*V]SR1N)7$,,T9N<RWK;D?:)ZOD<])^T^W:!VK9,
M*><!":+%"A(GVC+?1(AHPY8N9.,D0(4_H;T0D\$AN;GMUNXAW)VX:].QR\*:
M-;;^A1MYQ3 [5SN?+._CJ1XHEN?,;(= X#1ER3]8FW70L'<[0USD'2Y-/LLW
M<I4,S +LRBGPS'4/MPY[<>7KT4E*L%QCR1( Y[YS\^AEZ/2;Y +CJ]%L1 >L
MB[3[2=L4BU=BO=ALT\J4M-KB&J]<B=5,1)E8;6Q( 16TI@2MQM)VMLMZ9Q2#
M"YWY@ILD5Z5=STK\9.4*18;?*:Y7&77:Y)K/$@U\AT"MR&[8U5";D@!:7YS&
ME$(;LN2S(BNNJ5K39+TKEPRS^3;O=(5-ZR3,$H(KGMBFWA$ 334<]@$DC^/-
M<_\ HRXX-&L.KP3ERK1()-(E*&.ZWM4=O333:(XFJP?8V@>2=WZY1R?03<M?
M/*#UXO;R<"*1YSL(0D0!W9Q=416H0H;+L3M/%#2E9^HC&EM&FC:=R&M^UA3Z
MA<5@N/3.8]FD=DL%IYNW;804P8X^=/6+\Q4Z$5=C4V\\S_&:+SUV8;FR4\^/
MTD>9D6 25@"]*)-J<@2WOQ%]I(B8K%',D'YGVJMVNOV(H3G!3/-[C67M"S7&
M8Y1GM)*EQQ<I16</5!1#X L[,E:$-0WFKK&>VA<W26_8EHO:N4"@^:@O\6M@
MTW'8O1.FU2J'A4N?1)=,*&*Y3NRI)VJKM+$J)"V]V\A74@&Y3C>TQ%IT79EK
M;E/[)>E'MIY]Y?V.->7T$34@+T2!%K 'Z6W\?AW*4R%LYC\H1^A3$+73V(\2
MK3B*3:JGM)*1*5!^!;NV92]%N&?18'G"L':2-AZ.U%)P(5Z0-$5@5QMB'*O*
MC_/HU6K\$F>/R5.U(B'V<W"=G.ARH[YTJEL2WFX[+@[>#H:$<)NA1#IJ(B 9
M<%CW"T%J<@FW")KB-*GQ&R3<(:V01'E;6C3Z8["7=:]^FT:W[=&%TP& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M&!P?_M''^S6E_P"=)X??Z0E&R2Z>U^?E/V=X,KF8# 8# X-\-_ZBGSM_X=7B
MO_E'M>1TG^4>+O)E<S 8%O+0MDA1,=IUYC<\?,A:>C2I$*0SN5&<8T['FQ%M
MRHCS>W/5#K2DN-JUI2=ZWK6\#G2YXQ>0<*A N5!;H+;J _@(SESC$NYV-\&E
M3'$+71;!7)U9DA)2;#(L72R@XTBS27]$8D*(J.AI*4[:E&[B[ZLR1R+M,JRR
M44?I0T?5'^D7V<6DU.\38*Z=(L7:K5<;G^+5V*"F0;I9C_-SL4/'CS7X^JV5
M8W+9VM:_DPEQQ>=/YOY3!?KBW7NQ527'47Y59X\-@Q(0''3XU[HR^IA4;(5V
M$C\OQJES]EP%O>OFV3M)1#BF$-QG=BXX(>Z/6_(^H<@K$$#UJR="/W"..A5!
MVJ=(L6S1[HEGX>)B#+3&O,2N3V54J'TD"8.,#)/TX.7#EZ7O;+4=,7"Q5MP?
M(_FI[I+//8-<-LCB \MT%I\7+MABN03D&U<5Z51T?5"QNGXEL;"&K-"GKA3&
M'6DLL..I_C$)2LS$TBL5PSR+KQGDPH5UPLCG5(M"Y!:!JSS"%BG@4BN1N1(I
M8B:$O)L85!&OV^$L>_O>F8AV.Y'4VY&C_1EN/-(7807=3W5:V,Y3<)M5K4WF
M/0)ED)SX$B0 "7</ EC.2N1=[AN0R"BMCN+\TS"TXI;\*O1DK3I"_P!<158H
MGA\D\PHPWDPZ+U&-K=?BW>7=RIRX&21N5,L$*SP8%=VXP&4+LP04[+&RADV?
M'<*0W6G=*>2EMM#HO2G:]<^ZP]X]C:#0;S/B=*'C*!%(VTJ?*/&#[08R E7^
M/JVK;45'EK>$B$(S!!#:%QGI25MZ8TE.VR15WP1/)XQY-,0ST@;V8O.+DJBJ
MN,K,VF3';6B+SGD0YB2Q#&5W06MVDK>J[:7GC,&-N1&291(0ES24162W#$('
M".VUNB%6"'2H_.0_XK;+@:FP.E&?Q$./GWSRFZ$ILQT:571A6>S&3T>FJ(RG
MEMZ>V(E^]:T:VN6+CS93SC7;!OE,X+OEC,SZX[0;=*F27SI@?33QET=P[5=#
MT^E% @L-+G5!^%9G99,.](]Z"'K.^-QUAA@358+';N#](C=&Z5>Z[.YIS(R:
MMMX-47L<@JMZV%#'1.'AN.4&A&Q+@"*PL&.Z9]&74P_.G)D2QD!N-&4Z[M3!
M;BE6SR7RG@520/3U"8L])Y3:@56L1WH!!Q/.^CEBUTDQ)QV!$"-Q^H0)0PN&
M'#9Q)QV8%_#U/Z:D/NJ<42X4YSB_>T Z[*+]ZL]<;&5P*">>G=-G"%;.E9/<
M$,PBA(>(8CG9F[+;J /B37E+(3& SC:UJ=>>^N$3"RKX#Y3C=]5_*O0(%<W<
M#TRS+<@7H\ZQ8WSE]YS82L4*+_+@YCE1ANIA+,-<G0'GU2WSC#RE(W'0N.6X
MXMI.+U>WU2=<X5^Z.0O=ED1^<O1(9$^Q-DA:[ YQ7*VZ1E5^#!%C TZV]$K]
MDG/26(^FYZ]^J5:TU\#!F:X-?Y'C%;+#!\AMD0].";ZCT+E-NJ0/1"#(B"I7
M-+7#L#A>7(J](J$!&YCL5,F'J3#)%_J]*5-)2$;C-0RVV@9ZM79*+)$)2JN*
MG0[/8JC7AI:YUU6K9)!P7ER%*^A>(+$?+-@3F'HSS;DJ,W#6MUK6_5O1*:)/
M>,%^:I=46;"<IH]B+VZZOV")'M*8E.YM>^I6SCSM6OG&8K%6@QFS%(9HK@0)
M 2V-(D91+<ER4A^;,2X:N&:VCQTZ+;*-Y+P7^><^ W'MUJ^G$H!V*MJJP:N#
M89X16K8N,?Y38X:KD]'F_6'9BQBRDEXD\U$EM:@PG,)<7'*&_@* \+"!ADA;
M+CXX4/@/N1M2]1W'HD1F.XMC4^5.G:96MO>T_,^\[[?3WK6KU5LRNN P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P,<N%PJW/JI9+U
M>+"(J=,IP,I9;5:#\Z.+!UZOA8;Q N9+D9:VXT$<-@QUNO.N*2AMM&][WZ:P
M*>CWFH]*J@6\T.P#K54+%&7,!V 0]]0-*16Y#T5;\1[VI^1M,B.M'KZ?PIW@
MRPED,Z="%P9A,E+C0!PZ+(G3YTQYN-$A0HC*Y$J7*D/*0TQ&C,-J6M:MZ2E*
M=[WO6M8&-T&_4CJE+K'1^:VVO7R@W4-!L51N53+0CM:LH$DRF0/+A3 YZ1!(
MCYC*M*;=:6I*M?P;P3$QA.:X*LX)%G8IBB#>K-) RK.R*^*1\K@*$0ABI1#3
MVF?I=-M$)[+>T[<TYO:_72=ZUO>AU5TTN*&R!<0B3'P)1R<L6%C39L:+(,$V
MX$TJL<+9?=;<(3D"QDF3MEK2W-1X[CGI[&U;T&+]#Z9SOD=97<^HW>K<]J39
M>O '++<3@ZO!$&[:='UBL"E$BDB-$U//6(M&A1&O=[WY+Z$)UM2M:P1$SDJJ
ME?:;?/S/^3K&,L7Y,MQFA6K\,?\ G_ KE7M1=FZX0_1KX28S4UKY6_T^WY-?
M]^"J5J[;64B3YQ!T7*%559AJQS8$MDDV&DUYMQTY"GI@*DN,$!2&E?/'VGYV
M]Z]-H]?T8%R%%(!L6--"I"98PO AE!TM"'&TRH!".W+AR$H>0VZA+T=U*M:4
ME*M:W^G6M_HP.%W]HX_V:TO_ #I/#[_2$HV273VOS\I^SO!E<S 8# 8'!OAO
M_44^=O\ PZO%?_*/:\CI/\H\7>3*YF P*$FT0>&D&1,J/!*.P9;0V;,BKG1(
M9!QAQ$.5*A-283DR/'D;2M;27F5.)UM.EIWOW:#F^.\-^VM5TKHMY$DQEL>0
MXFN%1!NX)%4^.5CV/\YQ!HUHF"'28YY99+K;FXK4B A/HTYIQIM_9O="HK/(
MKDS64TCGG8*:)M1\KV>_28 HST(E6V.?=?D!Y H_6;(_-T1M\FC)E0T0)JW$
M1'ER7--*BI;TUH7"YRO#.[Z<JQ*#U)R4; ZD+8.&3M[GD1Q*T5P.+OAX-.D'
M9DC4BS3J_&UN&I2(OT[SOI[%:]'";E,WXFCND0>9V4#= D\&)X_R.B.60+-M
MX:<0)\< =?KXV>%4*)0/I!<LUTA$K?Z[3[6Q?Q;^5+^_C+=>*Q4_QNZ!>6B-
MDWY*V6V@3MR@S395BRW$..M-=B%$DR8B&-'1Z\L-)@#Y*PB)D4A-9DPF&]+T
MPZVMO1+CDD_I7%>L3.@74G2^N5JHL=&01"URM'[%;'B6Y1/EQJKF2P=4&8,=
MB*JD=B*5& XK<AEF1&F3=2XVY&T-"XI@5K\<>H11S(V7VP4()VA%KIX"VR;;
M>&#)6[6B<HV)Z#''..212KM8:X.D YHQ/RPH ]&Y QUC7OAK%KLOQ7[.RL;J
MO=B>$:9BT-Z*3.W.U7HB*,5]HQ"+$(<5T3611NOB09I3(L.ZU'843:BE=O1G
MF'8\P;F&E_&F]UN$A1_MGTE@/CHE?Y76VKCU<E51MR$LU*Q6"T2(+DPK/O6K
M.-Y\2*E1,QCXE-SI45J4S\KT]PMI>Z)XU]<Z+UTY;W.TKK5%(L"X4.O51ZPA
MYN_P:-7Y(N3/8A$V(\HG7K(-(R4_))?C3X\_49YAIMIWZDD3$1DC*1XQ7FY\
M61R6'V9BTV"JD.@5:_LV:X78D#:LESHP'Z$TS(!,54N_,J\,HV7CA9.GX"EG
M)"7)"E);=T7=C;'>D<6[*R5"M"^\"97319:#3N11QQ<J^9@-6'9XA-M-T8+6
M"*TSJ?S0>:E3XS.G$RD!V]QOJ7F&DH01,)=Z/XF=#MMQM14-VZRU\!-!\Z'4
M1$@U/(KHTFCD*+,^1P#+A.1[(0CSZ<\;@DWB+,AHO.=TZRXWZKV2XI@NO$*\
M:K<2I6^_1[PDJ-JFQ4:V7"^F(=2M5*OCO2Y; 1P2)$PG:IT&.&91*=(,-3!3
MD=+;+TY'Q,I%QGQ?$+PQZZERNK/]ME7),*\5:U&5VJU6V5!7^5.G<YOLBZ@@
M8ID) CV.Y!Z9(&3QLYR>.BN3-267UI5(C/EW0O9KQWZ3;NG]-)$N^,ICEI]F
MG5VJ54G<!L*H65FM7)5$.V!D$3AQQ9@")O%<DNQ)CKZ2"P[<YO>DNLL127')
M=Z_XI].%,]+<F]&&%REQD\<V[(4=OK4F]C>:]$Z%<;!^>"2RDJ56==&%W5$&
M1%!MZA1=1-ZTA^.XJ/H;H8%6?&/RGD\P%UDIV$:/F2Z*H46C&SUOL1M)HW$X
MY!/Q$GG2YZ*TFNJYF0?%D]_B4I3AQ[3B6W-NONEN%\"^%?0(;S1@CV=$ZVC(
M%T;!6J/^8XDT,=Z$13/L=ABQD&]Q6R!]]6W)?KI6Y+JM;5M6#='+!:X'A_V8
M*U4"$OJG\I)*K62FW+8^WW>X*C33W.[I7+G)+UJ/ C"A Z?V#=?:C%V";).,
M%D.;E1W97R.M+$ZH9SW?BO0;I98QXAV5OF\:Z,4JIZ9%V:[Q)P<M."V "7YK
M6D IH@?(!7LT6;G*+.(C%6)(]&D:WZ1W(9(F(;[Q8S$*+&AQD?'&B,,QH[?O
M6OXV&&TM-(][BEN+]K:-:]5;VK?_ &[WO#+WP& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P&!"/DMQM'D1X]=MX,NP+J:.R<MO'-%V=
ML=LLY7T72ND "C#8S4\6J>L>F=\NFM28^U[3Z:<1O];18FIB7/+LWVJ%]/M=
MW( _(V^5"J6RC0:7$'SWK]=[^+#1J<"IDJBR^IV+J[AX[R.4Z)=LB0\AG11J
MX2=D$E?B0F)DIJ-=<,6^GD%P7^67QOO7CA4+?+XZ$O5+B\Q=L55%199*M<ZF
M*@!;8&JT.0\Q"'DR5 3-%#Y2].M#7I+<G;$C3/P.5F)J;<DK-]K#N=-Z9X^#
M.0=D?M'+N?\ 7"-U'V*_C:^%+<#ISO98?>B8JB Z6_7ZN?LEIMLTF,=;17&
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M(VZKQCD1-D@7U)1@:6C+E,NO0(+2-OJUI"4#<B6)]N<-'J2 $CI2YQ&&/K4
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MU5?!CH3[K?AP_6QQ>T="EU@E(J]5,28NZ3TV37B%BLU?XU8/R/0[>3H=?'=
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M+5#K1U\"6>!"BK(Q]]E"X,J4RZ[\3,J%$=>96M/L]Y=LOP=Y>T)R^6FH'(9
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MZ_'(BRFEL2&5^F];]CK2]IWZ;U^C>!J#.^WQX7D&9C3_ (]4-I<^L\NILN;
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MPK0=H]6+V",IGZ939@@$A2B'NB^U.X:ER75*VQO7N9WOV;_2G>$G-JV9Z!W
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M0KN5*0ASLF)#F$1D5J3\;Z/=+>)+8/"& P& P& P& P& P& P& P& P& P&
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M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# X/_VCC_9K2_\
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MYM934(NS'>VM)AMIR!O7QON[T:TZITVUHY?X*57A=O\ 'OG1;R6K1VH!NO\
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M5+DO:1IUW;DIY]S6UZ;U^C6_;_[/T[P/DV8'UT*7L!9Y4<4"%SS!-]#+TA;
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M:K[H'A#$] LJM#+'X5%3O;LIJ,E1<>:4^17[Q\[9&L?,ZORV9&H]THK3+F[
M!"1:OT*H5>L4&O3!*!S!F>71%K-?NH4?[)\2)IQ"MI8VXEE2M$F)C%%!6_\
M&8Y$33N;\(C2R-BOHWF"S-DA@UCC-",]9L/+NK6OU5<&K$15"LL4G'<:)JBD
MB$B8F6EJ4WJ1K1<>,LAZFCF').D/AJMXV";(;G;XQ>5V"-- M_6%;5Y"C>9P
MJ\&%F#8QP64!O7P@6@.;<C!H[\AS2MHVMSU)%SQ8USV'XU]_[.Q-J%:ZH&F
M:$V58F!PZ*;20Y6Y5.MV,I$E6FL-,G-7V33.MMQU*?GKC.QI,QF*XOZ=7L&,
M0D2QFJ;>B5HZUTGF-$M%<YU?"O$Z8&;9_&.ED[<GI@?G N,=T9GAJ7 $62W$
M4/P8I#W,PX4N,07*;3(<2V,8P1.SU#Q1KJ$-"_&VSSH8T=?F3Q?\(I9#\OR#
M( L0ZZ&)$#-^64+2FJMX_N_B+T3ZR+.:#Q&(CTC;K"%%K5S?A_KOAR-'7"VV
M3C!/Y:^;LY61LO% $C_08+EEZ77K5;XT?\YD9UMC!)W%#4I$0G_\0&Q![,EB
M-'0E.VA6KFSFJ]ZX/S>U]1O#-/Z$)*W>SU.FO$Y0BI+18F:DOJ'+N5URKQPA
MK3[8X[;>3GQ@1HIILC((SV=.[;8E1]-$J9A)-4J/(I71H?,[-QBL5J[5*+:.
MJ!'Q[##=2--6CITNREY]=^I<&$+=-B6B8/,FM.#WH(@[-CKTO3RXSBQC5VC>
M+W?QSX0GH1H1S.T4W=.'D:ZRQ#=")5T 'R^Q6[GAEZH _P ZR=$Y53;Y1,0C
M4MB*5<"#F5-I5$8]&!4RL9/M/BZ'MY"WF.)6J#%JIZUW)SI3@@!*"*GPK;<H
MTVR-!X5QEV&;];T2@$'X++@K;C!->B"66%ON2-BIYL7Z+=N$=G+4V4OA=LBV
MOI%YXJ$N5ALXZ!3BE?#F>G$ =9F.JD'FR!B79D\JE,1B(6)/^04RTT[+8;VU
M\98N/)E%PF>)O%>I='@S^3VTZ1JG.0-WN!(;5W3E+H=9KM6+RAC,53DB,U%-
M2JY1R$SZA27Y<Z8XJ(W(<ESD1774BYA^"NM>+!"PD9 +@UF+'F;9R^W#"":D
M,<%2NM6IZK6.B @]D)6!%4K=HBR.\-DF]+E0A^Y! D^RMQ],C:Q6IGRNN<@I
MP0?Q^G<H*$A-OO$GG5DH;Q %%"@!!7IU?XG<I#K!2P3XNZZ+(V1M,<9!3IB1
M"0I$=#6O1.$J<T43.Z^*CE-%M$^3V6P&(S57D,"*W5WM6;17I2*A=*F1$26+
M5+-C9U^2-5/@R=S]R9"Z_-;6[\S:4/BI=* <^,5"ARD./.B0R0L?/BQ"<.2/
M)18TR(S(8CD($U*)D&<RTYI+K+R=.M.:VE6M*UO#*Z8&C\G[>?C9+.R"#T?K
MWY5F= <ZA*XTWY"]S:\?Y%T>NG\I,F>[PEKH".6J'2^B;V<=&_A?X8Z34IY4
M??N5K9K?/1O!ADP("[?XU\Q\@'Z82NRKX$LW/)!Q^E7CEW4.B<?OE>8M$.)
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M_3@5N P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M_P!V\(J<"@*E!P,62-EYC \2'@3"A2?)7\<:".'QW)<V9(<_^HQ&C,J6O?\
MV)3O @WDOE;XW=Y*)"\8[7SSIQ-8@V>1$I=BA'5+#UHN( 6">ER$MQE3 4V?
MAQ)/HKU9D2$MJUI7KK19B8S; X0P& P& P& P& P& P& P& P& P& P& P&
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MV:0W[$),3-S:>\(8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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ML*)':J0*!3TCH- "49Y%6@11R+V5.O.$H#K[D_44=[T[2GW;T,*4TZA>9^[
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M5_\ */:\CI/\H\7>3*YF P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MR--D0'MS" J41@I;:A0UHCKJ]W)[V+AOBV>KX7JM>,[G2NGA7N:\UFV$&[8
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M@Q8;:96D*=]FM.IVM9<9S9P#\IN)&!-!Z%>N5V8;>ZY2J58K*]N "(O<V!E
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MEP_=;8O\8:-^TN _-EP_=;8O\8:-^TN _-EP_=;8O\8:-^TN _-EP_=;8O\
M&&C?M+@/S9</W6V+_&&C?M+@/S9</W6V+_&&C?M+@/S9</W6V+_&&C?M+@/S
M9</W6V+_ !AHW[2X#\V7#]UMB_QAHW[2X#\V7#]UMB_QAHW[2X#\V7#]UMB_
MQAHW[2X%H9Z/8Y!HF!9Y9:5D!$$01F:_':&EC48VZ59A?$ZJTZVXY[PSWOU[
M=>W7M]-[]=^@7/\ -]R_=19O\8J%^U. _-]R_=19O\8J%^U. _-]R_=19O\
M&*A?M3@4)3H%H#C")>=RJTIA"H$PE,4T>H3CNHL&.Y*D;:;U:M?(Y\36_:GU
MUZ[_ $>NOX<*DJ%+:GPHDYC2],S8L>6SIS6DN::DM(>;TM.MJTE>D+UZZ]=^
MF\(JL!@,!@,!@,!@,!@,#";#;Y(<V+KPRLEK(3)BBIGV#Y@2"S$@")8B"\I]
MXR4'Z6Z](,M?&EO2_P!5*]JVGT3I04?YLN'[K;%_C#1OVEP'YLN'[K;%_C#1
MOVEP'YLN'[K;%_C#1OVEP'YLN'[K;%_C#1OVEP'YLN'[K;%_C#1OVEP'YLN'
M[K;%_C#1OVEP'YLN'[K;%_C#1OVEP'YLN'[K;%_C#1OVEP'YLN'[K;%_C#1O
MVEP'YLN'[K;%_C#1OVEP'YLN'[K;%_C#1OVEP'YLN'[K;%_C#1OVEP'YLN'[
MK;%_C#1OVEP'YLN'[K;%_C#1OVEP'YLN'[K;%_C#1OVEP'YLN'[K;%_C#1OV
MEP'YLN'[K;%_C#1OVEP'YLN'[K;%_C#1OVEP+3!Z+92,PW!B\KM2WZ^29$D=
MK.T-#>ICX82>;TPK=J]76OH#3'JK>D^B_<GT_1Z[*N7YON7[J+-_C%0OVIPA
M^;[E^ZBS?XQ4+]J<!^;[E^ZBS?XQ4+]J<"W%^CG@ ^08-<QM$,5"VPJ=+0:H
M\M4:.])9CKD?3,6=3[Z6/F]ZDHUM>TZW[=;WZ:V6DKX0P& P& P& P& P&!P
M?_M''^S6E_YTGA]_I"4;)+I[7Y^4_9W@RN9@,!@,#@WPW_J*?.W_ (=7BO\
MY1[7D=)_E'B[R97-'5H_^>^8_P#[[;/_ -69.!(N P& P& P& P& P& P& P
M& P& P(Z#?\ [4+[_P#HESG_ ._] P<$BX# 8&']"_\ D&\?_H?9?_X+-PL9
MKI6?_ENO?_@8G_[A'P3FOF$,!@,!@,!@,!@,!@1U,_\ VM5W_P#EU<O_ -9:
M)A>"1<(8# 8# 8# 8# 8# 8# 8# 8# 8& 4__P"8^K?_ *=C/\F/.L*S_"&
MP(T[%_\ LSMW_P"'M?\ WZ)A8S27A# 8# 8# 8# 8# 8'!_^T<?[-:7_ )TG
MA]_I"4;)+I[7Y^4_9W@RN9@,!@,#@WPW_J*?.W_AU>*_^4>UY'2?Y1XN\F5S
M1U:/_GOF/_[[;/\ ]69.!(N P& P& P& P& P& P& P& P& P(Z#?_M0OO\
M^B7.?_O_ $#!P2+@,!@8?T+_ .0;Q_\ H?9?_P""S<+&:Z5G_P"6Z]_^!B?_
M +A'P3FOF$,!@,!@,!@,!@,!@1U,_P#VM5W_ /EU<O\ ]9:)A>"1<(8# 8#
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ML346$[5D_4+M:K)!FU]>E:9(P)"7%+97I;:2=O*/58E%_*%R>:&#?NL]U-S
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MDIIA<Z.A6X\KWZWK:D--/G73&_1MB>Z)2/\ \QO]M;^[/*/?_MUX?>0OZ?\
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5@,!@,!@,!@,!@,!@,!@,!@,!@?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g131567g02k20.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g131567g02k20.jpg
M_]C_X0 817AI9@  24DJ  @              /_L !%$=6-K>0 !  0   !D
M  #_X0-S:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+P \/WAP86-K970@
M8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"(_/B \
M>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!
M9&]B92!835 @0V]R92 U+C,M8S Q,2 V-BXQ-#4V-C$L(#(P,3(O,#(O,#8M
M,30Z-38Z,C<@(" @(" @("(^(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO
M+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^(#QR9&8Z
M1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B('AM;&YS.GAM<$U-/2)H='1P.B\O
M;G,N861O8F4N8V]M+WAA<"\Q+C O;6TO(B!X;6QN<SIS=%)E9CTB:'1T<#HO
M+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E4F5F(R(@>&UL
M;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O(B!X;7!-33I/
M<FEG:6YA;$1O8W5M96YT240](GAM<"YD:60Z.#E!-4)#-C,S1$(Y13 Q,3@V
M138Y,3,S-C(Q-44T038B('AM<$U-.D1O8W5M96YT240](GAM<"YD:60Z0D,U
M-# P.3!!.4-&,3%%0CA#.#9&03@W038X-S%#-# B('AM<$U-.DEN<W1A;F-E
M240](GAM<"YI:60Z0D,U-# P.$9!.4-&,3%%0CA#.#9&03@W038X-S%#-# B
M('AM<#I#<F5A=&]R5&]O;#TB061O8F4@26Y$97-I9VX@,38N," H5VEN9&]W
M<RDB/B \>&UP34TZ1&5R:79E9$9R;VT@<W12968Z:6YS=&%N8V5)1#TB=75I
M9#HP,3,R-S$S92UB,3-F+31C83$M830W,"UA-60Y8V(W,&1E,3$B('-T4F5F
M.F1O8W5M96YT240](GAM<"YI9#ID8C4P969A,"TV-3DS+3(R-#8M.6-B8BTT
M,3EF,S(Y,S,T,F4B+SX@/"]R9&8Z1&5S8W)I<'1I;VX^(#PO<F1F.E)$1CX@
M/"]X.GAM<&UE=&$^(#P_>'!A8VME="!E;F0](G(B/S[_[@ .061O8F4 9,
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M6W5UJM5?-3":HD*9\=J0+3#MAI,>F,AP8V=U@QBL)*Y,N4ICP*=#(T$1Q9@
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M0W[I9 N9^9H*3,:YFL*L&44K>M;V])GBVW^<+I'T]5$?=T]AU[M@1ND@$W6
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MS7!!]M2$[1&^A9#$E[FRLZ)8H%78@;,$E1[>G'Y:INBHK[H]>RT?C 17W?\
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MXQU&]79-2Y=&Y#J G<TM40>W84<,C3BY-4\979HE #P*$1H]B"<6#82S"SP
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M RJ&.5KW&:MSZ@C3='H<]L+JIB<MU+'IY0$-:Q.N"B-$N+T>8G$ \))-LW3
M23KXR%G/Z>74M.VX=;12/S^\36]]@;VFJ.$2U^D;1'GQ>:CD@39:>)NB+B[K
MDC.6K/0M:00]^L\Q.G/&UHJCR -:<AV=!4/;(XXTQBVK$-D 7"N-)3JRHBPA
M5O:LQ*2"F@5^C&IW,3JFQM$7I<\-ZCW2@ $686$;70?6]"UH6M_'0M:WK?\
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M+9ALF P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M0]#_ *.$B(GC--4J6_\ I><SUGC%B\'6I2417DN9CE9,FNOF:8,S$:C;E*M
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M$?475+\L85L:CVBMA'LS,1=7HKO^M;V=\/\ :WO+_P"G_P!/UD>+_P#]7_\
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MWL._P?'6]ZPP_6 P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M)4C5<HVN1FQE]>FAB94"4445/#BL?7LIB:QZ,(E1D>0%'*CM"-"K<$YR0(1
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M'_/N"IZ'ZR/._P#;W2_]Z4'_ #[@J>A^LCSO_;W2_P#>E!_S[@J>A^LCSO\
MV]TO_>E!_P ^X*GH?K(\[_V]TO\ WI0?\^X*GH?K(\[_ -O=+_WI0?\ /N"I
MZ'ZR/._]O=+_ -Z4'_/N"IZ'ZR/._P#;W2_]Z4'_ #[@J>A^LCSO_;W2_P#>
ME!_S[@J>A^LCSO\ V]TO_>E!_P ^X*GH?K(\[_V]TO\ WI0?\^X*GH?K(\[_
M -O=+_WI0?\ /N"IZ'ZR/._]O=+_ -Z4'_/N"IZ'ZR/._P#;W2_]Z4'_ #[@
MJ>A^LCSO_;W2_P#>E!_S[@J>A^LCSO\ V]TO_>E!_P ^X*GH?K(\[_V]TO\
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M\=7*_P#B/*\CI/\ E'Q=Y,KF8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8'!_P#[''^VLK_S2<??ZA(-DET_%]_A/R=X,KF8# 8# X-T;_Z*
M>[?^.KE?_$>5Y'2?\H^+O)E<S 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# X/_\ 8X_VUE?^:3C[_4)!LDNGXOO\)^3O!E<S 8# 8'!NC?\
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M-,]XP)8 F&["$&S1A#K0S-@!_1!ZQ:^/PU^#7QRN;Z8# 8# 8# 8# 8# 8#
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M^BGNW_CJY7_Q'E>1TG_*/B[R97,P& P& P& P& P& P& P& P& P& P& P&
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MLQ3>Q.J:$B$0D\HF,*CTE>K0B29F>)77;MMAL%A0+_J@B%#C!'K7RCT ._\
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MB?I3#MG0)BG8QP4N@ [3J2]:(] @'"6LX91%SQM9AD[HXRD=6%W>S=3T&LJ
MV4*H1JR-VG#DT/+F:)G6R%5$E#VK=B$:63$L#<>NV@-$!5M&7L_0-E?TL)MR
MNJFV5A'9?*%E64STY7W1%032U7^$M5CL]?1F=,+Q+%T&?&)!*&B2E,J%8<M"
MVN,:=$S@3L00B&A4%GZU[0PBV3;,1=:++80P& P& P& P& P& P& P& P& P
M& P& P& P.#_ /V./]M97_FDX^_U"0;)+I^+[_"?D[P97,P& P&!P;HW_P!%
M/=O_ !U<K_XCRO(Z3_E'Q=Y,KF8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M',#R*\7W+W#*^2H!';4_0W0=4W&?T%;\NBJAH46ZLL&LFC:GGEM@;!+H-,X
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M-LE6D.Z!,21HC?NF["3=CLJ=<OD[)8<S 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M 8# 8# 8# 8# 8# 8# 8'!__ +''^VLK_P TG'W^H2#9)=/Q??X3\G>#*YF
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M0-C8@2DA"4F1($2<!118=:" L&M:U\-8997 8# 8# 8# 8# 8# 8# 8# 8#
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M20;L&$N>?%B9US=2+G-#+=LU\=WUW='B*,#";,Y4G!&&\IVD*U#'*Z:4!*5
MD7,$IE<Q]@"-9M:H4'*"TY)FBQ>T(7-5"):.Y)0Q&QU,ALN3E+).TMM,'5K
MT5JR:P%<5B]$HK=CT<<37B3L<1=W!CW^G!Q1_+?2_25[!!BM<X+#!GZ+.5QV
M3JR<H5A%I0Q2Z*K)E'75I+=43J!OD6ST$U8W2Q)?:88[,4+JC<27!I:YE/WH
MY)M/I*J)3N1Z;WA)S!%[)NG@Q\ YXIGG%]_2.EDTI0EHH7&J2C?V\GJURB\+
M@1TR)%"*[BJ-S,*2H$I4F>B$#>(T1[@> Q.D$>: I,66+F=']7<<THOBT9B)
MJ&3%-T,KABK**JTLI<T[LQ-$5FL4L6*O*%P+'HW4JCDUA#8O2K1Z'O1B;TC
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MM5.)QVE9R]T/$'90 D@+%ZW'%K\/Y8KB)2]CL(]UGTSG\?=$C@BFD[F"Z12
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M<U3'2KC7F5I@R^&V%(9=N-R=GA54193+[.<R7&(Q&'21/.HE6E=/AQZ5>U(
MN<?+&;O9BAT<4J,LE4I/)3DA*&Z;N.+>-<IT#-"9K.(_MTT?<TTKN[4DVBTH
M.&-HD\.84:>#RBMU6_G6EE;#4AJA:8F*).;G(YX7F*"C@+CPC%SP3/ :LC$#
M=)#(V=8].KY,&R%-TC>WIS"XJ7@,$8A1YD7&A((2H25IJ 6]J1D%%@.-WZO2
M'\&M$NTG81P?_P"QQ_MK*_\ -)Q]_J$@V273\7W^$_)W@RN9@,!@,#@W1O\
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MB<%8"0"+](#DVV3XN>Q;T(K;YHD*2=,VC*5:^0UI:S1$E4OI>=E0N2!LA_#
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M:?MVI2/H:OV=*-P5]*B4=.NI:M:JM229\,)"2V*I@]H1(2@Z";\JI,)TJVG
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MD-FP8=>[1PIC?'V0(IVFDRI0\B3(P:CT?BI4;5)C#7^0O8RT)!9OK]T]04
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M],"M1ID@\]7R4PTU0G9!)0RE-)='I5F_1HL&BQ%;) 8$6\&Z7V6\E5*J:G&
MGRF4E&R"F;TJT2,+TP@>APN[)XW3*;OB-,)FV,2]E?S4Z=&I]H29.4<$!Q9H
MQA%L;IXM?D/%]66.GES$KL:>N-?*Y+<3XWUPUO42-C%=V9<35+&:R9(QJBHR
M?(POFM6$_'I6]S7+4#8K>U(RTH=:2A3#=,+01>N66)3"S9JW*7(YTM5[CK](
M"%AR<Q"D5QJ',<)0EM)924DXA.:UL!)ANC3#A"/$,6MA#O0-$M7-#Q5!B7MP
MDSE-9L]/[Y:YUIR10H10%L:)$8X5I(ZBD47<HK'H4SQ@#;+H)*%1#JX$)"7Y
M:I"2>-?ZB"0@+NGAR8)NXKK\TYG,!<5H/4ZI]#!HI4TQ->(&IE-&LL-*.<&:
M/MB-)#"F=Y-D<?>@I7DZ2HG5<]-0B='&[WH)VQNE(D?YNA%>VFY7U]NY0DLB
M8N4:16-*%ZV+LZ"T$R6"Q2K8W%):SH&%K8U28IV8DKFT?+E$KD#TN5%(3BDC
M@J1'DNXKD^]I<LQ"U)-)WUPEDWCK58\:B<,N"'QI5'R(_:T4A+L\NK$RR,YS
MCSH_LX!%R)>@6GLRUM4KFM4),<8+19 R1$TD>"1R"P:&JVYEDI*Z-S.=6!*T
M[NN>6H\E>_7+8DDFSBVM#@E F1J21R.6GI6XH'N';*T67L1IFMB$)N5=X)PO
M!8>S15K=;'L^<JH.W<YQN)N\B.@S>K983RY-@3ZL8>!+$H3'&Q<B,?M"$Z+5
M1![HM+,V *DD(0:"7=/Z[L>LX9K1*Z(#(K9E@P>1-+]'91!OI2N"N X@AA=D
MV[8S0Q,#')8>\HE$5:G*\G=N*(4DJ-)6P").6,&TX1"&Z6\BY2@B)*R@:K"L
M%FMU#/I/;::YM/,876@]S*3,*6(2UP>&]UC*N#.\:<HBF0-!C,%C+9T:%O0!
M2ITQJ-(:42_)A8UR4W1MVB$H@MZV4US"'N-Z!DTE*1U.^'S97?MG12V;,129
MK7UXJ8V8S[61%+I&!I3-HT208RM^L0M#T7<Q >#H$I(>F][LFTWUG/56:9#V
M=0H@R!-7J2W[MC]^3Q&PJ6B$('-XVZ36+("2CGD]S-2-R?11.P&#-.,&Z6ZH
M.1XJA?&K6[!LI55T?M-3=4>HTY=%BJ[9[$.DBZ;I%A2U'%$L_5QEBGCB8^MK
M$H>C6E"YA)V61\NF2IR!N\TNOL!ATAMRO;"7NIFII6T5L)D8&,M<W>P<U60I
MA)KXY+FTU.:Y#/2&05(!*<4846#1QVAZ'Z@^@G)'BOEN$*&0UF3R"8(-[Z!=
MNDTKDF5LHUR"PG1X<GW1*?2MB4HAL"!Q<A")3FE&&? L&AFCUZO4+^2##^&>
M/0-<?KN(?1H#)=4]8-<J7*$O$6;K#GE7VS"5];RXZ3F&H5BF2I'EY$E>MK-I
M_09)FM.H'L?P.)-+NR]4GR?E:E3Y6KE,L?'(EMD$G>9.X0YV>6-%$'A_DE$/
M//DQ,$F.;B5X@RRO7(LQP*)4AT8X(@*M>D1BG1PW2TABX1H9P;(2W.4GE]H,
M$3CT38I$@ETAC\J0VH=&YO*+>0/]H&%,98I \O%ES'[2*Q%"2IU*](D,T5HL
M&P&#=*5H!SD@I><FKJ27MM>U;+I4Z3FT*R1LC:-H=I+J!-<(9SH<$I$0*)@<
MSFQ.YOANC#35RUO(V#V]'+/?),WQXLY,.<H5-;;8KE='.2D2:/*:P5(T*%8W
ME,IAE4:N_4>TI3'-9ZP8%GZ>W?YSTGAV9\ND]'M^@WWA>E(BBO"M;5N:\N]9
M3NS*]DQUJ3BTHO)FERBR\V I+ A\'ADFJQA9I%$W>,KJ?,:JZ:1IF=T1KAMY
MR).-(H(VE2^P7=,\5K(W'WIJVVG.,_D<O*3QE T'Z=T$-2E.[H0I/4J)BI%&
MHPQ[*>',DX)(R4VR6P!10=E)@#V,8C*$);R35DY12EJE!DC=&6:6G+[6DC08
MX)"4C@YSBD'F@9 P;&G;BE9,</A#Z>8  #0JRUWI,T?Z->WA;E'97!U1[A;5
M!7I^?EB9 3,D2)S:6.KJ_>5FY5%&F.)UR[5=U]%&UVDD4)CQ#B@<3DHU>EY>
MQG"-(" @!=TIDI"M8Y7J^T5Z2U'^V9;9\R03F<O<G<H:H7%.K7!H?6R1(W-$
M)88VS,+(0QP='K28"76OFAG&;%L1F\),VAY%Q-6 4B.&K;&L5\9X9#TL*K&*
M.#S$Q;J6O-V!!9^*/QT22+IGES1*W*L61M M>S7-84TMH$Q)X!#4&G%W2LM,
M(O$9FXUG*75]^7U6-A'S&.G(G-N*;UTD40F=5D-K<S#RS]*2--\\6_ DH91W
MSA17]+X!&6,BL4:X+J*%L*R+Q%]?(OM'*F"<UJ\,,?JIJF-8.L3DKA(VGZ1)
MDE>%O4W:$I[V:@,3RLQ^*-:S=IS?6(PPT9=TS-MUUR4P*9)]=>K*L9Z;7:=0
M.V9W#3OL4WQ6P;=K=LC3;%K ?4[1#D#HVJ23(4R+%#8UJT+.J7,Z8XQ+O>U6
ME(W-4DW"L"?XDPPANL>UHC'D515'24L3QIRB):JQ8-1SJ>]5T3*%SK#G10B<
MVY:X+RU2AJVW"7(W$].=H1>B=$C=S3E;M*I[5=*WDB6>3:N9=5$A?9+#I'"M
MQ8\P"V20Q_@;LE>F>91B6,#XV&L4D4" 2<E_JE8"3P[]10<)$T@VH.2FFL+^
M3V"THC&N$UMS[#*%K9"JD&WY?)5"5T6ODHLF2I!-B0IMEORPTS0%7HTY0N(V
MJV/1)6RB]EG*XKNE:QN;HM94Z43AUDTN;#')@J]@>V%H.80L[N"F[>(N>OW
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M_P!CC_;65_YI./O]0D&R2Z?B^_PGY.\&5S,!@,!@<&Z-_P#13W;_ ,=7*_\
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MD, KIQ:CG8_[?QM[CC^WE%NHV5.F,8%B +JO7.CEHLE 2D)4#<#CRBTVC3#
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M!@,!@,!@,!@,!@,!@,!@<'_^QQ_MK*_\TG'W^H2#9)=/Q??X3\G>#*YF P&
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M*5X33@$A 9G*\8CFZ.89<'_^QQ_MK*_\TG'W^H2#9)=/Q??X3\G>#*YF P&
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M#?'(T\S)WN6EY+1G2+) FH[IZ0.,X?P+XA+T-E#7"&%#'3D"=C-()-4D_%:
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M+W;SU;]G0NUX%6^X3QS:5GHNV)"VLDL0N3+3%JNZ5!X_9E BC)*XI$#I9@9
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MU/\ ;2%$'&" 5LL1E.D<WCB3CP7(8S6<*B/ZJ*B-W*8EMRIZ_;T]2$I;$7D
MVI*L"%PDLL&I(\MPB!>MQ1I3E"8PH6A&!$#>M"=W.]$Y2"24K#"M1V4O]710
MB#QE1:&F*0.D38BHA#8JK"G56)IL<3TH&",QQ>H" QW]!*5&</6MF@$+X;)J
MP,>LOFX,[;JXBE@4@&S43>ZLC1 X]*X'J=I&I"2W2)[:&Z+MJ_[0$-Z-.K2+
ME2<HC198#23C ZT( MBIX\FKL\UXZ)66C,&"6\T%.$?D.FNZI2SOU6@6,DKD
MQR6+!;K1>T2K1[;(9 H"0W:)=C0*58] 3_ >_2#!67=D:]A7*$NB4+E-4Q+G
MF3P6!OCZ^5W(Z]8:V>HE#)+I<=J3/$+=XVE4L\=?-.9!FEZA"82H]\ O=%Z]
M;P3,\[8B"RSC)R3/:ZLY+S$O26"]260R-9!7FJE2:;R*M-MCS,7Q[4,"DPJ2
MO5?[=$2MS4G[./:OF"33Q%>X 6Q.[G:-^B>AN.Z+B,RZ5DVJ;G5@Q7G^3WS&
M44965:ZW=:%3UI'7"P0+ZP/<7%*]2AB D;1*4"HA3ML+,WHWW@!^(]%B,ITY
M6ENFA\R6?'%\QIYFI1\1/#L-;,C8*AKYW.1S9::SREW;IH?%@K"2YJD="D:I
M<6J'M6%624:/^F$ M$FXXM'M^W^%6:&W&^V_,.;7B,<\GG6G=3:]GU],UM:/
MK4  4TFE42* \O35-SSTY29O]:33LL5[*3)0F'C++V6(RY7JB>D>QN'K.Z/G
M3-7@ZE9+'?('0DD8;C,-K%B<.AVB]FN9O$4C,$D!3@5-9V[QM/7)H7%N,+$-
M*;LH 0"$ >BQ..41V6B=K$YB5O5GL+Y.:'4R&*MS&KNAE=I-7QSU'&E(>3N-
M*;/;EBT2YG;DRE47\B-U 66 9@?:WK8M?$E3W1'TKT!S565-LUJS6.PNW*JM
M^XZ4IUV=F,B 2N*.KI8-H,=6,$FE3H\+@1MUC5>OZP)RXXPX\U 2B-]H&S2M
M PL1,S4<4SQZQ.<'%##Y'%)S22]M?D$\F$!?H])H(J0O+6SC*'9\HA[HVK1I
MW% U#7 V_+D0QED;.#M6,/KU\2:HQLB[N4(\GFUA_/TM9UE1RD16V.-1>34N
MOMN7U%%R"I]'W1E4RN41\@R&FJ])U[6XN#DB8"E!I2G:LD.]':+67#E;85;]
MR);3PGJ*1J.=YK,G!V53 ^FI&KJN62\F6-S6@=GEX6P,U4\+!RAC;7-.:L5A
M(,.(*.+&(WVQ@$(FL:ZT],FM?D*4QF3/<QLKFZ1PVH7TMCF3O)IC6+O&:ODX
MC-(BF>3+W1Q4-4*?1&EZ)"G5#3*-B#Z-!^.OA@K+NRJ9]Y>G]I1E(C>:#FMU
MQ&(II9#4J9PKR26E&($_)D9R.31DDHY;+66(O21S3C+6I=%(E):@O81B"8'X
MC6N=/)\WR<WV9*J_^9YX0W)(4+A+YO"?>K9-9CXV*V]&H=91*HWZ@2ES0J6I
M&G&H6JR1EC3E%[&/8 AWH:USI[6ISY@MQ*.]F-PH6SD421NK,9<C4KKV:)8R
MWQQ2!Z?&H=AHS'(EE1L*Q.%6K(VL+ E-!HTP(1!T+0J8TU:ZNM+C.VGZ#$N=
MC<QV9*&Z9_3:T*72^JIF_(;#"V)7KZ?!@*'!R<$TS"S&$*_:;]!7:2B ;\/;
MV$6"LHZTVMLO3FP3Q,]L]Q4<)_9I1&X?8>VRPH%MX:IJ\. 8E$(M,]I7?YU#
M*'5U %L;4*[TJSU&M)B "'_0P5+),JV@XLUV3(8ZKJ".LL37/**WWQE/AC0U
MQES96TAZD"2R7-"-.D9ES2SN):M86Z#+,(3'A-,T$ ]"V-6HH[AY'!$) ^(+
M2YR! OFAUK*GA'-ZS#$/G8]&7%89 ) X$N>F;YICAR%6;MJ4C]:9L).%[02
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M]'1CHZ*/U:19O70J,WI,V:42*N$\SIK[=Q$"I.ZVQ]+>G!/")$.,B$G/5JE
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M_HU[YZB###$,QF-5,!:J33AJ;6E:4TQM<]3526>L^DJE)9[F I0N,+$G)./
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MK?E6PG&5:M0UN@\8O[K29=+1)^@!(&IV=9<H9FB;*F!>D=5+=H"@);@6>H^
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MT^"&ZF\/G2%A<\0Q]D1]'\\S9%S#XWX)#ZGKMLG$'03)QY+G)UUO*WIP9D4
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M[MKG'F;:.9R:*U@H;6QE)V^IT;E(7,\YU.)4[+T7W(Y7Q6ICGBWDD7[P>.A
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M,(6!6EVE<DQ+4I7'H#W(&BQ+T@BSB]E@'\"QA&ZIX72QC]Y6+\@UT6C '7F
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MF]*V;4<)M"KJOBK7TUR#KMNCW&I[*>+"7Q6L=3"'Q0<$NHASBL?2-TX__?Q
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MXDL"JKDJMAKJJ*7;+AF=:N%OR*H8I6L0D4E?(':L6M9ECLK5_0%2)>G?I,R
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MZIYOM*-OZX5ZM<A>H/7TC0/#C,(;'$JFSSE+BV'A6K)+ OI!2EQ4>H:IL C
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M:EG/5=6 Z2FO;54<C]#%69>O0$E5HZ]C"0N8V-7@_H#:F/1'NSTF)_\ QM<
M6R] &^.\\?5CY/X5+7;8)9[%44?H*#/M@P#S 5FJ4M#LZL"=? ^OI@RNW'D"
M<3FR%"&&"58S-7H-: @$WQ<T0OIA)_NF#$7W(Y]O3BL2R>*ZR6:^P] -!56Q
M>TUOD1G]\+K=9')RW8Z#F*7\2KJ"30M"Z;CJ=2>N3VL:G=CHYM04T'@3@5C/
M$I"$&C.^*KE5>JFD%\-G5$;H-?"Q@0(;!CCCRD38303:U*+:C[%:>?I[,)1*
M7%RB8.143>AETK^T(7,IXM%)8*UT6Z W/.E*4@"[<:WXW?Q\/59"C/&;>]-]
M%\8VE H.U,:&M&MT8KB=+TM6J+Y;8G4;E8-YV "KJ6BC+SC 5M6V4P/%CHPL
M[U!U<8CZ=G-,:EB5<G0)-F5)SB8F/UR6%Z*X!O"T^I+.N6.K(#N'R^]_&!93
M8C<)2^,\@%'..Y9<;W;:8[:".*M-;RX(9ZB QB)/'[QVC1&&)ME@V,D91$5V
MGU4HA/B<Z"8>?(Y %U'<[2./4AW10?0M(4[9CS6\ELM^J&%M9#3<D1N+H:*T
M7&F6Q9'*UBLTUJ<GID<'A6T(24SRO5'B (DU.<7>O!J4@\-G5;JS=0-.W1M<
M;&F1%WJ6BTUEMPMAK_IZ*V;TW!;T34_><8B/.[1>BDMZA,7,C"IPD,RDB*.
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M:UK>OCA;G@GG"& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P.#_ /V./]M97_FDX^_U"0;)
M+I^+[_"?D[P97,P& P&!P;HW_P!%/=O_ !U<K_XCRO(Z3_E'Q=Y,KF8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'!__ +''^VLK_P TG'W^
MH2#9)=/Q??X3\G>#*YF P& P.#=&_P#HI[M_XZN5_P#$>5Y'2?\ */B[R97,
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MI/\ E'Q=Y,KF8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'!
M_P#[''^VLK_S2<??ZA(-DET_%]_A/R=X,KF8# 8# X-T;_Z*>[?^.KE?_$>5
MY'2?\H^+O)E<S 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8&GNEAP!DE#)"'J<
M0]HFDE+,-CD0=),RH)0_E$Z,V:8R,"M:4[.I96BA>K9!1F@^G?Q_^F\%2W#
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M_%]_A/R=X,KF8# 8# X-T;_Z*>[?^.KE?_$>5Y'2?\H^+O)E<S 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# U:;0B'V3$9' ; C+),
MX3+VA8PRB*R1N2N["_LKB4(A:V.K:M+-2K$:DH6PB ,.];P<&L5!2=0T!#2:
M\I&M8754))<7!XU&8+'VZ.M1SR[&A.=7I:G;B"?GWES- $2A6?LQ0?L(?6,7
MIU\"S,SK*4,(8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8'!__L<?[:RO_-)Q]_J$@V273\7W^$_)W@RN9@,!@,#@W1O_ **>[?\ CJY7
M_P 1Y7D=)_RCXN\F5S,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,#@__ -CC_;65_P":3C[_ %"0;)+I^+[_  GY.\&5S,!@,!@<&Z-_]%/=
MO_'5RO\ XCRO(Z3_ )1\7>3*YF P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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@!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g131567g03d78.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g131567g03d78.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2124&AO=&]S:&]P(#,N,  X0DE-! 0
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M;G10<F]O9E-E='5P3V)J8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P
M   *<')O;V93971U<     $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F
M    "7!R;V]F0TU92P X0DE-!#L      BT    0     0      $G!R:6YT
M3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O;VP      $-L8G)B;V]L
M  !29W--8F]O;       0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS
M8F]O;       3F=T=F)O;VP      $5M;$1B;V]L      !);G1R8F]O;
M    0F-K9T]B:F,    !        4D="0P    ,     4F0@(&1O=6) ;^
M          !'<FX@9&]U8D!OX            $)L("!D;W5B0&_@
M    0G)D5%5N=$8C4FQT                0FQD(%5N=$8C4FQT
M        4G-L=%5N=$8C4'AL0&@            *=F5C=&]R1&%T86)O;VP!
M     %!G4'-E;G5M     %!G4',     4&=00P    !,969T56YT1B-2;'0
M              !4;W @56YT1B-2;'0               !38VP@56YT1B-0
M<F- 60           !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E
M8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG          UC
M<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG       X
M0DE- ^T      ! #O_XU  (  @.__C4  @ ".$))300F       .
M     #^    X0DE-! T       0   !X.$))3009       $    'CA"24T#
M\P      "0           0 X0DE-)Q        H  0         ".$))30/U
M      !( "]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &       ! #(
M   ! %H    &       ! #4    ! "T    &       !.$))30/X      !P
M  #_____________________________ ^@     ____________________
M_________P/H     /____________________________\#Z     #_____
M________________________ ^@  #A"24T$"       $     $   )    "
M0      X0DE-!!X       0     .$))300:      ,U    !@
M    W    E\          0                         !
M  )?    W                      !                         !
M   !        ;G5L;     (    &8F]U;F1S3V)J8P    $       !28W0Q
M    !     !4;W @;&]N9P          3&5F=&QO;F<          $)T;VUL
M;VYG    W     !29VAT;&]N9P   E\    &<VQI8V5S5FQ,<P    %/8FIC
M     0      !7-L:6-E    $@    =S;&EC94E$;&]N9P         '9W)O
M=7!)1&QO;F<         !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN
M#6%U=&]'96YE<F%T960     5'EP965N=6T    *15-L:6-E5'EP90    !)
M;6<@    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P   -P     4F=H
M=&QO;F<   )?     W5R;%1%6%0    !        ;G5L;%1%6%0    !
M    37-G951%6%0    !       &86QT5&%G5$585     $       YC96QL
M5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$585     $       EH;W)Z
M06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@    =D969A=6QT    "79E
M<G1!;&EG;F5N=6T    /15-L:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +
M8F=#;VQO<E1Y<&5E;G5M    $453;&EC94)'0V]L;W)4>7!E     $YO;F4
M   )=&]P3W5T<V5T;&]N9P         *;&5F=$]U='-E=&QO;F<
M#&)O='1O;4]U='-E=&QO;F<         "W)I9VAT3W5T<V5T;&]N9P
M.$))300H       ,     C_P        .$))3001       ! 0 X0DE-!!0
M      0    $.$))300,     !G$     0   *     Z   !X   ;,   !FH
M !@  ?_8_^(,6$E#0U]04D]&24Q%  $!   ,2$QI;F\"$   ;6YT<E)'0B!8
M65H@!\X  @ )  8 ,0  86-S<$U31E0     245#('-21T(
M  $  /;6  $     TRU(4" @
M                           18W!R=    5     S9&5S8P   80   !L
M=W1P=    ?     48FMP=    @0    4<EA96@   A@    49UA96@   BP
M   48EA96@   D     49&UN9    E0   !P9&UD9    L0   "(=G5E9
M TP   "&=FEE=P   ]0    D;'5M:0   _@    4;65A<P  ! P    D=&5C
M:   !#     ,<E120P  !#P   @,9U120P  !#P   @,8E120P  !#P   @,
M=&5X=     !#;W!Y<FEG:'0@*&,I(#$Y.3@@2&5W;&5T="U086-K87)D($-O
M;7!A;GD  &1E<V,         $G-21T(@245#-C$Y-C8M,BXQ
M   2<U)'0B!)14,V,3DV-BTR+C$
M                                 %A96B        #S40 !     1;,
M6%E:(                     !865H@        ;Z(  #CU   #D%A96B
M      !BF0  MX4  !C:6%E:(        "2@   /A   ML]D97-C
M !9)14,@:'1T<#HO+W=W=RYI96,N8V@              !9)14,@:'1T<#HO
M+W=W=RYI96,N8V@
M                9&5S8P         N245#(#8Q.38V+3(N,2!$969A=6QT
M(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="               N245#(#8Q.38V
M+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="
M                 &1E<V,         +%)E9F5R96YC92!6:65W:6YG($-O
M;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$              "Q2969E<F5N8V4@
M5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M,BXQ
M                  !V:65W       3I/X %%\N !#/%  #[<P !!,+  -<
MG@    %865H@      !,"58 4    %<?YVUE87,          0
M              */     G-I9R      0U)4(&-U<G8        $      4
M"@ / !0 &0 > ", *  M #( -P [ $  10!* $\ 5 !9 %X 8P!H &T <@!W
M 'P @0"& (L D "5 )H GP"D *D K@"R +< O #! ,8 RP#0 -4 VP#@ .4
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M(#Y@/J ^X#\A/V$_HC_B0"- 9$"F0.=!*4%J0:Q![D(P0G)"M4+W0SI#?4/
M1 -$1T2*1,Y%$D5519I%WD8B1F=&JT;P1S5'>T? 2 5(2TB12-=)'4EC2:E)
M\$HW2GU*Q$L,2U-+FDOB3"I,<DRZ30)-2DV33=Q.)4YN3K=/ $])3Y-/W5 G
M4'%0NU$&45!1FU'F4C%2?%+'4Q-37U.J4_940E2/5-M5*%5U5<)6#U9<5JE6
M]U=$5Y(
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M&24V6&>7H;3!T=?A&B<S-#4W0T1&1U565V5V>(&&IM;_Q  = 0$  00# 0
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M9J@5^;DA21K9B@,_<G!%>.UM#MVD:Z2$%4)XP<D-M^P<(+G(CBZ:JF,::M*
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MUQY?^B2O^'>_=JJEEMM'C=KA3[>Z0'X[TP#7O#5'^H=[_P"GY?\ VJJ^'7#
MXXZZ,/AQ"MG_ /715N3,FYO!>W]L@MEK(T!4EW2)UV40LJXDK"_03 P&78UR
M';2$XZ;E.7RS.$&!VY%#$(=4#& ->*+)IB_:B<4W9K7*G<A2EQQM'*PV5' #
MDASE903W!2P2=@,[5]D]9<2]"\/H[<C6&I;;9>V0I;$9]XNSI"4CTC'M\=+L
MU\ D J:86 2 2,UIH/5[V?\ KO2A(Y %OYH$^4_F2^!GY8F OG^6*_RAY8%'
MO$OH16[?;RN_Z.LZ_P B^NPCF\PB<VX[(3XW/D=1Z_)GNQSYSMUVK2O_ +8G
M!#M@V;W=0V3CSDV.X=CUQZO9=OGOP&2<;X(K=/#FY/"&?VBSK$F1:];SM42N
M'T6V<+,;%'('$"D7DJU*H,9Z/0.H/ED7>1Z*)U $A#F, AK!+UIJ_:=<2U>K
M7*@%9(;<=1EAT@9(:D(YF7" 1D(62-P0"#6[M&\1]#\0(RY.C]26V]I;2%OL
M1WN2;'2HX2J3 ?#4V.%$$ O1T ]Q-9RUT=9M49V_BB;&;')4ESNLL*M&M3QA
M)-ZA9H4\\VG7T-%+M%)*.7/%1$S'O&+1U*MU44Y9F=9HJ\5/'*)%7=@IL_AY
M<.(,03TZ-97,CI4TJ=&6F.N.EQ:5AIPI?<:*%D((RVL<_* H':O-/'_3_ 6Z
M+L;G%Z8U:+BZU):LUR97/8GNQHZVER8_:PXTEMUAMQYM79R6U<A=66BGG7S9
MGV35G:Y7<6.R[5'C>:IBUB=H3UC,,JO,2]F:LVAW 3+N::LWQU&C%VR!LU(W
M0CVJ#@!9H)BNX,IT6N96K)-YSJ\.M7$,(4U'6&4MM1EJ44=BAA2F@A2N;*DD
MJ4L$*42G S?@K:^%MLTB4\)EQ9.GUSWTR9[)DN2)=P;2@.^=O3&VY*W&FU-)
M0E24MMME(:2E)WW*$0#W'6&UM^M=\T[KMO\ M]!-/*V2H&MR2R1%V]>2%W-6
MAP@H(E3<)5N!:R<T#4YRF(#U1DFS*8I@.X+VF[<BL6DM1:E64V6U29B$JY5O
M@):C(5@DI5)>4VR%@#/(%E9[DDX!U]K;BKP^X=MI5J_4]NM+RT<[4%2G)5R=
M024A;=NAMR)I;4H%(>+ 9"MBL5I^'5^V@&< CZW(0)"IV"\-2W -R%[P+YAB
ME>&=]G;^N<%;&5[?8$Q.($UFG^1?7?(5>80^;?\ -BX1N?([O7"<^SFK30\L
M;@>7 @7J[<A."\;%< @'.,%'9]OTW'YK'+OTWK<K#6Z' V?T3'Q-DJNVIVDB
M+AS!E77BK0S;E[ ,X>5>:;QT^V; =0B8.U8\K4Z@B1-8YRB76$WO2VH=.+";
MS:I<%*CRH><1S1W%>#<ALK84K&Y2'.8=Z16ZM&<3] \062[I#5%KO*T(+CL1
MIXLW%A (!6_;9269S3840.T6P&U'U5J&]9^UC]9Y7\ZS+NYY'9GUP=QFY96M
M*W!?&6>-S#F)K2;@C1*5L=EI.0Z55T)!T<Z9VT,G8;)%NIU=L)GR4,B^-'(N
M7X-FRUTE79 <NV?6R-]R>G7V9JTH\J\]?9\/HUO9MYZ6^]3K%65MO+WY9EL&
M-<9W-$'N.H=M&D=VN6I:ZQE6#/&-,>NPKV*L<G2,9:#EY1M)2UD.4;*I SJ4
MX%ND[9QW?7X#/X?'K4C*]R!R[[$ D]/'.VWO]U2ZD\-UTVBP'R,:.S>I(^C*
MV^=1\IF"=!<J()#(>E3KZ=6]68X"N*?S;^3@5,8"L"H]J17,H="1W=3T\*JY
M$_JC;;I]=.X]140.\/HM;E^FFNZWD=/_ #G?[1!XN3<ST\S32:Q&8Z)5V@)K
MR$D_4@DDJOEBEHMD55[O&JUF&02A2JJR=1FH!&8=L6<G*LGX[_C3'*-ATZ#)
MV]PP=CG?P&X&:GKZ0/4_B^HIB&7:W%C$U?</B<D6QR;7(HQDHFQQD@D=*(R/
M5V:YC+-(B;=MGK.6A_.=&KLRAY!UQCI2%6=",$C_ ,_CM4@Y&XP>\>'R/W@5
MB[Q%S7SNF5>U 3%06^4L1K]P%,/E"-F!N*@B \% 2KBER(=H>8 ?MA =5M'"
MP?8<_'Z[ZI7ZN_C5:G:3:]YO4"VYX1Z5^U592@XVQ[&Y#N6X^]R<JZB*],L+
MAE2R6:,2M,E%)O)-6G1;&;C&<93(]LH^M]N7?N9!DM#PC>1C940%J)SS9Z;8
M&V^^=_NJ$$D#88QUR>\^'+C\??4X6+?"^;28"%BELI9TSW>KDV,R<O9"I*4"
MAU)=PV,151%"LRU.OLL1BNH44U"+VI94[<1 IT5#"<*"M1SN<$8QDX V_E4\
MB<Y[\YZ#K[\9Q\:XCQ1:";;:3MR;I!PDAGI1%,/J(GCRRD( _A I0Y_R:J:^
MT3\?[)JEWI\%?(5*UT>_WLS9U]DS?^?YS4.>NKWU6CU1\?F:P?UC.J,TZ>.(
MHB#H#>*GMQ^6D9%OCJ)E2@ZBZ?!,>UM+9(L,>'/KFT>[61CJY#N3(-IR;.J=
M=1>-A9=JI2D9/S/A5507;/.B;N9ZBSQ/=MU#,T9'J4-D8B$["13A9O+YGNE?
MD!%\R?I'L2+^O8IJ2B#H356&-79-1*/$I&M4@8D8U=W65X'*G;'>#U]NWB/;
MWGQ(JWR;Y)S\,?Q\=_N'<*ES<^&WZ;:\&I%),LY,Y [<R);,VRF0\VDJ*8$!
MXFV>5IW6_4E. K 56OJM?,,8HMA1'R@HYE?K'PZGZZ;544I(QC;P'3[NG7?I
MUWJ(O<9TQ=ZG1OM#C>!L,S':\D8KK8D<Y!AU8D@VJ&J+)4'2S3*M/C1-7,EX
M_*D"QI:Q1D=$/*T)U)@D/7BL LC>>;(P=_;GZ_$T((QRX&^?_ _Q%:>[5-R:
M6[WKI8$W&DKIZDXR=E2FR<I7!<%=HQ4Y&8E0@)]NP=@8QG$4,U$OU8A9QY;Q
M2,.U,\12="LF2Z?L0/:._P 3GP'B/&K0R7@?#/R/7/3K^'0#I_06FIJ*K<+*
M6&=D&D3!P48]F)F5D%TVK",BHQJJ]D9%ZY5$J3=HR:(+.7*ZIBII(I'.<P 4
M1U8J_5)S<[OGWL=:;<=-[/\ 8<,W2-MD>\51G9MH_?55*TU)J^)&O,CYCM2
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M<.G#B&#7G9_=YA>S$2:G<(16++?'Y>GGJ@")4F2$5C,]I<(.EU.U,OREZ!!
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MU&\T;1D5L/Y"J2UXI]5?.8A.J3[M>N7*C.&SA0CR*82*S-[RR;+&5$(268J
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M6JXE'E-9(X 8)YE_K*^\^SV^SY5'(G &!M[/;G^'6I7=I_3?V;[*TQ=8"PS
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M],QG;H4=FF\05N6^Y@ $)+DB*IL2BC.$":W)2@ !(2 ,:=%Z*^V<KH%AR%G
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M%B%5G\5S5:G6C4ZG*;)20K60)5&5*)"IBLY!O#I**$ 0CP  XK"\ #'3V_\
MBIW^MOYUD7$GA6:$TED)//N[6W7&/,J"[VNXMQY%T=XLIWB=0IKE:[!?A737
M,/"I@IS1SVB?M< <Q3)TDDDD;9]M1C?.<9'=X_$>X?#[K(NV#:/M]V<8Z;XO
MV\8ZB*#62JD=RJ[<SF1L5HE03%,\U;;-)K.INPR9RB8J2LB\508(&!C%MV,>
MD@T2BIK9'2E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI7__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g131567g26a01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g131567g26a01.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1X64&AO=&]S:&]P(#,N,  X0DE-! 0
M    '?J^=G0X0DE-! 0      %0< 5H  QLE1QP"   " _\< E  "')R,CDS
M-S0Y' (% #--:6-R;W-O9G0@5V]R9" M(#$S,34V-U]"<FED9V5":6\@+2 R
M,#(Q(%!R;WAY+F1O8W@X0DE-!"4      !#N/BV66]#)CT&\U:?*EX8=.$))
M300Z      #E    $     $       MP<FEN=$]U='!U=     4     4'-T
M4V)O;VP!     $EN=&5E;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I
M>'1E96Y":71B;V]L      MP<FEN=&5R3F%M951%6%0    !       /<')I
M;G10<F]O9E-E='5P3V)J8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P
M   *<')O;V93971U<     $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F
M    "7!R;V]F0TU92P X0DE-!#L      BT    0     0      $G!R:6YT
M3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O;VP      $-L8G)B;V]L
M  !29W--8F]O;       0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS
M8F]O;       3F=T=F)O;VP      $5M;$1B;V]L      !);G1R8F]O;
M    0F-K9T]B:F,    !        4D="0P    ,     4F0@(&1O=6) ;^
M          !'<FX@9&]U8D!OX            $)L("!D;W5B0&_@
M    0G)D5%5N=$8C4FQT                0FQD(%5N=$8C4FQT
M        4G-L=%5N=$8C4'AL0'+            *=F5C=&]R1&%T86)O;VP!
M     %!G4'-E;G5M     %!G4',     4&=00P    !,969T56YT1B-2;'0
M              !4;W @56YT1B-2;'0               !38VP@56YT1B-0
M<F- 60           !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E
M8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG          UC
M<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG       X
M0DE- ^T      ! #O_XU  (  @.__C4  @ ".$))300F       .
M     #^    X0DE-! T       0   !X.$))3009       $    'CA"24T#
M\P      "0           0 X0DE-)Q        H  0         ".$))30/T
M       2 #4    ! "T    &       !.$))30/W       <  #_________
M____________________ ^@  #A"24T$"       $     $   )    "0
M   X0DE-!!X       0     .$))300:      ,U    !@
M?P   )4          0                         !              "5
M    ?P                     !                         !     !
M        ;G5L;     (    &8F]U;F1S3V)J8P    $       !28W0Q
M!     !4;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG
M    ?P    !29VAT;&]N9P   )4    &<VQI8V5S5FQ,<P    %/8FIC
M 0      !7-L:6-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)
M1&QO;F<         !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U
M=&]'96YE<F%T960     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@
M    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M         $QE9G1L;VYG          !"=&]M;&]N9P   '\     4F=H=&QO
M;F<   "5     W5R;%1%6%0    !        ;G5L;%1%6%0    !
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M300H       ,     C_P        .$))3001       ! 0 X0DE-!!0
M  0    ".$))300,     !01     0   )4   !_   !P   WD   !/U !@
M ?_8_^T #$%D;V)E7T--  '_[@ .061O8F4 9(     !_]L A  ," @("0@,
M"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,# P,
M# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1# P,
M# P,$0P,# P,# P,# P,# P,# P,# P,# P,# P,# S_P  1" !_ )4# 2(
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M<>5KA_U)"K]=Z75TSK^7TNH
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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GH01;EGSN82.<3:238Z\LB6S-RT9O10B.MDFK<Z7XOB^+XOB^?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g131567g26b02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g131567g26b02.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2NT4&AO=&]S:&]P(#,N,  X0DE-! 0
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MEN=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O &8 ( !3 &4 = !U '
M    IP<F]O9E-E='5P     0    !";'1N96YU;0    QB=6EL=&EN4')O;V
M8    )<')O;V9#35E+ #A"24T$.P     "+0   !     !       2<')I;G
M1/=71P=71/<'1I;VYS    %P    !#<'1N8F]O;       0VQB<F)O;VP
M   %)G<TUB;V]L      !#<FY#8F]O;       0VYT0V)O;VP      $QB;'
M-B;V]L      !.9W1V8F]O;       16UL1&)O;VP      $EN=')B;V]L
M    !"8VMG3V)J8P    $       !21T)#     P    !29" @9&]U8D!OX
M           $=R;B!D;W5B0&_@            0FP@(&1O=6) ;^
M    !"<F1456YT1B-2;'0               !";&0@56YT1B-2;'0
M        !2<VQT56YT1B-0>&Q <L            IV96-T;W)$871A8F]O;
M$     4&=0<V5N=6T     4&=0<P    !09U!#     $QE9G15;G1&(U)L=
M               %1O<"!5;G1&(U)L=                %-C;"!5;G1&(U
M!R8T!9            $&-R;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P4F
M5C=$)O='1O;6QO;F<         #&-R;W!296-T3&5F=&QO;F<         #6
M-R;W!296-T4FEG:'1L;VYG          MC<F]P4F5C=%1O<&QO;F<      #
MA"24T#[0      $ $L     0 " 2P    !  (X0DE-!"8       X
M      /X   #A"24T$#0      !    '@X0DE-!!D       0    >.$))30
M/S       )           ! #A"24TG$       "@ !          (X0DE- _
M0      !( -0    $ +0    8       $X0DE- _<      !P  /________
M____________________\#Z   .$))300(       0     0   D    )
M   #A"24T$'@      !      X0DE-!!H      S4    &
M"#    A          !                          $              (
M0   "#                      $                         $
M$       !N=6QL     @    9B;W5N9'-/8FIC     0       %)C=#$
M $     %1O<"!L;VYG          !,969T;&]N9P          0G1O;6QO;F
M<   "#     %)G:'1L;VYG    A     9S;&EC97-6;$QS     4]B:F,
M !       %<VQI8V4    2    !W-L:6-E241L;VYG          =G<F]U<$
ME$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -87
M5T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54>7!E     $EM9R
M     &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M          3&5F=&QO;F<          $)T;VUL;VYG    @P    !29VAT;&
M]N9P   (0    #=7)L5$585     $       !N=6QL5$585     $
M!-<V=E5$585     $       9A;'1486=415A4     0      #F-E;&Q497
MAT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4     0      "6AO<GI!;&
MEG;F5N=6T    /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R=$
M%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L=     MB9T
M-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N90
MET;W!/=71S971L;VYG          IL969T3W5T<V5T;&]N9P         ,8F
M]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/=71S971L;VYG       X0D
ME-!"@       P    "/_         X0DE-!!$       $! #A"24T$%
M  !     (X0DE-! P     (:\    !    A    (,   &,  #*I   (9, &
M !_]C_X@Q824-#7U!23T9)3$4  0$   Q(3&EN;P(0  !M;G1R4D="(%A96B
M 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@<U)'0@
M  ]M8  0    #3+4A0("
M                       !%C<')T   !4    #-D97-C   !A    &QW='
M!T   !\    !1B:W!T   "!    !1R6%E:   "&    !1G6%E:   "+    !
M1B6%E:   "0    !1D;6YD   "5    '!D;61D   "Q    (AV=65D   #3
M   (9V:65W   #U    "1L=6UI   #^    !1M96%S   $#    "1T96-H
M $,     QR5%)#   $/   " QG5%)#   $/   " QB5%)#   $/   " QT97
MAT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L971T+5!A8VMA<F0@0V]M<&
M%N>0  9&5S8P         2<U)'0B!)14,V,3DV-BTR+C$              !
M)S4D="($E%0S8Q.38V+3(N,0
M                              6%E:(        /-1  $    !%LQ865
MH@                     %A96B        !OH@  ./4   .06%E:(
M   &*9  "WA0  &-I865H@        )*    ^$  "VSV1E<V,         %D
ME%0R!H='1P.B\O=W=W+FEE8RYC:               %DE%0R!H='1P.B\O=W
M=W+FEE8RYC:
M            !D97-C         "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D
M="(&-O;&]U<B!S<&%C92 M('-21T(              "Y)14,@-C$Y-C8M,B
MXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M              9&5S8P         L4F5F97)E;F-E(%9I97=I;F<@0V]N9&
MET:6]N(&EN($E%0S8Q.38V+3(N,0              +%)E9F5R96YC92!6:6
M5W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M               '9I97<      !.D_@ 47RX $,\4  /MS  $$PL  UR>
M   5A96B       $P)5@!0    5Q_G;65A<P         !
M           H\    "<VEG(     !#4E0@8W5R=@        0     !0 *
M\ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4 %D 7@!C &@ ;0!R '< ?
M"! (8 BP"0 )4 F@"? *0 J0"N +( MP"\ ,$ Q@#+ -  U0#; .  Y0#K /
M  ]@#[ 0$!!P$- 1,!&0$? 24!*P$R 3@!/@%% 4P!4@%9 6 !9P%N 74!?
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MP'_)C]*?VZ_DO^W/]M____[0 ,061O8F5?0TT  ?_N  Y!9&]B90!D@
M'_VP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,$0P,#
MP,# P,# P,# P,# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4% X.#@
MX4$0P,# P,$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,#/
M_  !$( (, A ,!(@ "$0$#$0'_W0 $  G_Q $_   !!0$! 0$! 0
M #  $"! 4&!P@)"@L!  $% 0$! 0$!          $  @,$!08'" D*"Q   0
M0! P($ @4'!@@% PPS 0 "$0,$(1(Q!4%181,B<8$R!A21H;%"(R054L%B,S
M1R@M%#
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MNR=O[\[]M>NY"Y\_R>XM21U1UI0JX'4'[#+S^NI<22-AK/=[C$BW6-B;$/\
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<ML"B#-M#CLMIQA*&F6T(1C&,)3C'UN_6?7__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g131567g26c03.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g131567g26c03.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[16D4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %8B^51(X0DE-! 0      %0< 5H  QLE1QP"   " _\< E  "')R,CDS
M-S0Y' (% #--:6-R;W-O9G0@5V]R9" M(#$S,34V-U]"<FED9V5":6\@+2 R
M,#(Q(%!R;WAY+F1O8W@X0DE-!"4      !#N/BV66]#)CT&\U:?*EX8=.$))
M300Z      #E    $     $       MP<FEN=$]U='!U=     4     4'-T
M4V)O;VP!     $EN=&5E;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I
M>'1E96Y":71B;V]L      MP<FEN=&5R3F%M951%6%0    !       /<')I
M;G10<F]O9E-E='5P3V)J8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P
M   *<')O;V93971U<     $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F
M    "7!R;V]F0TU92P X0DE-!#L      BT    0     0      $G!R:6YT
M3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O;VP      $-L8G)B;V]L
M  !29W--8F]O;       0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS
M8F]O;       3F=T=F)O;VP      $5M;$1B;V]L      !);G1R8F]O;
M    0F-K9T]B:F,    !        4D="0P    ,     4F0@(&1O=6) ;^
M          !'<FX@9&]U8D!OX            $)L("!D;W5B0&_@
M    0G)D5%5N=$8C4FQT                0FQD(%5N=$8C4FQT
M        4G-L=%5N=$8C4'AL0'+            *=F5C=&]R1&%T86)O;VP!
M     %!G4'-E;G5M     %!G4',     4&=00P    !,969T56YT1B-2;'0
M              !4;W @56YT1B-2;'0               !38VP@56YT1B-0
M<F- 60           !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E
M8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG          UC
M<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG       X
M0DE- ^T      ! #O_XU  (  @.__C4  @ ".$))300F       .
M     #^    X0DE-! T       0   !X.$))3009       $    'CA"24T#
M\P      "0           0 X0DE-)Q        H  0         ".$))30/T
M       2 #4    ! "T    &       !.$))30/W       <  #_________
M____________________ ^@  #A"24T$"       $     $   )    "0
M   X0DE-!!X       0     .$))300:      ,U    !@
M=@   '8          0                         !              !V
M    =@                     !                         !     !
M        ;G5L;     (    &8F]U;F1S3V)J8P    $       !28W0Q
M!     !4;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG
M    =@    !29VAT;&]N9P   '8    &<VQI8V5S5FQ,<P    %/8FIC
M 0      !7-L:6-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)
M1&QO;F<         !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U
M=&]'96YE<F%T960     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@
M    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M         $QE9G1L;VYG          !"=&]M;&]N9P   '8     4F=H=&QO
M;F<   !V     W5R;%1%6%0    !        ;G5L;%1%6%0    !
M37-G951%6%0    !       &86QT5&%G5$585     $       YC96QL5&5X
M=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$585     $       EH;W)Z06QI
M9VYE;G5M    #T53;&EC94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!
M;&EG;F5N=6T    /15-L:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#
M;VQO<E1Y<&5E;G5M    $453;&EC94)'0V]L;W)4>7!E     $YO;F4    )
M=&]P3W5T<V5T;&]N9P         *;&5F=$]U='-E=&QO;F<         #&)O
M='1O;4]U='-E=&QO;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))
M300H       ,     C_P        .$))3001       ! 0 X0DE-!!0
M  0    ".$))300,      N?     0   '8   !V   !9   I!@   N# !@
M ?_8_^T #$%D;V)E7T--  '_[@ .061O8F4 9(     !_]L A  ," @("0@,
M"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,# P,
M# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1# P,
M# P,$0P,# P,# P,# P,# P,# P,# P,# P,# P,# S_P  1" !V '8# 2(
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ME))))*4DDDDI22222E)))
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M   " @,!                "@@) @,&"__$ "T0   & @(!  D% 0
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KY7K3&WI-/45AU:TM;DJ7(Z[C1IK63'GN4)3T@EQI8U:Q$=E(8(@)Q'__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
